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  Shock	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  Proteoglycan	  IBP	   	   Insulin-­‐like	  Growth	  Factor-­‐binding	  Protein	  ICM	   	   Intermediate	  Cell	  Mass	  Id	   	   Inhibitor	  of	  Differentiation	  gene	  IHC	   	   Immunhistochemistry	  ILK	   	   Integrin-­‐like	  kinase	  IP3	   	   Inositol	  1,4,5-­‐trisphosphate	  irf8	   	   Interferon	  Regulatory	  Factor	  8	  JNK	   	   c-­‐Jun	  N-­‐terminal	  Kinases	  kb	   	   kilobase	  kDa	   	   kilodalton	  KI67	   	   Antigen	  KI-­‐67	  KOH	   	   Potassium	  Hydroxide	  LEF1/TCF	   Lymphoid	  enhancer-­‐binding	  factor	  1/T-­‐cell	  Factor	  lh	   	   Lateral	  hindbrain	  lmo2	   	   LIM	  domain	  only	  2	  LOF	   	   Loss	  of	  Function	  LRP	   	   Low	  density	  lipoprotein	  Receptor-­‐related	  Protein	  M.	  musculus	   Mus	  Musculus	  MAPK	   	   Mitogen-­‐activated	  protein	  kinase	  MBT	   	   Mid-­‐Blastula	  Transition	  mg	   	   Milligram	  MHC	   	   Myosin	  Heavy	  Chain	  ml	   	   Milliliter	  mM	   	   millimolar	  MO	   	   Morpholino	  mpx	   	   myeloid-­‐specific	  peroxidase	  MQ	   	   MilliQ	  MRF	   	   Myogenic	  Regulatory	  Factor	  mRNA	   	   Messenger	  Ribonucleic	  Acid	  Msx	   	   Msh	  homeobox	  Myf	   	   Myogenic	  Factor	  gene	  myoD	   	   Myogenic	  Differentiation	  gene	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n	   	   Notochord	  NDS	   	   Normal	  Donkey	  Serum	  NFAT	   	   Nuclear	  factor	  of	  activated	  T-­‐cells	  NGS	   	   Normal	  Goat	  Serum	  NHEJ	   	   Non-­‐homologuous	  End	  Joining	  nkx2.5	   	   NK2	  transcription	  factor	  related	  gene	  nl	   	   nanoliter	  NPM1	   	   Nucleophosmin	  O/N	   	   Overnight	  OA	   	   Osteoarthritis	  ORF	   	   Open	  Reading	  Frame	  P-­‐SMAD	  Phosporylated	  MAD	  homolog	  p300/CBp	   E1A	  binding	  protein/	  CREB-­‐binding	  protein	  Pax	   	   Paired	  Box	  gene	  PBI	   	   Posterior	  Blood	  Islands	  PBS	   	   Phosphate	  Buffered	  Saline	  PBST	   	   PBS	  +	  Tween20	  PCP	   	   Planar	  Cell	  Polarity	  PCR	   	   Polymerase	  Chain	  Reaction	  Pent	   	   Pentagone	  PFA	   	   Paraformaldehyde	  pg	   	   picogram	  PKC	   	   Protein	  Kinase	  C	  PLPM	   	   Posterior	  Lateral	  Plate	  Mesoderm	  pol	   	   viral	  polymerase	  gene	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  qPCR	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  C3	  botulinum	  toxin	  substrate	  1	  rag2	  	   	   Recombination	  activating	  gene	  2	  RBI	   	   Rostral	  Blood	  Islands	  RCASBP	  Replication	  Competent	  ALV	  LTR	  with	  a	  Splice	  acceptor	  (Bryan	  high-­‐titer	  	  	   Polymerase)	  RhoA	   	   Ras	  homolog	  gene	  family	  gene	  Rock1	   	   Rho-­‐associated,	  coiled-­‐coil-­‐containing	  protein	  kinase	  1	  rRNA	   	   Ribosomal	  Ribonucleic	  Acid	  runx1	   	   Runt-­‐related	  transcription	  factor	  1	  SEM	   	   Standard	  Error	  of	  Means	  SFRP	   	   secreted	  Frizzled-­‐related	  protein	  SHH	   	   Sonic	  Hegdehog	  SIP1	   	   Smad	  Interacting	  Protein	  1	  six3b	   	   Sine	  culis	  homeobox	  homolog	  3b	  slb	   	   Silberblick	  SMAD	   	   MAD	  homolog	  SMO	   	   Spemann-­‐Mangold	  Organizer	  SMOC	   	   SMOC	  domain	  smoc1/2	  	   Secreted	  Modular	  Calcium-­‐binding	  Protein	  1/2	  Smurf	   	   SMAD	  specific	  E3	  ubiquitin	  protein	  ligase	  snb	   	   Somitabun	  snh	   	   Snailhouse	  SP	   	   Signal	  peptide	  Sparc	   	   Secreted	  Protein	  Acidic	  and	  Rich	  in	  Cysteine	  spi1B	   	   spleen	  focus	  forming	  virus	  proviral	  integration	  oncogene	  SPOCK	   	   Sparc/Osteonectin,	  Cwcv	  and	  Kazal-­‐Like	  Domains	  Proteoglycan	  ss	   	   Somite	  Stage	  Stat	   	   signal	  transduction	  and	  activation	  of	  transcription	  swr	   	   swirl	  t	   	   Telencephalon	  T-­‐ALL	   	   T-­‐cell	  acute	  lymphoblastic	  leukemia	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tal1	   	   T-­‐cell	  acute	  lymphocytic	  leukemia	  1	  TALEN	   	   Transcription	  activator-­‐like	  effector	  nucleases	  TBX	   	   T-­‐box	  gene	  TCA	   	   Trichloroacetic	  acid	  TGFβ	   	   Transforming	  Growth	  Factor	  β	  TIGM	   	   Texas	  Institute	  for	  Genomic	  Medicine	  TILLING	   Targeting	  Induced	  Local	  Lesions	  in	  Genomes	  TMEFF	   	   Transmembrane	  protein	  with	  EGF-­‐like	  and	  two	  follistatin-­‐like	  domains	  TREAT-­‐OA	   Translational	  Research	  in	  Europe	  Applied	  Technologies	  forOsteoarthritis	  Tsg	   	   Twisted	  Gastrulation	  TY	   	   Thyroglobulin	  domain	  UA	   	   Umbilical	  artery	  UAS	   	   Upstream	  activation	  sequence	  UTR	   	   Untranslated	  Region	  VA	   	   Vitelline	  artery	  VDA	   	   Ventral	  Dorsal	  Aorta	  ved	   	   Ventrally	  expressed	  dharma/bozozok	  antagonist	  vent	   	   Ventral	  expressed	  homeobox	  vox	   	   Ventral	  homeobox	  vWC	   	   von	  Willebrand	  factor	  type	  C	  WIF	   	   Wnt	  Inhibitory	  Factor	  WISH	   	   Wholemount	  In-­‐Situ	  hybridization	  Wnt	   	   Wingless-­‐type	  MMTV	  integration	  site	  family	  X.	  laevis	  Xenopus	  laevis	  YSE	   	   Yolk	  Sac	  Extension	  ZFN	   	   Zinc-­‐finger	  nuclease	  ZPA	   	   Zone	  of	  Polarizing	  Activity	  μm	   	   Micrometer	  	  	  In	  this	  manuscript	  standard	  nomenclature	  guidelines	  were	  used:	  	  	   	   	   	   Gene/mRNA	   	   	   Protein	  
	  D.	  rerio	  	   	   	   smoc2	  	   	   	   	   Smoc2	  H.	  sapiens	  /	  G.	  gallus	   	   SMOC2	   	   	   	   SMOC2	  M.	  musculus	   	   	   Smoc2	   	   	   	   SMOC2	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1.1	  Background	  and	  rationale	  
	  How	  many	  times	  do	  we	  use	  our	  joints	  throughout	  the	  day?	  How	  many	  joints	  do	  we	  use	  while	  walking,	   typing,	   or	  working	  out?	  How	  many	   times	  do	  we	   stretch	  our	  neck,	  flex	  our	  knee,	  elbow	  or	  fingers?	  You	  only	  notice	  the	  importance	  of	  your	  joints	  when	  you	  suffer	  from	  an	  injury	  induced	  by	  sport,	  trauma	  or	  ageing.	  Joints	  can	  get	  damaged	  in	  many	  ways	  and	  the	  most	  common	  joint	  condition	  leading	  to	  chronic	   disability	   is	   osteoarthritis	   (OA).	   During	   OA	   the	   articular	   cartilage	   is	  progressively	   lost	   in	   combination	   with	   a	   mild	   chronic	   non-­‐specific	   joint	  inflammation,	   a	   thickening	   of	   the	   subchondral	   bone	   and	   the	   presence	   of	  osteophytes	  at	   the	   joint	  margins.	  This	  results	   in	   joint	  pain,	  swelling	  around	  the	  joint,	  inflammation,	  crepitus,	  and	  limited	  joint	  functionality	  with	  pain	  at	  the	  end	  of	  the	  range	  (Dal-­‐Pra	  et	  al.,	  2006).	  While	  some	  therapies	  are	  available,	  they	  focus	  on	  either	  drastic	   steps	   like	   the	  entire	   joint	   replacement	  or	  a	  host	  of	  pain	   relief	  therapies	   offering	   a	   “supervised	   neglect”	   to	   the	   patient	   instead	   of	   a	   control	   of	  disease	  progression	  or	  cure.	  Increasing	  evidence	  indicates	  that	  the	  onset	  and	  progression	  of	  a	  condition	  in	  the	  joint,	   like	   OA,	   is	   regulated	   by	   the	   same	   signaling	   pathways	   involved	   in	   the	  development	   of	   cartilage	   and	   bone	   (Lories,	   2008).	   Investigation	   of	   these	  pathways	  with	  all	  its	  ligands,	  receptors,	  positive	  and	  negative	  regulators	  and	  the	  interaction	  between	  all	  of	  these	  is	  crucial	  to	  understand	  the	  homeostasis	  and	  the	  associated	  disabling	  conditions	  of	  the	   joint.	  Therefore,	  a	  highly	  purified	  protein	  extract	   from	   bovine	   articular	   cartilage	   was	   analyzed	   by	   direct	   protein	  sequencing	   and	   assessed	   for	   its	   chondrogenic	   activity	   in	   an	   in-­‐vivo	   ectopic	  chrondrogenic	   assay.	   This	   screen	   resulted	   in	   the	   identification	   of	   several	  proteins	   including	   GDF5	   (Chang	   et	   al.,	   1994)	   and	   FRZB1	   (Hoang	   et	   al.,	   1996).	  Both	  proteins	  were	  already	  shown	  to	  be	  associated	  with	  joint	  development	  and	  joint	  disease	  (Lories	  and	  Luyten,	  2005;	  Lories	  et	  al.,	  2007).	  The	  third	  protein	  was	  identified	  as	  the	  extracellular	  protein	  SMOC2	  (Secreted	  Modular	  Calcium-­‐binding	  Protein	   2).	   Importantly,	   genetic	   analysis	   revealed	   a	   statistically	   significant	  association	  between	  SMOC2	  and	  hip	  OA	  in	  selected	  patient	  populations	  (TREAT-­‐OA;	   unpublished	   data).	   For	   SMOC2,	   no	   function	   in	   the	   developing	   joint	   or	   the	  damaged	  joint	  has	  been	  described.	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As	  embryonic	  pathways	  were	  shown	  to	  be	  reactivated	  during	  disease	  processes,	  the	  study	  of	  developmental	  pathways	  regulated	  by	  genes	  of	  interest	  is	  important	  for	   the	   understanding	   of	   the	   molecular	   basis	   of	   postnatal	   disease	   processes	  (Lappin	  et	  al.,	  2002;	  Lees	  et	  al.,	  2005;	  Roxburgh	  et	  al.,	  2006).	  The	  conservation	  of	  signaling	  events	  across	  species	  and	  organs	  permits	  us	  to	  study	  some	  mechanistic	  aspects	   of	   a	   disease	   using	   developmental	   models.	   The	   advantage	   of	   the	  developmental	   over	   the	   clinical	  models	   in	   unraveling	   the	  molecular	   basis	   of	   a	  disease	  lies	  in	  the	  speed	  (much	  faster),	  the	  cost	  (significantly	  lower),	  the	  ethical	  issues	   (no	   human	   subjects	   or	   postnatal	   animal	   models)	   and	   the	   possibility	   to	  carry	  out	  complex	  genetic	  experiments,	  to	  mention	  a	  few.	  Arthritic	  diseases	  and	  disorders,	  such	  as	  OA,	  could	  be	  at	  least	  partially	  associated	  by	  such	  a	  reactivation	  of	  the	  developmental	  program	  (Luyten	  et	  al.,	  2006;	  Lories,	  2008).	  Therefore,	  we	  used	  developing	  zebrafish,	  chicken	  and	  mice	  embryos	  to	  model	  the	  network	  of	  a	  newly	  identified	  OA	  associated	  gene	  and	  its	  connection	  with	  the	  disease	  process.	  	  
1.2	  SMOC2,	  an	  extracellular	  matrix	  protein	  	  
1.2.1	  Extracellular	  matrix	  One	   of	   the	   factors	   that	   allows	   for	   the	   transition	   from	   a	   single	   cell	   to	   a	  multicellular	  organism	  was	  the	  emergence	  of	  secreted	  structural	  proteins.	  They	  created	  an	  environment	  where	  many	  cells	  could	  stay	  for	  an	  extended	  period	  of	  time	   in	  physical	   proximity.	   This	  permitted	   for	   cell-­‐cell	   communication,	   cellular	  differentiation	  and	  eventually	  the	  formation	  of	  complex	  multicellular	  organisms.	  The	  structural	  function	  of	  the	  ECM	  is	  at	  the	  level	  of	  cells	  (formation	  of	  a	  micro-­‐environment),	   organs	   (shape	   and	   boundaries)	   or	   organisms	   (tissue	   elasticity,	  shock	   absorption).	   The	   composition	   of	   the	   extracellular	   matrix	   is	   complex,	  organism-­‐,	   organ-­‐	   and	   time-­‐dependent	   and	   may	   include	   proteoglycans	   and	  fibrous	   proteins	   like	   collagens,	   fibronectin,	   elastins,	   laminins	   and	  many	   others	  (Frantz	   et	   al.,	   2010).	   Proteoglycans	   are	   secreted	   glycoproteins	   containing	  hydrophilic	  glycosaminoglycans	  (GAGs)	  that	  can	  absorb	  many	  water	  molecules,	  leading	  to	  the	  swelling	  of	  the	  proteins	  into	  a	  gel-­‐like	  structure.	  They	  are	  essential	  for	   shock	   absorption	   (e.g.	   knee	   cartilage).	   The	   fibrous	   proteins	   are	   structural	  elements,	   which	   contribute	   to	   the	   elasticity	   of	   the	   tissue	   and	   regulate	   cell	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migration	   by	   modulating	   cell	   interaction	   and	   adhesion.	   Additionally,	   the	   ECM	  participates	  in	  signaling	  processes	  by	  regulating	  the	  distribution	  of	  morphogens,	  the	   storage	   of	   ligands	   and	   interacting	   directly	   with	   secreted	   ligands	   and	   their	  receptors	  (Frantz	  et	  al.,	  2010).	  	  
1.2.2	  Matricellular	  proteins	  Only	   in	   the	   past	   two	   decades,	   the	   matrix	   surrounding	   the	   cells	   has	   been	  recognized	   as	  more	   than	   just	   a	   structural	  mesh	   holding	   cells	   together.	  Next	   to	  proteoglycans	  and	  fibrous	  proteins,	  the	  ECM	  harbors	  matricellular	  proteins	  that	  do	   not	   contribute	   to	   the	   structural	   aspect	   of	   the	   matrix.	   These	   proteins	   are	  defined	   as	   secreted	   proteins	   that	   regulate	   the	   interaction	   of	   the	   cells	  with	   the	  structural	   components,	   secreted	   growth	   factors,	   proteases,	   hormones,	   or	  cytokines	  among	  others	   (Bornstein	  and	  Sage,	  2002).	  As	   the	   composition	  of	   the	  ECM	  is	  tissue	  dependent,	  the	  function	  of	  matricellular	  proteins	  differs	  depending	  on	  the	  type	  of	  tissue	  and	  the	  specific	  micro-­‐environment.	  A	   secreted	   protein	   must	   meet	   several	   conditions	   to	   qualify	   as	   matricellular	  protein,	   including:	   a)	   high	   expression	   levels	   during	   development	   and	   upon	  injury;	   b)	   binding	   to	   many	   cell	   surface	   receptors,	   ECM	   components,	   growth	  factors,	  cytokines	  or	  proteases;	  c)	  de-­‐adhesive	  properties;	  d)	  no	  structural	  role;	  and	  e)	  a	  discrete	  phenotype	  when	  targeted	  for	  gene	  disruption	  in	  mouse	  models	  (Bornstein,	  2009).	  The	  prototypical	  matricellular	  proteins	  are	  SPARC,	  tenascin-­‐C	  and	   thrombospondin-­‐1,	   but	   close	   family	   members	   and	   thrombospondin-­‐2,	  osteopontin,	  CCN,	  and	  tenascin-­‐X	  have	  been	  added	  to	  this	  family	  over	  the	  years	  (Bornstein,	  2000;	  Bornstein	  and	  Sage,	  2002;	  Bornstein,	  2009).	  	  	  
1.2.3	  SPARC	  	  The	  SPARC	  family	  of	  matricellular	  proteins	  includes	  SPARC/BM-­‐40/osteonectin,	  hevin,	  SMOC	  proteins	  SMOC1	  and	  SMOC2,	  testican1,	  2	  and	  3	  (SPOCK)	  and	  Fstl-­‐1	  (Fig	  1.1)	  (Bradshaw,	  2012).	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Figure	  1.1:	  Domain	  organization	  of	  the	  SPARC	  family	  of	  matricellular	  proteins	  The	  Follistatin-­‐like	  domain	  (FS),	  the	  Extracellular	  Calcium	  binding	  domain	  (EC),	  the	  Thyroglobulin	  domain	  (TY),	  the	  domain	  with	  a	  high	  similarity	  to	  the	  von	  Willebrand	  factor	  type	  C	  (vWC),	  the	  Signal	  peptide	  (SP)	  and	  the	  Smoc	  domain	  (SMOC).	  All	  members	  of	  the	  family	  contain	  the	  FS	  and	  the	  EC	  domain.	  (Adapted	  from	  (Vannahme	  et	  al.,	  2003)	  	  All	   members	   contain	   a	   common	   domain	   organization	   with	   an	   Extracellular	  calcium-­‐binding	  domain	  (EC	  domain)	  and	  a	  Follistatin-­‐like	  domain	  (FS	  domain).	  SPARC	  additionally	  contained	  an	  N-­‐terminal	  acidic	  region,	  which	  was	  shown	  to	  interact	  with	  Ca2+	  ions	  and	  hydroxiapatite.	  	  SPARC	   is	  widely	  expressed	  during	  embryonic	  development	   in	  mice,	  but	   loss	  of	  SPARC	  only	  results	  in	  mild,	  non-­‐lethal	  phenotypes	  such	  as	  early	  onset	  of	  cataract,	  increased	  adipogenesis,	  osteopenia	  and	  lax	  skin	  to	  mention	  a	  few	  (Delany	  et	  al.,	  2000;	  Bradshaw	  and	  Sage,	  2001;	  Brekken	  and	  Sage,	  2001;	  Bradshaw	  et	  al.,	  2002;	  Bradshaw,	   2009).	   As	   these	   defects	  were	   suggestive	   of	   a	   defective	   extracellular	  matrix,	  it	  was	  shown	  that	  many	  of	  these	  defects	  could	  be	  attributed	  to	  the	  altered	  synthesis/assembly	   of	   major	   structural	   basal	   lamina	   components	   like	   fibrillar	  collagen.	  Next	   to	   the	   role	   in	   ECM	   assembly,	   SPARC	  was	   shown	   to	   regulate	   the	  activity	   of	   matrix	   metalloproteinases	   and	   to	   modulate	   different	   signaling	  pathways	  by	  interfering	  with	  the	  ligand-­‐receptor	  interaction	  of	  the	  PDGF,	  VEGF,	  bFGF	  and	  TGFβ1	  signaling	  (Tremble	  et	  al.,	  1993;	  Gilles	  et	  al.,	  1998;	  Brekken	  and	  Sage,	   2001;	   Nischt	   et	   al.,	   2001;	   Wakefield	   and	   Roberts,	   2002;	   McClung	   et	   al.,	  2007).	  Recently,	  Sparc	  was	  shown	  to	  be	  downstream	  of	  Fgf21	  and	  to	  specifically	  mediate	   the	   development	   of	   erythroid	   progenitor	   cells	   during	   the	   primitive	  hematopoiesis	  in	  zebrafish	  embryos	  (Ceinos	  et	  al.,	  2013).	  	  	  
1.2.4	  SMOC2	  SMOC2,	   discovered	   independently	   in	   several	   laboratories	   including	   ours,	   was	  characterized	   as	   a	   secreted	   modular	   protein	   with	   high	   expression	   levels	  throughout	  development	  in	  many	  different	  tissues	  (Vannahme	  et	  al.,	  2003;	  Maier	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et	   al.,	   2008).	   In	   mice,	   the	   onset	   of	   Smoc2	   expression	   was	   reported	   in	   the	  Reichert’s	  membrane	  at	  E8.5.	  At	  E12.5	  Smoc2	  transcripts	  could	  also	  be	  detected	  in	   the	   face	  prominences,	   limbs	  and	  somites	  and	  at	  E14.5	  additional	   expression	  was	  detected	  in	  the	  heart,	   lungs	  and	  kidneys	  (Maier	  et	  al.,	  2008).	  In	  adult	  mice,	  SMOC2	   was	   detected	   in	   the	   spleen,	   thymus,	   ovaries,	   cartilage,	   muscle,	  hippocampus	   and	   skin.	   Although	   some	   reports	   indicated	   a	   similar	   expression	  pattern	   of	   Smoc1	   and	   Smoc2,	   other	   studies	   reported	   on	   a	   more	   mutually	  exclusive	  expression	  pattern	  of	  Smoc1	  and	  Smoc2	  in	  the	  brain	  and	  gonads	  (Pazin	  and	  Albrecht,	  2009;	  Okada	  et	  al.,	  2011;	  Rainger	  et	  al.,	  2011).	  Nevertheless,	  Smoc1	  expression	   was	   shown	   to	   be	   restricted	   to	   the	   basement	   membranes,	   whereas	  
Smoc2	  was	  predominantly	  found	  in	  the	  non-­‐basement	  membranes	  (Vannahme	  et	  al.,	  2002;	  Vannahme	  et	  al.,	  2003;	  Maier	  et	  al.,	  2008).	  Just	  like	  other	  members	  of	  the	  SPARC	   family,	  SMOC2	  contains	  a	  FS	  and	  an	  EC	  domain.	   In	  addition,	  SMOC1	  and	   SMOC2	   proteins	   have	   an	   extra	   putative	   SMOC	   domain,	   flanked	   by	   two	  thyroglobulin	  domains	  (TY)	  that	  separate	  the	  FS	  and	  the	  EC	  domain	  (Fig	  1.1).	  	  The	  SMOC2	  EC	  domain	  consists	  of	  2	  EF-­‐hand	  motifs	  that	  are	  able	  to	  interact	  with	  Ca2+	   ions	   changing	   the	   conformation	   of	   the	   protein	   as	   shown	   by	   circular	  dichroism	   spectroscopy	   (Vannahme	   et	   al.,	   2003).	   The	   FS	   domain	   is	   present	   in	  proteins	  like	  Follistatin,	  TMEFF1	  and	  TMEFF2	  among	  others	  and	  consists	  of	  a	  N-­‐terminal	  EGF	  like	  domain	  and	  a	  C-­‐terminal	  Kazal	  domain	  (Esch	  et	  al.,	  1987;	  Eib	  and	  Martens,	   1996;	   Hohenester	   et	   al.,	   1997;	   Horie	   et	   al.,	   2000).	   In	   contrast	   to	  SPARC,	  the	  FS	  domain	  of	  SMOC2	  only	  contains	  the	  C-­‐terminal	  part	  (Vannahme	  et	  al.,	   2003).	   Kazal	   domains	   were	   described	   to	   inhibit	   the	   activity	   of	   multiple	  proteinases	  such	  as	  trypsin	  and	  elastase	  by	  directly	  interacting	  with	  the	  enzyme.	  Although	   similar	   to	   the	   Kazal	   proteinase	   inhibitors,	   no	   FS	   domains	   have	   been	  shown	   to	   inhibit	   proteinase	   activity.	   The	   TY	   domains	   are	   mainly	   present	   in	  SPARC	   family	   members	   (testicans	   and	   SMOC	   proteins),	   different	   cell	   surface	  antigens	  and	   insulin-­‐like	  growth	   factor-­‐binding	  protein	  (IBP)	  (Vannahme	  et	  al.,	  2003;	  Sala	  et	  al.,	  2005).	  The	  domain	  is	  assumed	  to	  be	  involved	  in	  the	  proteolytic	  degradation	   of	   the	   protein	   although	   other	   functions	   like	   modulating	   the	  interaction	  with	  binding	  partners,	  or	  influencing	  the	  conformation	  of	  the	  protein,	  have	   been	   suggested	   as	  well	   (Molina	   et	   al.,	   1996).	   Finally,	   the	   60	   amino	   acids	  long	   SMOC	   domain	   is	   a	   specific	   domain	   for	   the	   SMOC1	   and	   SMOC2	   proteins.	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Computer	   modeling	   suggests	   that	   this	   peptide	   folds	   into	   a	   random	   coil	  separating	   the	   two	   TY	   domains.	   No	   similarity	   has	   been	   found	   between	   this	  putative	  domain	  and	  any	  other	  known	  protein	  or	  peptide.	  	  In	  all	  SPARC	  family	  members,	  except	   for	   the	  SMOC	  subfamily,	   the	  FS	  domain	   is	  immediately	  followed	  by	  the	  EC	  domain	  (Vannahme	  et	  al.,	  2002;	  Vannahme	  et	  al.,	  2003).	  In	  SPARC	  an	  interaction	  was	  described	  between	  the	  FS	  and	  the	  EC	  domain	  that	   resulted	   in	   a	   stabilized	   Ca2+	   affinity	   (Hohenester	   et	   al.,	   1997;	  Busch	   et	   al.,	  2000).	   In	   the	   SMOC	   proteins	   however,	   a	   TY-­‐SMOC-­‐TY	  module	   is	   inserted	   that	  separates	  the	  FS	  and	  EC	  domain	  by	  more	  than	  220	  amino	  acids.	  Furthermore,	  the	  FS-­‐EC	   interaction	  was	   shown	   to	   involve	   the	  β5	   sheet	  and	   its	  preceding	   loop	  of	  the	   FS	  domain	   and	   the	  proline-­‐rich	   loop	   (helix	  E)	   connecting	   the	   two	  EF-­‐hand	  motifs	  of	   the	  EC	  domain.	   In	  SMOC	  proteins,	   this	  β5	  sheet	  of	   the	  FS	  domain	  and	  the	  helix	  E	  of	  the	  EC	  domain	  are	  preserved,	  whereas	  the	   loop	  preceding	  the	  β5	  sheet	  is	  not	  (Vannahme	  et	  al.,	  2003).	  The	  effect	  of	  the	  insertion	  of	  the	  TY-­‐SMOC-­‐TY	  module	  and	  the	  loss	  of	  the	  β5	  sheet-­‐preceding	  loop	  on	  the	  interaction	  of	  the	  FS	  and	  EC	  domain	  is	  unknown.	  	  Despite	   many	   studies	   performed	   on	   SMOC2,	   its	   molecular	   function	   and	  mechanism	   of	   action	   is	   not	   clear.	   It	   has	   been	   shown	   that,	   in	   endothelial	   cells,	  SMOC2	   stimulates	   mitogenesis	   and	   potentiates	   angiogenic	   activity	   induced	   by	  growth	  factors	  like	  bFGF	  and	  VEGF	  (Rocnik	  et	  al.,	  2006).	  In	  addition,	  SMOC2	  was	  shown	  to	  be	  upregulated	  in	  tubulating	  endothelial	  cells	  and	  therefore	  suggested	  to	  play	  a	  role	  in	  the	  angiogenic	  switch	  in	  tumors.	  In	  human	  keratinocytes,	  SMOC2	  was	   shown	   to	   interact	   with	   Integrin	   α5β1	   and	   α5β6	   and	   to	   promote	   their	  migration	   (Maier	   et	   al.,	   2008).	   Furthermore,	   SMOC2	   was	   shown	   to	   be	  downstream	  of	  BMP	  signaling	  in	  C2C12	  myoblasts	  and	  downstream	  of	  Hedgehog	  signaling	   in	   mouse	   testis,	   mesonephros	   and	   kidney	   (Korchynskyi	   et	   al.,	   2003;	  Pazin	  and	  Albrecht,	  2009).	   SMOC2	  was	  also	   shown	   to	  be	   important	   for	   serum-­‐induced	   entry	   into	   the	   S	  phase	  of	   the	   cell	   cycle	   and	   the	   growth	   factor	   induced	  DNA	  synthesis	  (Liu	  et	  al.,	  2008).	  This	  appears	  to	  be	  mediated	  via	  the	  induction	  of	  cyclin	  D1,	  which	   is	  dependent	  on	   integrin-­‐linked	  kinase	  activity.	   Just	   as	   the	  EC	  domain	   of	   SPARC,	   the	   EC	   domain	   of	   SMOC2	  mediates	   the	   conformation	   of	   the	  protein	   by	   binding	   to	   Ca2+	   ions	   (Vannahme	   et	   al.,	   2003).	   Furthermore,	   SMOC2	  was	   reported	   to	   interact	  with	  CRP	  and	  vitronectin	   (Novinec	  et	  al.,	  2008).	  Next,	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SMOC2	   also	  appeared	   to	  be	  associated	  with	  vitiligo,	  although	   this	  depended	  on	  the	  population	  investigated	  (Alkhateeb	  et	  al.,	  2010;	  Birlea	  et	  al.,	  2010;	  Alkhateeb	  et	  al.,	  2013).	  Finally,	  SMOC2	  was	  reported	  to	  be	  associated	  with	  craniofacial	  and	  dental	  defects	  that	  could	  be	  phenocopied	  in	  the	  zebrafish	  by	  using	  smoc2	  specific	  morpholinos	  (Bloch-­‐Zupan	  et	  al.,	  2011;	  Melvin	  et	  al.,	  2013).	  Recent	   studies	   have	   shown	   that	   the	   SMOC2	   candidate	   orthologue	   in	   D.	  melanogaster,	  pentagone	  (pent),	  regulates	  the	  life	  span	  and	  the	  fecundity	  of	  the	  fly	   and	   regulates	   the	   generation	   of	   a	   BMP	   signaling	   gradient	   (Li	   and	   Tower,	  2009).	   Mechanistically,	   Pent	   interacts	   with	   Dally,	   a	   heparan	   sulphate	  proteoglycan	  and	  also	  a	  binding	  partner	  of	  Dpp,	  a	  BMP	  orthologue.	  By	  doing	  so,	  Pent	  was	  suggested	  to	  either	  promote	  the	  distribution	  of	  Dpp,	  or	  antagonize	  the	  co-­‐receptor	   function	   of	   Dally	   or	   to	   regulate	   the	   interaction	   of	   Dpp	   and	   Dally	  (Vuilleumier	  et	  al.,	  2010;	  Vuilleumier	  et	  al.,	  2011).	  	  
1.3	  Gastrulation	  
	  
1.3.1	  Introduction	  	  After	  fertilization,	  cells	  undergo	  rapid	  mitotic	  divisions	  resulting	  in	  the	  formation	  of	   number	   of	   blastomers.	   Once	   the	   rate	   of	   cell	   division	   slows	   down,	   these	  blastomers	  undergo	  intense	  migration	  and	  change	  their	  relative	  position	  during	  the	  process	  of	  gastrulation	  (Greek	  gaster:	  stomach,	  gut).	  As	  a	  result,	  the	  embryo	  becomes	   organized	   into	   three	   germ	   layers	   (endoderm,	   ectoderm	   and	  mesoderm),	   from	   which	   all	   further	   structures	   and	   organs	   develop.	   The	  endoderm	   gives	   rise	   to	   epithelial	   tissues	   of	   the	   gut,	   the	   ectoderm	   to	   skin	   and	  neural	  tissue	  and	  mesoderm	  to	  muscles,	  connective	  tissues,	  organs	  and	  gonads.	  This	   process	   requires	   coordinated	   changes	   in	   cell	   shape,	   movements	   and	  adhesion.	   The	   subsequent	   directional	   migration	   of	   cells	   of	   the	   different	   germ	  layers	   results	   in	   the	   establishment	   of	   the	   primary	   body	   axes.	   Although	  gastrulation	   is	   a	   universal	   process	   and	   most	   of	   the	   cellular	   processes	   are	  common,	  the	  regulation	  of	  the	  process	  differs	  widely	  across	  species.	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1.3.2	  Zebrafish	  gastrulation	  	  A	   fertilized	   oocyte	   undergoes	   discoidal	   meroblastic	   cleavages	   leading	   to	   the	  formation	   of	   a	   number	   of	   blastomeres	   on	   one	   side	   of	   the	   yolk	   (Fig	   1.2A).	  Cleavage	  continues	  until	  around	  the	  tenth	  cell	  division	  (Kane	  and	  Kimmel,	  1993;	  Langdon	   and	   Mullins,	   2011),	   the	   mid-­‐blastula	   transition	   (MBT),	   when	   zygotic	  transcription	   starts,	   cell	   cycle	   slows	   down	   and	   cell	   motility	   increases.	   At	   this	  stage	   the	   embryo	   forms	   a	   blastula	   and	   three	   different	   cell	   types	   can	   be	  distinguished:	   the	   cells	   located	   closest	   to	   and	   fused	   with	   the	   yolk	   (the	   yolk	  syncytial	   layer),	   the	  most	   superficial	   epithelial	   cells	   (the	   enveloping	   layer)	   and	  the	  blastomeres	   in	  between	  (the	  deep	  cells)	  (Fig	  1.2B).	  At	  5	  hpf,	  gastrulation	  is	  initiated	   with	   the	   migration	   of	   the	   blastoderm	   towards	   the	   vegetal	   pole	  (epiboly).	  Radial	   intercalation	  by	  changes	   in	  cell	  shape,	  microtubule	   length	  and	  actin	  distribution	  was	   suggested	   to	  be	   the	  driving	   force	   resulting	   in	   a	   thinning	  blastoderm	  stretching	  over	  the	  yolk	  surface	  (Fig	  1.2C).	  Around	  6	  hpf,	  when	  half	  of	   the	   yolk	   is	   covered	  with	   cells,	   the	   epiblast	   at	   the	   edges	   of	   the	   cellular	   front	  starts	   migrating	   inwards	   and	   upwards	   back	   towards	   the	   animal	   pole	  (involution).	  This	  results	  in	  a	  thickening	  along	  the	  ridge	  of	  the	  cellular	  layer,	  the	  germ	   ring,	   which	   consists	   of	   an	   epiblastic	   ectodermal	   layer	   and	   internal	  hypoblastic	   mesendodermal	   cells	   (Fig	   1.2D)	   (Langdon	   and	   Mullins,	   2011;	  Solnica-­‐Krezel	  and	  Sepich,	  2012).	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Figure	  1.2:	  Cell	  migration	  during	  early	  zebrafish	  development	  A-­‐F.	   Schematic	   representation	   of	   different	   embryonic	   stages	   of	   zebrafish	   development:	   8	   cell	   stage	   (A),	  blastula	   stage	   (B-­‐C:	   lateral	   view)	   and	   gastrula	   stage	   (D-­‐E:	   lateral	   view	   and	   F:	   dorsal	   view).	   Initially,	   cells	  accumulate	  on	  top	  of	  the	  yolk	  (A).	  Later,	  these	  cells	  spread	  out	  over	  the	  surface	  of	  the	  yolk	  (epiboly:	  purple	  arrows)	  and	  become	  organized	  in	  three	  cell	   layers:	   the	  enveloping	   layer	  (purple),	   the	  deep	  cells	  (orange),	  and	  the	  yolk	  syncytial	   layer	  (turquiose)	  (B).	  When	  the	  cells	  have	  covered	  50%	  of	  the	  yolk,	   involuting	  cells	  (red	  arrows	  in	  C)	  at	  the	  cellular	  front	  develop	  a	  ring	  of	  mesodermal	  tissue	  (germ	  ring:	  orange	  in	  D-­‐F).	  At	  the	  dorsal	   side,	   mesodermal	   cells	   start	   accumulating	   (red	   arrows)	   to	   form	   the	   shield	   and	   hence	   the	   dorso-­‐ventral	   axis	   (D).	   Subsequently,	   the	   mesodermal	   cells	   organize	   themselves	   in	   axial,	   adaxial	   and	   paraxial	  mesoderm	  by	  converging	  towards	  the	  dorsal	  side	  and	  extending	  towards	  the	  animal	  pole	  (convergence	  and	  extension).	   This	   also	   results	   in	   the	   formation	   of	   the	   anterior-­‐posterior	   axis	   (E-­‐F:	   orange,	   blue	   and	   green	  arrow).	  Based	  on	  (Gilbert,	  2006;	  Slack,	  2013).	  	  At	  the	  same	  time,	  the	  epiblastic	  and	  hypoblastic	  cells	  start	  to	  develop	  a	  localized	  thickening	   on	   the	   future	   dorsal	   side	   of	   the	   embryo	   (convergence).	   This	  temporary	   structure	   is	   called	   the	   embryonic	   organizer	   or	   shield	   and	   is	   the	  hallmark	   of	   the	   establishment	   of	   the	   dorso-­‐ventral	   axis	   (Fig	   1.2E).	   From	   the	  shield	   and	   while	   epiboly	   continues,	   cells	   migrate	   towards	   the	   animal	   pole	  (extension)	   thereby	   establishing	   the	   anterior-­‐posterior	   axis	   (Fig	   1.2F).	   Cells	  located	   adjacent	   to	   the	   shield	   will	   also	   migrate	   towards	   the	   dorsal	   side	   and	  follow	  the	  extension	  along	  the	  newly	  formed	  anterior-­‐posterior	  axis.	  During	  the	  convergence	   and	   extension	   process,	   the	   mesendodermal	   progenitors	   undergo	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medio-­‐lateral	  elongation	  and	  intercalation,	  and/or	  directed	  migration	  dependent	  on	  their	  dorso-­‐ventral	  location.	  As	  a	  result,	  by	  the	  end	  of	  gastrulation	  all	  cells	  are	  repositioned	   to	   the	   proper	   location	   along	   the	   anterior-­‐posterior	   and	   dorso-­‐ventral	   axis.	  During	   the	   following	  developmental	   stages,	   the	   embryo	  will	   grow	  further,	  as	  tissues	  develop	  and	  organs	  mature.	  Although	  cells	  continue	  extensive	  migration	   and	   their	   fate	   is	   not	   fully	   determined,	   lineage-­‐tracing	   experiments	  have	  shown	  what	   tissues	  can	  develop	   from	  each	  segment	  of	   this	  early	  gastrula	  embryo	  (Fig	  1.3)	  (Gilbert,	  2006;	  Slack,	  2013).	  	  
	  
Figure	  1.3:	  Fate	  map	  of	  the	  early	  zebrafish	  gastrula	  Lateral	   view,	   dorsal	   to	   the	   right.	   Ectoderm,	  mesoderm	   and	   endoderm	   are	   indicated	   in	   blue,	   orange	   and	  green	  respectively.	  Not	  all	  organ	  fates	  are	  indicated.	  Adapted	  from	  (Gilbert,	  2006;	  Kimelman,	  2006).	  	  When	  comparing	   the	  overall	  processes	   involved	  during	  vertebrate	  gastrulation	  across	  species,	  the	  same	  principle	  applies:	  cells	  organize	  themselves	  to	  form	  the	  blueprint	   of	   the	   future	  body	  plan.	  When	   comparing	   the	   early	   and	   late	   gastrula	  embryos	   of	   animal	  models	   like	  D.	   rerio,	   X.	   laevis,	   G.	   gallus	   and	  M.	  musculus,	   a	  great	   similarity	   in	   tissue	   organization	   is	   apparent,	   despite	   the	   difference	   in	  morphology	  (Fig	  1.4).	  All	   these	  embryos	  develop	  three	  germ	  layers,	   three	  body	  axes,	   (pre-­‐)	   specified	   cell	   populations,	   and	   an	   equivalent	   of	   the	   Spemann-­‐Mangold	  Organizer	  (SMO).	  These	  structures	  and	  cell	  populations	  are	  the	  result	  of	  conserved	   changes	   at	   the	   cellular	   level	  where	   cells	   undergo	   changes	   in	   shape,	  direction,	   adhesion	   and	  migration	   properties.	   Although	   in	   general	   the	   cellular	  changes	   are	   similar	   in	   all	   of	   these	   organisms,	   the	   regulation	   and	   the	   timing	   is	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species	  dependent.	  This	  results	  in	  the	  different	  morphology	  that	  can	  already	  be	  seen	  at	  these	  early	  stages	  of	  development	  (Fig	  1.4).	  	  	  
	  
Figure	  1.4:	  Comparison	  of	  gastrula	  stage	  embryos	  As	  gastrulation	  starts,	  each	  of	  the	  embryos	  has	  a	  group	  of	  cells	  functioning	  as	  an	  equivalent	  of	  the	  Spemann-­‐Mangold	   organizer	   (SMO).	   By	   the	   end	   of	   gastrulation,	   the	   three	   germ	   layers	   have	   formed	   and	  migrated	  relatively	   to	   each	   other	   resulting	   in	   an	   internal	   endodermal	   layer	   (yellow),	   an	   external	   ectodermal	   layer	  (blue)	  and	  the	  mesodermal	  layer	  in	  between	  (red).	  Adapted	  from	  (Gilbert,	  2006)	  	  The	  most	  obvious	  difference	   is	   the	  ex	  utero	  development	  of	   the	  zebrafish,	   frog	  and	  chicken	  embryos	  while	  mouse	  embryos	  develop	  in	  utero.	  Furthermore,	  the	  cleavage	  pattern	  of	  the	  embryos	  differs	  greatly.	  Zebrafish	  and	  chicken	  embryos	  undergo	   discoidal	   telolecithal	   meroblastic	   cleavage,	   while	   amphibians	   like	   X.	  laevis	  undergo	  displaced	  radial	  mesolecithal	  holoblastic	  cleavage	  and	  mammals,	  like	   M.	   musculus	   and	   H.	   sapiens	   undergo	   rotational	   isolecithal	   holoblastic	  cleavage.	  At	  later	  stages,	  chicken	  and	  mouse	  embryos	  develop	  a	  condensation	  of	  cells	   along	   the	   anterior-­‐posterior	   axis	   that	   results	   in	   the	   development	   the	  primitive	  streak.	  The	  anterior	  most	  part	  of	  the	  primitive	  streak	  develops	  into	  the	  organizer	   or	   node	   (Hensen’s	   node	   in	   chicken	   embryos	   and	   the	   node	   in	  mouse	  embryos).	  This	  organizing	  center	  later	  regresses	  posteriorly	  and	  secretes	  various	  transcription	   factors	   that	  pattern	   the	  embryo	  along	   the	  anterior-­‐posterior	  axis.	  This	   is	   in	   contrast	   with	   the	   organizer	   in	   X.	   laevis	   and	   D.	   rerio,	   where	   the	  organizer	  is	  specified	  at	  the	  dorsal	  side	  and	  does	  not	  migrate.	  In	  X.	  laevis	  and	  D.	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rerio	  embryos	  the	  cells	  migrate	  towards	  the	  organizer,	  while	  in	  G.	  gallus	  and	  M.	  musculus	   the	   organizer	   migrates	   while	   patterning	   the	   surrounding	   tissue.	   In	  addition,	  G.	  gallus	  and	  M.	  musculus	  embryos	  have	  secondary	  organizing	  centers,	  the	  hypoblast	  and	  the	  anterior	  visceral	  endoderm	  (AVE)	  respectively.	  The	  AVE,	  blocks	   the	   mesoderm	   inducing	   signals	   from	   the	   node,	   whereas	   the	   chicken	  hypoblast	  gives	  rise	  to	  extra-­‐embryonic	  tissues	  (Gilbert,	  2006;	  Slack,	  2013).	  The	  induction	  of	  the	  dorso-­‐ventral	  axis	  and	  the	  different	  early	  structures	  in	  the	  gastrulating	  embryo	  requires	  a	  tight	  spatiotemporal	  control	  of	  the	  changes	  in	  cell	  shape,	   migration,	   adhesion	   and	   differentiation.	   The	   ECM	   is	   ideally	   suited	   to	  provide	   the	   environment	   that	   allows	   a	   homogenous	   mass	   of	   cells	   to	   develop	  different	  characteristics.	  Structural	  components	  like	  Fibronectin	  were	  shown	  to	  bind	   to	   one	   of	   its	   Integrin	   receptors,	   Integrin	   α5β1	   and	   α5β3,	   resulting	   in	   the	  contraction	  of	  actin	   filaments	   thereby	  changing	   the	  shape	  of	   the	  cell	   (Danen	  et	  al.,	  2002;	  Mao	  and	  Schwarzbauer,	  2005;	  Davidson	  et	  al.,	  2006).	  Furthermore,	  the	  differential	   development	   of	   tissues	   and	   cells	   is	   also	   a	   result	   from	   the	   tightly	  regulated	   balance	   of	   signaling	   pathways	   like	   BMP,	   WNT,	   Nodal	   and	   FGF	   to	  mention	   a	   few.	   It	   is	   their	   specific	   interaction	   that	   balances	   the	   expression	   of	  target	  genes	   required	   for	   the	   changes	   in	   cell	   shape,	   adhesion	  and	  motility,	   and	  their	  differentiation.	  	  
1.3.3	  Regulation	  of	  gastrulation:	  BMP	  &	  WNT	  	  1.3.3.1	  BMP	  signaling	  	  BMP	   signaling	   is	   initiated	   by	   the	   binding	   of	   BMP	   ligands	   (BMP2,	   4,	   7)	   to	   both	  type	   I	   and	   type	   II	   serine/threonine	   kinase	   receptors	   as	   a	   dimer	   (Fig	   1.5).	   The	  type	  I	  receptors	  that	  can	  interact	  with	  BMP	  ligands	  are	  ActRIa	  (ALK2),	  BMPRIa	  (Alk3)	  and	  BMPRIb	  (ALK6)	  while	  the	  type	  II	  receptors	   include	  BMPRII	  (TβRII),	  ActRII	  and	  ActRIIb.	  When	  BMP	  ligand	  dimers	  interact	  with	  the	  type	  II	  receptors,	  the	  latter	  phosphorylates	  the	  type	  I	  receptor,	  thereby	  initiating	  the	  formation	  of	  a	  receptor	  complex.	  In	  the	  canonical	  BMP	  signaling	  pathway,	  the	  activated	  type	  I	  receptor	  will	  phosphorylate	  the	  receptor-­‐SMAD	  proteins	  (SMAD1,	  5,	  8)	  that	  will	  interact	  with	  the	  co-­‐SMAD	  (SMAD4)	  and	  as	  a	  complex	  translocate	  to	  the	  nucleus,	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bind	  to	  the	  target	  sequences	  and	  influence	  the	  transcription	  of	  BMP	  target	  genes.	  In	  parallel,	   the	  non-­‐canonical	  BMP	  signaling	  pathway,	   the	  BMP-­‐MAPK	  pathway	  can	   also	   mediate	   BMP	   signals	   (Balemans	   and	   Van	   Hul,	   2002;	   Ramel	   and	   Hill,	  2012).	  Whether	  BMP	  ligands	  signal	   through	  the	  canonical	  or	   the	  non-­‐canonical	  pathway	   depends	   on	   the	   composition	   of	   the	   receptors.	   In	   case	   of	   a	   preformed	  complex	  or	   type	   I	  and	   type	   II	   receptors,	   it	  was	  shown	  canonical	  BMP	  signaling	  was	   favored.	   In	   case	   of	   ligand	   binding	   induced	   receptor	   complex	   formation,	  signaling	  through	  the	  BMP-­‐MAPK	  pathway	  was	  initiated.	  Other	  receptors	  of	  the	  TGFβ	  superfamily	  bind	  TGFβ,	  Activin	  and	  Nodal	   ligands	  and	  signaling	  by	   these	  ligands	   is	   mediated	   by	   the	   R-­‐SMAD	   proteins	   SMAD2	   and	   3	   and	   the	   co-­‐SMAD	  protein	  SMAD4	  (Gilboa	  et	  al.,	  2000;	  Nohe	  et	  al.,	  2002).	  	  BMP	   signaling	   is	  modulated	   in	   the	   extracellular	   compartment	   by	   soluble	   BMP	  antagonists,	   like	  NOGGIN,	  CHORDIN,	  FOLLISTATIN	  among	  others,	   that	  bind	   the	  ligand	   and	   prevent	   ligand-­‐receptor	   interaction.	   BAMBI,	   a	   dominant	   negative	  receptor	   prevents	   the	   formation	   of	   the	   receptor	   complex	   by	   sequestering	   the	  receptors.	   Intracellularly,	   inhibitory-­‐SMAD	  proteins	   (SMAD6,	   7)	   antagonize	   the	  activation	  of	  SMAD1,	  5,	  8.	  SMAD6	  was	  also	  shown	  to	  compete	  with	  SMAD1,	  5,	  8	  for	  SMAD4	  (Balemans	  and	  Van	  Hul,	  2002).	  Smurf-­‐1	  interacts	  with	  SMAD1	  and	  8	  pushing	   them	   towards	   ubiquitination-­‐mediated	   degradation.	   	   In	   the	   nucleus,	  negative	   cofactors	   like	   SIP1	   and	   positive	   cofactors	   like	   p300/CBp	   affect	   target	  gene	  expression	  by	  changing	  the	  chromatin	  structure	  and	  affecting	  the	  binding	  of	  the	  SMAD	  complex	   to	   the	  DNA	   target	   sequence.	  Furthermore,	  BMP	  signaling	   is	  also	  affected	  by	  the	  crosstalk	  with	  other	  signaling	  pathways	  like	  TGFβ,	  Wnt	  and	  ERK-­‐MAPK	  signaling	  adding	  to	  the	  complexity	  of	  the	  pathways	  and	  permitting	  a	  tight	   spatiotemporal	   regulation	  of	   target	  gene	  expression	   (Massague	  and	  Chen,	  2000).	  	  
	  	   22	  
	  
Figure	  1.5:	  Schematic	  overview	  of	  SMAD	  dependent	  BMP	  signaling	  Ligand	   binding	   to	   receptor	   dimers	   induces	   the	   phosphorylation	   of	   type	   1	   receptors	   and	   SMAD1/5/8	  proteins,	   which	   interact	   with	   co-­‐SMAD	   proteins	   and	   translocate	   to	   the	   nucleus	   to	   activate	   target	   gene	  transcription.	  	  1.3.3.2	  Function	  of	  Bmp	  signaling	  during	  zebrafish	  gastrulation	  Bmp	  family	  members	  play	  an	  essential	  role	  in	  generating	  a	  dorso-­‐ventral	  pattern	  as	  zebrafish	  mutants	   like	   swirl	  (bmp2b),	  snailhouse	  (bmp7),	  somitabun	   (smad5),	  
lost-­‐a-­‐fin	   (alk8),	  mini	   fin	   (alk2),	   chordino	   (chordin),	   and	   ogon	   (sizzled)	   present	  defects	  in	  dorso-­‐ventral	  development	  (Langdon	  and	  Mullins,	  2011).	  	  Prior	  to	  gastrulation	  Bmp	  mRNA	  is	  expressed	  uniformly	  throughout	  the	  embryo.	  Yet,	   the	   early	   dorsal	   specific	   expression	   of	   Bozozok	   inhibits	   the	   expression	   of	  Bmp	  ligands	  from	  initial	  stages	  onwards.	  Subsequently,	   the	  development	  of	  the	  shield	   and	   the	   secretion	   of	   inhibitory	   dorsal	   factors	   (Chordin,	   Noggin1,	  Follistatin-­‐like2)	   from	   this	   organizing	   center,	   results	   in	   blocking	   Bmp	   ligand-­‐receptor	   interactions.	   Further	   fine-­‐tuning	   of	   the	   Bmp	   signal	   is	   controlled	   by	  additional	   regulators	   like	   Tolloid,	   Sizzled,	   Twisted	   gastrulation	   and	  Crossveinless-­‐2,	  as	  all	  these	  factors	  affect	  the	  maturation	  and	  function	  of	  Chordin	  (Schier	  and	  Talbot,	  2005;	  Langdon	  and	  Mullins,	  2011).	  	  These	   opposing	   actions	   of	   the	   ventral	   Bmps	   and	   the	   dorsal	   Bmp	   antagonists	  create	  a	  gradient	  of	  Bmp	  signaling	  from	  the	  ventral	  to	  the	  dorsal	  side,	  allowing	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differential	  differentiation	  and	  cell	  fate	  specification	  along	  this	  axis.	  In	  addition,	  it	   was	   shown	   that	   this	   Bmp	   gradient	   also	   regulates	   cell	   movements	   as	   it	  establishes	   a	   reverse	   gradient	   of	   Cadherin-­‐mediated	   cell	   adhesion	   (Von	   der	  Hardt	  2007).	  Bmp	  mutant	  zebrafish,	  like	  snailhouse,	  swirl,	  and	  somitabun	  do	  not	  only	   present	   dorso-­‐ventral	   patterning	   defects	   but	   also	   the	   migration	   of	   the	  ventrolateral	   cells	   is	   compromised	   (Mullins	   et	   al.,	   1996;	   Schmid	   et	   al.,	   2000;	  Mintzer	   et	   al.,	   2001;	   Little	   and	  Mullins,	   2004).	   As	   expression	   of	   non-­‐canonical	  Wnt	   ligands	   was	   shown	   to	   be	   altered	   when	   levels	   of	   Bmp	   signaling	   are	  manipulated,	  it	  was	  suggested	  that	  Bmp	  signaling	  modulates	  the	  cell	  movements	  by	   regulating	   the	   expression	   of	   non-­‐canonical	   Wnt	   ligands	   like	   Wnt5b	   and	  Wnt11	  (Myers	  et	  al.,	  2002).	  Wnt	  signaling	  also	  regulates	  the	  gradient	  of	  Bmp	  signaling.	  During	  early	  stages	  of	  embryonic	  development,	  canonical	  Wnt	  signaling	  plays	  a	  dual	  role	  dependent	  on	  the	  stage	  of	  the	  embryo.	  Initially,	  β-­‐catenin	  induces	  the	  dorsal	  organizer	  specific	  expression	   of	   bozozok,	   thereby	   negatively	   regulating	   Bmp	   signaling	   at	   this	  location.	   During	   later	   stages	   Wnt8	   was	   shown	   to	   induce	   ventral	   genes	   like	  
vox/vent/ved,	   thereby	   promoting	   Bmp	   signaling	   and	   thus	   ventral	   fates.	  Furthermore,	   Fgf	   signaling	   also	   affects	   dorso-­‐ventral	   patterning	   of	   the	   early	  gastrula	  embryo	  by	  repressing	  the	  expression	  of	  Bmp	  ligands	  Bmp2b	  and	  Bmp7	  in	   the	   dorsal	   cells,	   independent	   of	   Chordin	   (Fig	   1.6)	   (Schier	   and	   Talbot,	   2005;	  Langdon	  and	  Mullins,	  2011).	  	  	  
	  
Figure	  1.6:	  Bmp	  mediates	  the	  patterning	  of	  the	  zebrafish	  early	  gastrula	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A	   gradient	   of	   Bmp	   signaling	   is	   maintained	   by	   the	   balance	   of	   Bmp	   ligands	   on	   the	   ventral	   side	   and	   Bmp	  antagonists	  produced	  at	  the	  dorsal	  side	  of	  the	  embryo.	  At	  this	  stage	  Bmp	  mediated	  signaling	  is	  induced	  by	  Wnt8	   and	   its	   own	   target	   genes	   vox/vent/ved	   and	   repressed	   by	   Chordin,	   Noggin1,	   Follistatin-­‐like	   2,	  Goosecoid	   and	   FGF.	   Chordin	   is	   further	   regulated	   by	   Tolloid,	   Bmp1,	   Tsg,	   Cvl2	   and	   the	   Bmp	   target	   genes	  
vox/vent/ved.	  Adapted	  from	  (Langdon	  and	  Mullins,	  2011).	  	  1.3.3.3	  Wnt	  signaling	  	  There	   are	   several	   pathways	   transducing	  Wnt	   signaling	   (Rao	   and	   Kuhl,	   2010).	  The	  canonical	  Wnt	  signaling	  pathway	  is	  dependent	  on	  β–catenin	  (Fig	  1.7).	  In	  the	  OFF	  state,	  β–catenin	   is	   captured	  and	  phosphorylated	  by	  a	  destruction	  complex	  composed	  of	  APC,	  CK1,	  Axin	  and	  GSK3β.	  This	  results	  in	  the	  ubiquitination	  of	  β–catenin	  and	  the	  subsequent	  degradation	  by	  the	  proteasome.	  Upon	  Wnt	  binding	  to	   the	   FRIZZLED	   receptor	   and	   the	   coreceptor	   LRP6/5,	   DISHEVELLED	   (dsh)	   is	  recruited	  to	  the	  ligand	  receptor	  complex,	  which	  results	  in	  the	  phosphorylation	  of	  dsh.	  Subsequently,	  CK1	  is	  recruited	  leading	  to	  the	  phosphorylation	  of	  the	  LRP5/6	  coreceptor	  by	  CK1	  and	  GSK3β.	  This	  then	  serves	  as	  a	  docking	  site	  for	  the	  binding	  of	  Axin,	   resulting	   in	   the	   release	   of	   β–catenin	   into	   the	   cytoplasm	   leading	   to	   the	  cytoplasmic	  accumulation	  and	  the	  eventual	   translocation	  to	   the	  nucleus.	  There,	  β–catenin	   displaces	   the	   repressor	   groucho	   from	   the	   LEF1/TCF	   regulatory	  complex	   and	   regulates	   the	   activation	   of	   canonical	   Wnt	   target	   genes	   (Clevers,	  2006).	  The	  non-­‐canonical	  Wnt	  pathways	   is	  β–catenin	   independent	  and	  the	  two	  most	  studied	  pathways	  are	  the	  planar	  cell	  polarity	  pathway	  (PCP)	  and	  the	  Ca2+	  pathway	   (Fig	   1.7).	   The	   PCP	   pathway	   affects	   cell	  migration	   and	   contraction	   by	  regulating	   cell	   polarity	   and	   cytoskeletal	   organization.	   Upon	   ligand	   binging,	  DISHEVELLED	  can	  either	  activate	  ROCK1,	  in	  a	  RHOA/DAAM	  dependent	  manner	  or	   JNK	   in	   a	   RAC1	   dependent	   manner.	   The	   Ca2+	   pathway	   is	   activated	   by	   Wnt	  ligand-­‐receptor	   interaction	   inducing	   the	   release	   of	   Ca2+	   ions	   from	   the	  endoplasmatic	   reticulum	   through	   the	   induction	  of	   IP3	  via	   a	   trimeric	  G-­‐protein.	  The	   Ca2+	   ions	   will	   then	   activate	   Ca2+	   sensitive	   enzymes	   like	   PKC,	   CaMKII	   and	  NFAT	  (Logan	  and	  Nusse,	  2004;	  Gao	  and	  Chen,	  2010;	  Sugimura	  and	  Li,	  2010;	  De,	  2011).	  Wnt	   signaling	   involves	   19	   different	   ligands	   identified	   so	   far	   binding	   to	   several	  different	   receptors	   making	   it	   one	   of	   the	   most	   complex	   signaling	   cascades.	   In	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addition,	  Wnt	   signaling	   is	   modulated	   by	   the	   extracellular	   inhibitors	   (SFRP1-­‐5,	  WIF	  and	  Cerberus)	  that	  can	  bind	  directly	  to	  the	  Wnt	  ligands	  and	  prevent	  them	  to	  bind	   to	   the	   receptors.	   Another	   class	   of	   factors	   that	   modulate	   Wnt	   signaling	  interfere	  with	  the	  LRP5/6	  coreceptor,	  like	  DICKOPF,	  WISE	  and	  SCLEROSTIN	  and	  are	  therefore	  specific	  for	  the	  canonical	  pathway	  (Kawano	  and	  Kypta,	  2003).	  	  
	  
Figure	  1.7:	  Schematic	  overview	  of	  canonical	  and	  non-­‐canonical	  Wnt	  signaling	  In	   the	   OFF-­‐state,	   the	   canonical	  Wnt	   signaling	   represses	   target	   gene	   activation	   by	   the	   degradation	   of	   β–catenin	  mediated	  by	  the	  destruction	  complex.	  Upon	  ligand	  binding,	  this	  destruction	  complex	  dissociates	  due	  to	   the	   recruitment	   of	   these	   factors	   to	   the	   receptor	   complex	   and	   allows	   β–catenin	   to	   accumulate	   in	   the	  cytoplasm	  and	  translocate	  to	  the	  nucleus	  where	  it	  activates	  target	  gene	  transcription.	  In	  the	  non-­‐canonical	  Wnt/PCP	   signaling,	   Dsh	   activates	   Rock1	   and	   JNK	   mediated	   signaling	   resulting	   in	   cytoskeletal	  rearrangements.	  Non-­‐canonical	  Wnt/Ca2+	  signaling	   is	  dependent	  on	  the	  release	  of	  Ca2+	  to	  activate	  CaMKII,	  PKC	  or	  NFAT.	  	  1.3.3.4	  Function	  of	  Wnt	  during	  zebrafish	  gastrulation	  The	   specification	   of	   the	   dorsal	   axis	   preludes	   the	   initiation	   of	   extensive	   cell	  migration	   and	   changes	   in	   cell	   shape	   and	   adhesion	   properties.	   Just	   like	   the	  specification	  of	   the	  dorso-­‐ventral	   axis,	   all	   cellular	  movements,	   from	  epiboly,	   to	  involution,	  intercalation,	  extension	  and	  conversion	  are	  tightly	  regulated	  in	  space	  and	  time	  by	  a	  number	  of	  signaling	  pathways.	  In	  zebrafish,	  the	  non-­‐canonical	  Wnt	  signaling	  was	  shown	  to	  be	  the	  main	  signaling	  pathway	  involved	  as	  this	  pathway	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regulates	   cytoskeletal	   organization	   by	  modulating	   actin	   and	  microtubules,	   and	  cellular	  adhesion	  by	  regulating	  Cadherin	  localization	  and	  turnover.	  	  The	   involvement	   of	   non-­‐canonical	   Wnt/PCP	   signaling	   during	   gastrulation	   is	  illustrated	  by	  the	  zebrafish	  mutants	  ppt	  (wnt5b),	  slb	  (wnt11),	  knypek	  (glypican	  4)	  and	   trilobite	   (strabismus)	   which	   present	   cell	  movements	   defects.	   Furthermore,	  the	   Wnt/Ca2+	   pathway	   also	   regulates	   gastrulation	   as	   the	   release	   of	   Ca2+	   ions	  appeared	  to	  activate	  enzymes	  like	  PKC	  and	  CamKII	  that	  control	  cell	  adhesion	  and	  movement.	   In	   addition,	  Disheveled,	   Fz7,	   and	  Flamingo,	   the	   small	  GTPases	  Rho,	  Rac	  and	  Cdc42,	  and	  Jun-­‐N-­‐terminal	  kinase	  (JNK)	  are	  other	  core	  component	  of	  the	  non-­‐canonical	  Wnt	  pathways	  that	  affect	  gastrulation	  by	  regulating	  polarized	  cell	  movements,	  and	  the	  actin	  and	  myosin	  cytoskeleton.	  Interestingly,	  in	  the	  absence	  of	   non-­‐canonical	   Wnt	   signaling	   convergence	   and	   extension	   movements	   are	  impaired,	   but	   they	   are	   not	   absent,	   indicating	   other	   regulatory	   mechanisms	  contribute	   to	   this	   process.	   This	   is	   illustrated	   by	   the	   conversion	   and	   extension	  defects	   when	   the	   levels	   of	   the	   Wnt	   signaling	   independent	   factors	   Stat3,	   Slit2,	  Sprouty	   and	   Protocadherin	   8	   among	   others	   are	   altered	   (Heisenberg	   and	  Tada,	  2002;	  Rohde	  and	  Heisenberg,	  2007).	  	  	  
1.4	  Hematopoiesis	  	  	  
1.4.1	  Introduction	  Hematopoiesis	  (from	  αἷμα:	  blood	  and	  ποιεῖν:	  to	  make)	  refers	  the	  process	  of	  the	  generation	   of	   blood	   cells.	   Hematopoietic	   development	   starts	   right	   after	  gastrulation	  and	  continues	  throughout	  adult	  life	  to	  produce	  and	  replenish	  blood	  cells.	   In	   vertebrates,	   the	   different	   progenitors	   are	   induced	   in	   multiple	  hematopoietic	   waves	   in	   anatomically	   distinct	   domains.	   During	   the	   initial	   or	  primitive	  hematopoietic	  wave	  the	  hemangioblasts	  generate	  the	  first	  erythrocytes	  and	  macrophages	  to	  provide	  the	  rapidly	  developing	  embryo	  with	  oxygen	  and	  the	  first	   line	   of	   defense	   against	   pathogens.	   This	   hemangioblast	   was	   defined	   as	   a	  common	  precursor	   for	  both	  endothelial	  and	  hematopoietic	  cells	   that	  retain	   the	  ability	  to	  give	  rise	  to	  new	  primitive	  erythroblasts	  (Jagannathan-­‐Bogdan	  and	  Zon,	  2013).	  Over	  the	  years,	  some	  controversy	  has	  arisen	  over	  the	  term	  hemangioblast	  as	  a	  bipotential	  precursor.	  It	  appears	  that	  these	  precursor	  cells	  represent	  a	  state	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of	   competence	   rather	   than	  a	  precursor	   state.	   In	  vitro	   these	   cells	   are	   capable	  of	  differentiating	   into	   endothelial	   cells,	   whereas	   in	   vivo	   evidence	   of	   endothelial	  differentiation	   is	  absent	   (Amaya,	  2013).	  Hemangioblasts	  are	  not	  hematopoietic	  stem	   cells,	   as	   the	   latter	   can	   give	   rise	   to	   all	   blood	   cells	   (erythrocytes,	  megakaryocytes,	  myeloid	   cells	   and	   lymphocytes)	   during	   the	   definitive	  wave	   of	  hematopoiesis.	  The	  development	  of	  the	  hematopoietic	  system	  has	  been	  of	  great	  interest	   as	   the	   study	   of	   this	   system	   can	   help	   researchers	   understand	   blood	  disorders	  and	  cancers.	  In	  particular,	  research	  for	  the	  regulation	  and	  the	  behavior	  of	   hematopoietic	   stem	   cells	   within	   their	   niche	   gained	   more	   interest	   over	   the	  years,	   especially	   since	   hematopoieisis	   is	   an	   evolutionary	   conserved	   process	  allowing	   the	   use	   of	   different	   animal	   models.	   When	   comparing	   hematopoietic	  processes	   in	  different	  animal	  models,	  species	  dependent	  differences	   in	   location	  and	  timing	  can	  be	  seen	  (Fig	  1.8).	  	  
	  
Figure	  1.8:	  Comparison	  of	  locations	  of	  hematopoiesis	  in	  M.	  musculus,	  H.	  sapiens	  and	  D.	  rerio	  In	  mouse	  and	  humans,	  embryonic	  hematopoiesis	  takes	  place	  in	  the	  yolk	  sac.	  From	  there	  and	  together	  with	  precursors	   derived	   from	  AGM,	   umbilical	   artery	   (UA),	   vitelline	   artery	   (VA)	   and	   placenta	   for	  mouse,	   these	  precursors	   migrate	   into	   the	   fetal	   liver.	   Hematopoiesis	   then	   proceeds	   by	   colonizing	   thymus,	   and	   bone	  marrow,	   the	   two	   main	   hematopoietic	   niches.	   In	   zebrafish,	   similar	   migratory	   processes	   take	   place	   with	  precursors	  deriving	  from	  an	  initial	  wave	  and	  a	  definitive	  wave	  that	  later	  migrate	  to	  the	  thymus,	  the	  kidney	  marrow	  (analogous	  to	  the	  bone	  marrow	  in	  mammals)	  and	  the	  caudal	  hematopoietic	  tissue	  (CHT).	  Timing	  of	  the	   different	   event	   differs	   greatly	   across	   species:	   conclusion	   of	   hematopoiesis	   in	   the	   thymus	   or	   bone	  marrow	  (or	  kidney	  marrow	   in	   zebrafish)	   starts	   around	  4	  dpf	   in	   zebrafish,	  15	  dpf	   in	  mice	  and	  70	  days	   in	  humans.	  Adapted	  from	  (Cumano	  and	  Godin,	  2007;	  Jagannathan-­‐Bogdan	  and	  Zon,	  2013).	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Yet,	  the	  genetic	  regulation	  and	  the	  molecular	  program	  of	  the	  different	  blood	  cell	  lineages	  is	  highly	  identical,	  which	  allows	  us	  to	  use	  the	  best	  suited	  animal	  model	  to	  investigate	  a	  particular	  aspect	  of	  blood	  cell	  development.	  	  
1.4.2	  Zebrafish	  hematopoiesis	  Similar	   to	   other	   vertebrates,	   zebrafish	   hematopoiesis	   occurs	   in	   multiple	  successive	  waves	   in	  anatomically	  distinct	   sites	   (Davidson	  and	  Zon,	  2004;	  Ellett	  and	   Lieschke,	   2010;	   Jagannathan-­‐Bogdan	   and	   Zon,	   2013).	   The	   primitive	  hematopoietic	   wave	   (10hpf	   -­‐	   1dpf)	   initiates	   in	   both	   the	   anterior	   and	   the	  posterior	   lateral	   plate	  mesoderm	   (ALPM	  and	  PLPM)	   (Fig	   1.9A).	  Anteriorly,	   the	  mesoderm	  differentiates	  into	  the	  rostral	  blood	  islands	  (RBI,	  most	  rostral	  ALPM)	  and	   cardiac	   progenitors	   (most	   caudal	   ALPM).	   Posteriorly,	   the	   bilaterally	  organized	  mesoderm	  fuses	  at	  the	  midline	  and	  develops	  into	  the	  intermediate	  cell	  mass	   (ICM).	   Both	   the	  RBI	   and	   the	   ICM	  harbor	   bipotent	   hemangioblasts.	   In	   the	  RBI,	   these	   hemangioblasts	   will	   give	   rise	   to	   precursors	   of	   myeloid	   cells	   and	  endothelial	   cells,	  while	   the	   ICM	  will	  produce	  erythrocytes	  and	  endothelial	   cells	  (Fig	   1.9B).	   During	   the	   next	   wave,	   or	   intermediate	   hematopoiesis	   (>30hpf),	  erythroid-­‐myeloid	  progenitors	  (EMP)	  are	  formed	  in	  the	  posterior	  blood	  islands	  (PBI),	   the	  most	  caudal	  part	  of	   the	  ICM	  (Fig	  1.9B).	  These	  EMPs	  can	  differentiate	  into	   both	   erythroid	   and	  myeloid	   cells.	   At	   the	   same	   time,	   the	   anterior	  myeloid	  precursors	  differentiate	  into	  macrophages	  or	  neutrophils.	  At	  30	  hpf,	  multipotent	  hematopoietic	   stem	   cells	   appear	   in	   the	   ventral	   dorsal	   aorta.	   Eventually,	   these	  HSCs	  will	  migrate	  out	  of	   the	  VDA	  and	  populate	   the	  kidney,	   the	   thymus	  and	  the	  caudal	  hematopoietic	  tissue	  (CHT)	  (Fig	  1.9B-­‐C).	  Around	  4-­‐5	  dpf	  and	  after	  further	  migration	   into	   the	  kidney	  and	   the	   thymus,	   their	   final	   location,	   they	  are	  able	   to	  give	   rise	   to	   all	   hematopoetic	   lineages	   during	   the	   further	   development	   of	   the	  zebrafish.	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Figure	  1.9:	  Mapping	  the	  different	  sites	  of	  hematopoeisis	  at	  different	  stages	  of	  zebrafish	  development	  A-­‐C:	   Anterior	   to	   the	   left	   A:	   dorsal	   view	   B-­‐C:	   lateral	   view	   dorsal	   to	   the	   top.	   A.	   A	   5ss	   embryo	   with	  hematopoietic	  precursors	  located	  in	  the	  anterior	   lateral	  plate	  mesoderm	  (ALPM)	  and	  the	  posterior	   lateral	  plate	   mesoderm	   (PLPM)	   (purple).	   Cardiac	   progenitors	   are	   located	   posteriorly	   of	   the	   hematopoietic	  precursors	  in	  the	  ALPM	  (pink).	  B.	  24-­‐30	  hpf	  embryo	  with	  myeloid	  precursors	  (green)	  in	  the	  rostral	  blood	  islands	   (RBI),	   erythroid	   precursors	   (red)	   in	   the	   inner	   cell	   mass	   of	   the	   PLPM,	   and	   erythro-­‐myeloid	  precursors	   (orange)	   in	   the	   posterior	   blood	   islands	   (PBI).	   Along	   the	   ventral	   wall	   of	   the	   dorsal	   aorta,	  hematopoietic	  stem	  cells	  are	  formed	  that	  migrate	  later	  into	  the	  thymus,	  kidney	  and	  CHT	  (blue	  zones	  in	  C).	  Adapted	  from	  (Monteiro	  et	  al.,	  2011)).	  	  
1.4.3	  Transcriptional	  regulation	  of	  embryonic	  hematopoiesis	  in	  zebrafish	  The	  location	  and	  time	  specific	  generation	  of	  cells	  of	  the	  different	  hematopoietic	  lineages	  requires	  tight	  control	  by	  regulatory	  factors	  (Fig	  1.10).	  	  In	  the	  ALPM,	  mesoderm	  specific	  transcription	  factors	  like	  gata4-­‐6	  are	  expressed	  during	  initial	  stages	  of	  somitogenesis.	  It	  was	  shown	  that	  the	  loss	  of	  these	  factors	  resulted	  in	  a	  reduction	  or	  even	  a	  loss	  of	  myeloid	  cells	  in	  the	  ALPM	  at	  24	  hpf	  and	  cardiac	   migration	   defects	   at	   22-­‐24	   hpf.	   These	   Gata	   transcription	   factors	   were	  shown	  to	  be	  essential	   for	  the	  specification	  of	  the	  anterior	  hemangioblast	  as	  the	  markers	  scl,	  lmo2,	  gata2,	  fli1,	  and	  etsrp	  were	  absent	  or	  reduced	  in	  gata5-­‐6	  double	  morphants	  (Peterkin	  et	  al.,	  2009).	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myeloid	  development,	  further	  differentiation	  of	  the	  myeloid	  lineage	  is	  regulated	  by	   the	   level	   of	   spi1b	   expression	   that	   was	   shown	   to	   be	   regulated	   by	   its	   own	  transcriptional	  target,	  runx1,	  thereby	  establishing	  a	  negative	  feedback	  loop.	  Low	  levels	  of	   spi1b	  were	   shown	   to	   induce	  neutrophils,	  whereas	  high	   levels	   induced	  macrophages	  (Fig	  1.11)	  (Jin	  et	  al.,	  2012).	  	  
	  
Figure	   1.11:	   Differential	   regulation	   of	   erythroid	   versus	   myeloid	   cell	   fate	   during	   primitive	   and	  
intermediate	  hematopoiesis	  Genetic	  interactions	  between	  gata1,	  spi1b	  and	  tif1γ	  determine	  the	  fate	  of	  the	  precursors.	  In	  the	  RBI	  (green)	  spi1b	   blocks	   the	   expression	   of	   gata1,	   thereby	   promoting	   myeloid	   fates.	   In	   the	   PLPM	   derivered	   cell	  populations,	  tif1γ	  enters	  the	  play	  by	  regulating	  gata1	  and	  spi1b	  positively.	  In	  the	  ICM	  (red),	  gata1	  blocks	  the	  expression	  of	   spi1b,	   thereby	  promoting	   erythroid	   cell	   fate.	   In	   the	  PBI	   (orange)	   however,	   spi1b	   and	  gata1	  block	   each	   other’s	   expression	   resulting	   in	   the	   generation	   of	   both	   erthrocytes	   and	  myeloid	   cells.	   Further	  specification	  of	  the	  myeloid	  lineage	  is	  determined	  by	  the	  level	  of	  spi1b,	  and	  its	  transcriptional	  target	  runx1.	  High	  levels	  promote	  macrophage	  fates	  whereas	  lower	  levels	  induce	  neutrophils.	  Adapted	  from	  (Monteiro	  et	  al.,	  2011;	  Xu	  et	  al.,	  2012).	  	  
1.4.4	  Zebrafish	  as	  a	  model	  for	  hematopoietic	  conditions	  	  The	  regulatory	  cascade	  directing	  hematopoiesis	  in	  humans	  is	  highly	  conserved	  in	  zebrafish.	   Consequently,	   the	   contribution	   of	   the	   studies	   in	   zebrafish	   to	   the	  understanding	  of	  hematopoiesis,	  the	  development	  and	  behaviour	  of	  the	  HSC	  and	  the	  hematopoietic	  malignancies	  is	  not	  to	  be	  underestimated	  (Table	  1.1).	  	  Forward	  genetic	   screens	   resulted	   in	   the	   identification	  of	  new	   regulatory	   genes	  associated	   with	   hematopoietic	   development	   and	   disease.	   For	   example,	   the	  analysis	   of	   the	  weissherbst	   mutant	   resulted	   in	   the	   identification	   of	   a	   new	   iron	  transporter	   ferroportin1,	   associated	   with	   human	   hemochromatosis	   type	   4.	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Similarly,	   hspa9b,	   related	   to	   myelodysplastic	   syndrome	   and	   ddx18,	   related	   to	  acute	   myeloid	   leukemia	   were	   discovered	   (Donovan	   et	   al.,	   2000;	   Craven	   et	   al.,	  2005;	  Payne	  et	  al.,	  2011).	  The	  analysis	  of	  the	  function	  of	  a	  candidate	  gene	  has	  been	  limited	  to	  the	  injection	  of	  mRNA	  or	  a	  morpholino	   into	  a	  one-­‐cell	   stage	  embryo	  resulting	   in	  a	   transient	  gain-­‐	  or	  loss-­‐of-­‐function.	  Despite	  the	  transient	  nature	  of	  these	  experiments,	  this	  has	  led	  to	  many	  important	  observations	  and	  it	  still	  is	  a	  powerful	  tool	  to	  analyze	  in	  a	  relatively	  fast	  way	  the	  function	  of	  a	  gene	  compared	  to	  the	  more	  traditional	  murine	   knockout.	   However,	   many	   efforts	   have	   been	   done	   to	   improve	   the	  generation	   of	   zebrafish	   transgenics	   in	   order	   to	   be	   able	   to	   perform	   reverse	  genetic	   screens	   in	   zebrafish.	   Using	   ENU	   screening,	   TILLING	   (targeted	   induced	  local	   lesions	   in	   genome),	   zinc-­‐finger	   nucleases	   (ZFNs)	   or	   CRISPR/Cas9	   specific	  defects	   in	  targeted	   loci	  can	  be	  generated	  yielding	  new	  mutants	  to	  analyze	  gene	  function.	  This	  resulted	  in	  the	  identification	  of	  genes	  like	  NPM1	  in	  acute	  myeloid	  leukemia,	  RPS19	   in	  Diamond-­‐Blackfan	  anemia	  and	  VHL	   in	  Chuvash	  polycytemia	  (Danilova	   et	   al.,	   2008;	   Uechi	   et	   al.,	   2008;	   van	   Rooijen	   et	   al.,	   2009;	   Bolli	   et	   al.,	  2010).	  Furthermore,	  the	  recent	  application	  of	  the	  Tol2	  transposons,	  Cre-­‐loxP	  and	  Gal4-­‐UAS	   systems	   allowed	   the	   generation	   of	   stable	   transgenic	   hematopoietic	  cancer	   models	   like	   for	   T	   cell	   acute	   lymphoblastic	   leukemia	   (T-­‐ALL),	   where	  mouse	  Myc	   was	   driven	   by	   the	   zebrafish	   rag2	   promotor	   or	   for	   AML1-­‐ETO,	   the	  most	  common	  chromosomal	  rearrangement	  in	  AML	  (Langenau	  et	  al.,	  2003;	  Yeh	  et	  al.,	  2008).	  Zebrafish,	  is	  a	  very	  efficient	  platform	  to	  screen	  chemical	  compounds	  and	  assess	  their	   effect	   on	   hematopoiesis	   (Yeh	   et	   al.,	   2009;	   Ridges	   et	   al.,	   2012).	   The	  development	   of	   transgenic	   reporter	   lines	   and	   mutants	   zebrafish	   will	   only	  contribute	   further	   to	   the	   elucidation	   of	   the	   role	   of	   certain	   players	   during	   the	  process	   of	   hematopoiesis.	   This	   was	   already	   illustrated	   with	   the	   discovery	   of	  prostaglandin	  E2	  as	  a	  HSC	  inducing	  factor	  (North	  et	  al.,	  2007)	  Finally,	   transplantation	   based	   xenografts	   in	   zebrafish	  were	   also	   established	   to	  investigate	   hematopoiesis	   associated	   cancers	   (ie.	   erythroleukemia	   and	   acute	  promyelocytic	   leukemia)	   and	   assess	   the	   efficacy	   of	   small	   molecules	   on	   tumor	  progression	  (Corkery	  et	  al.,	  2011;	  Pruvot	  et	  al.,	  2011).	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Zebrafish	  mutant	   Gene	   Human	  disease	   Reference	  
weissherbst	   Ferroportin	   Hemochromatosis	   (Donovan	  et	  al.,	  2000)	  
frascati	   Mitoferrin	   Hypochromic	  anemia	   (Shaw	  et	  al.,	  2006)	  
shiraz	   Glutaredoxin	  5	   Hypochromic	  anemia	   (Wingert	  et	  al.,	  2005)	  	  
dracula	   Ferrochelatase	   Erythropoietic	  protoporhyria	   (Childs	  et	  al.,	  2000)	  
merlot	   Protein	  4.1r	   Hemolytic	  anemia	   (Shafizadeh	  et	  al.,	  2002)	  
retsina	   Solute	  carrier	   family	  4,	  anion	  
exchanger	  1	  
Congenital	  dyserythropoietic	  anemia	  type	  II	   (Paw	  et	  al.,	  2003)	  
riersling	   Beta-­‐spectrin	   Hereditary	  spherocytosis	   (Liao	  et	  al.,	  2000)	  
sauternes	   Gamma-­‐aminolevulinate	  
synthetase	  
Congenital	  sideroblastic	  anemia	   (Brownlie	  et	  al.,	  1998)	  
vlad	  tepes	   Gata1	   Familial	  dyserythropoietic	  anemia	  &	  thrombocytopenia	   (Del	  Vecchio	  et	  al.,	  2005)	  
yquem	   Uroporphyrinogen	  
decarboxylase	  
Porphyria	  tarda	  &	  hepatoerythropoietic	  porphyria	   (Wang	  et	  al.,	  1998)	  
zinfandel	   Globin	  locus	   Hypochromic	  anemia	   (Brownlie	  et	  al.,	  2003)	  
Table	  1.1:	  The	  zebrafish	  embryo	  as	  a	  model	  for	  human	  blood	  disorders	  Based	  on	  (Jing	  and	  Zon,	  2011;	  Martin	  et	  al.,	  2011;	  Kulkeaw	  and	  Sugiyama,	  2012).	  	  
1.5	  Chicken	  limb	  development	  	  The	  development	  of	  the	  limbs	  initiates	  with	  the	  emergence	  of	  the	  limb	  buds	  from	  the	   lateral	  plate	  mesoderm	   in	   the	   flank	  of	   the	  body.	  At	   specific	   locations	  along	  the	   anterior-­‐posterior	   axis	   limb	   fields	   are	   specified	   upon	   condensation	   of	  ectodermal	  and	  underlaying	  mesodermal	  cells.	  The	   lateral	  plate	  mesoderm	  and	  the	  adaxial	  mesoderm	  (somites)	  will	   later	  develop	   into	  muscle,	   cartilage,	  bone,	  tendons	  and	  vasculature.	  The	  ectoderm	  however	  will	  give	  rise	  to	  the	  skin	  and	  its	  derivatives	  like	  hair	  and	  nails	  (Gilbert,	  2006).	  The	  specification	  of	  the	  position	  of	  the	   limb	   fields	   was	   shown	   to	   depend	   on	   the	   combined	   action	   of	   retinoic	   acid	  (RA),	   T-­‐Box	   (TBX4	   and	   5),	   Homeobox	   (HOX),	   Fibroblast	   Growth	   Factor	   (FGF8	  and	   10)	   and	   WNT	   (WNT2b	   and	   WNT8c)	   signaling	   (Lewandoski	   et	   al.,	   2000;	  Kawakami	   et	   al.,	   2001).	   Once	   specified,	   the	   outgrowth	   of	   the	   limb	   is	   further	  regulated	  by	  the	  distal	  most	  cells	  of	  the	  limb,	  the	  apical	  ectodermal	  ridge	  (AER)	  (Fig	  1.12A).	  This	  ectodermal	   thickening	   is	   induced	  by	  mesenchymal	  BMP4	  and	  FGF10	   signals,	   and	   by	   secreting	   FGF4	   and	   FGF8	   itself,	   it	   maintains	   the	  proliferation	   of	   the	   underlying	   mesenchymal	   cells	   (Niswander	   et	   al.,	   1993;	  Ohuchi	  et	  al.,	  1997;	  Saunders,	  1998).	  The	  identity	  of	  the	  digits	  along	  the	  anterior-­‐posterior	  axis	  (AP)	  is	  determined	  by	  a	  group	  of	  Sonic	  Hedgehog	  (SHH)	  producing	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cells	  localized	  in	  the	  posterior	  mesenchyme,	  the	  Zone	  of	  Polarizing	  Activity	  (ZPA)	  (Riddle	   et	   al.,	   1993).	   The	   exact	   localization	   of	   this	   ZPA	   is	   dependent	   on	   the	  interactions	   of	   RA,	   dHAND	   and	   HOX	   factors.	   The	   specification	   of	   the	   dorso-­‐ventral	   axis	   is	   dependent	   on	   the	   dorsal	   expression	   of	  WNT7a,	   and	   the	   ventral	  repressor	  activity	  of	  EN-­‐1	  on	  the	  expression	  of	  WNT7a	   in	  the	  ventral	  ectoderm	  (Fig	  1.12B)	  (Niswander,	  2003).	  	   	  
	  
Figure	  1.12:	  Molecular	  regulation	  of	  the	  outgrowth	  and	  patterning	  of	  the	  chicken	  limb	  bud	  	  A-­‐B.	  Schematic	  representation	  of	  an	  outgrowing	  limb	  bud	  with	  the	  different	  organizing	  centers:	  the	  apical	  ectodermal	  ridge	  (AER),	  the	  zone	  of	  polarizing	  activity	  (ZPA)	  and	  the	  ectoderm	  that	  regulate	  the	  proximo-­‐distal	   outgrowth	   (A),	   the	   anterio-­‐posterior	   (A)	   and	   the	   dorso-­‐ventral	   differentiation	   (B),	   respectively.	   A.	  Dorsal	  view,	  anterior	  to	  the	  top.	  B.	  Posterior	  view,	  dorsal	  to	  the	  top.	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2.1	  General	  objective	  	  SMOC2	   was	   extracted	   from	   bovine	   articular	   cartilage	   20	   years	   ago	   by	   our	  laboratory	   together	   with	   GDF5	   (Chang	   et	   al.,	   1994)	   and	   FRZB1	   (Hoang	   et	   al.,	  1996)	  and	  showed	  a	  potent	  osteo-­‐chondrogenic	  acitivity	  in	  vivo.	  Over	  the	  years,	  research	  has	  shown	  SMOC2	  is	  involved	  in	  many	  different	  processes	  and	  had	  been	  associated	  with	  many	   conditions.	   However,	   the	   role	   of	   SMOC2	   in	   the	   cartilage	  and	  bone	  is	  still	  unknown.	  At	  the	  beginning	  of	  this	  project,	  there	  was	  no	  evidence	  for	  an	  interaction	  of	  SMOC2	  with	  any	  known	  signaling	  cascade.	  With	  this	  project	  we	   aimed	   at	   the	   identification	   of	   a	   SMOC2-­‐associated	   pathway	   and	   the	  investigation	  of	  the	  function	  of	  Smoc2	  in	  that	  pathway.	  	  	  
2.2	  Specific	  aims	  	  
2.2.1	  Identification	  of	  the	  Smoc2-­‐associated	  signaling	  cascade	  in	  zebrafish	  
embryos	  	  To	  understand	  the	  molecular	  events	  regulated	  by	  Smoc2,	   the	  Smoc2	  associated	  signaling	   pathway	   needs	   to	   be	   identified.	   Currently	   one	   of	   the	  most	   robust,	   in	  
vivo,	   methods	   for	   pathway	   identification	   is	   based	   on	   the	   zebrafish	   model	  organism.	  Therefore,	  we	  will	  carry	  out	  gain	  and	  loss	  of	  function	  experiments	  by	  injecting	   smoc2	   morpholino	   and	   smoc2	   mRNA	   in	   the	   one-­‐cell	   stage	   embryos	  respectively.	  Subsequently	  we	  will	  perform	  a	  molecular	  analysis	  to	  assign	  those	  genes	   to	   signaling	   pathways	   as	   well	   as	   developmental	   processes	   such	   as	   cell	  migration	  and/or	  differentiation.	  	  	  
2.2.2	  Generation	  of	  tools	  to	  investigate	  the	  role	  of	  SMOC2	  in	  the	  chicken	  
developing	  limb	  	  Zebrafish	   is	   very	  useful	   in	  pathway	   identification	  projects	  but	   is	   inadequate	   to	  study	   the	   function	   of	   genes	   in	   the	   endochondral	   bone	   formation	   and	   joint	  induction	   since	   in	   the	   fish	   they	   occur	   in	   a	   very	   different	   way	   than	   in	   higher	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vertebrates.	   To	   address	   the	   function	  of	   SMOC2	  during	   those	  processes	  we	  will	  use	  the	  in	  ovo	  developing	  chick	  embryo.	  Therefore,	  SMOC2	  will	  be	  cloned	  in	  the	  RCAS	  viral	  vector	  and	  locally	  injected	  in	  the	  chicken	  limb	  bud.	  Using	  histological	  techniques	   and	   WISH	   analysis	   we	   will	   perform	   a	   preliminary	   analysis	   of	   the	  induced	  phenotype.	  	  	  
2.2.3	  Analysis	  of	  the	  Smoc2-­‐/-­‐	  phenotype	  in	  mice.	  	  Up	   to	   date,	   no	   description	   of	   the	   murine	   Smoc2-­‐/-­‐	   phenotype	   was	   published.	  Therefore,	   using	   histological	   stainings	   and	   morphological	   observations	   we	  performed	  a	  preliminary	  analysis	  of	  the	  function	  of	  SMOC2	  in	  the	  mouse	  model.	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3.1	  Model	  systems	  
3.1.1	  The	  zebrafish	  model	  system.	  The	   zebrafish	   is	   a	   relatively	   new	  model	   system	   that	  was	   first	   used	   during	   the	  1930s	   for	   the	   investigation	  of	  karyokinesis	  and	   the	  mechanism	  of	   cell	  division.	  Already	  at	  that	  point	   it	  was	  suggested	  the	  zebrafish	  was	  a	   favorable	   laboratory	  subject	  not	   just	  to	  be	  used	  in	  ornamental	  aquaria.	  From	  the	  1950	  onwards,	   the	  appreciation	   for	   the	   zebrafish	   as	   a	   laboratory	   animal	   only	   increased.	   Zebrafish	  were	  primarily	  used	  for	  anatomical	  studies	  and	  toxicity	  assays.	  Already	  then,	  the	  potential	   of	   the	   zebrafish	   as	   a	   model	   was	   recognized:	   1)	   zebrafish	   females	  produce	   hundreds	   of	   eggs	   weekly	   that	   are	   fertilized	   externally;	   2)	   the	  development	   of	   the	   embryo	   and	   larvae	   is	   extremely	   quick	   compared	   to	   other	  animal	  models;	  3)	  embryos	  are	  transparent	  allowing	  visualization	  of	  developing	  organs	   and	   structures;	   4)	   they	   are	   small,	   and	   can	   be	   housed	   in	   a	   small	   space	  compared	   to	   other	   models;	   5)	   embryos	   can	   be	   systemically	   manipulated	   by	  injection	   at	   the	   one-­‐cell	   stage.	   Recently,	   much	   attention	   has	   gone	   to	   the	  development	   of	   transgenic	   reporters	   and	   tissue	   specific	   knock-­‐outs,	   and	   the	  induction	   of	   targeted	   mutations.	   Using	   ENU	   screening,	   TILLING	   (targeted	  induced	   local	   lesions	   in	   genome),	   zinc-­‐finger	   nucleases	   (ZFNs),	   TALEN,	  Crispr/Cas9,	  Tol2	  transposons,	  Cre-­‐loxP	  and	  Gal4-­‐UAS	  systems	  stable	  transgenic	  models	  can	  be	  generated	  to	  investigate	  gene	  function	  and	  to	  model	  diseases.	  	  
3.1.2	  The	  chicken	  model	  system	  To	   investigate	   the	   function	   of	   SMOC2	   it	   is	   required	   to	   assess	   it	   in	   its	   specific	  environment,	   the	  articular	   joint.	  Although	  perfectly	  suited	   for	   the	   identification	  of	  the	  pathway	  associated	  with	  SMOC2,	  the	  zebrafish	  model	  cannot	  be	  used	  for	  these	   functional	   studies,	   as	   zebrafish	   do	   not	   have	   human-­‐like	   joints.	   However,	  the	  chicken	  limb	  model	  provides	  the	  environment,	  similar	  to	  human	  joints,	  that	  is	  needed	  to	  assess	  the	  function	  of	  SMOC2.	  	  The	  chicken	  embryo	  is	  probably	  one	  of	  the	  oldest	  animal	  models	  used	  to	  study	  the	   development	   of	   an	   embryo	   (Stern,	   2004).	   This	   model	   allows	   the	   study	   of	  many	   organs,	   including	   limbs	   in	   an	   in	   vivo	   setting	   (Tickle,	   2003).	   The	   chicken	  embryo	  has	  been	  successfully	  used	  to	  study	  various	  aspects	  of	  human	  diseases,	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including	  skeletal	  defects	  (Simmons	  and	  Gilliam,	  1981;	  Brown	  et	  al.,	  2003;	  Tickle,	  2004).	  The	  use	  of	  chicken	  embryos	  resulted	  in	  many	  important	  discoveries	  such	  as	   the	  molecular	   basis	   of	   anterio-­‐posterior	   and	   proximo-­‐distal	   axis	   formation,	  the	   first	   cellular	   oncogene,	   and	   the	   oscillating	   gene	   expression	   during	  somitogenesis	   as	   well	   as	   articular	   cartilage	   development	   (Rosier	   and	   O'Keefe,	  1998;	   Rosier	   et	   al.,	   1998;	   Stern,	   2005).	   The	   main	   advantages	   of	   the	   chicken	  embryo	  are	  the	  availablility,	  the	  low	  cost	  and	  the	  ease	  of	  manipulation.	  Although	  the	  embryo	  develops	   in	  ovo,	   this	  does	  not	  prevent	  experiments	  where	  cells	  are	  tracked,	  beads	  are	  implanted	  or	  tissues	  are	  grafted.	  In	  addition,	  it	  allows	  for	  the	  screening	  of	  chemicals	  and	  gene	  delivery	  by	  electroporation	  or	  viral	  infection.	  The	  RCAS	   virus	   is	   derived	   from	   the	   avian	  Rous	   Sarcoma	  Virus	   that	   contains	   4	  genes:	   gag,	   pol,	   env	   and	   the	   src	   oncogene.	   In	   the	   RCAS	   viruses	   the	   latter	   is	  replaced	   by	   an	   expression	   cassette	   that	   contains	   a	   ClaI	   restriction	   site,	   which	  allowed	   the	   cloning	   of	   the	   open	   reading	   frame	   (ORF)	   of	   the	   gene	   of	   interest	  downstream	  of	  the	  env	  gene	  (Morgan	  and	  Fekete,	  1996;	  Gordon	  et	  al.,	  2009).	  The	  gag,	  pol	  and	  env	  genes	  encode	  structural	  components	  (viral	  coats)	  and	  enzymes	  for	  replication	  (Fig	  3.1).	  The	  viral	  coat	  proteins	  are	  of	  critical	  importance	  for	  the	  infection,	  as	   they	  have	   to	   interact	  with	   their	  corresponding	  cellular	  receptor.	  A	  series	   of	   RCAS	   subfamilies	   have	   been	   developed,	   all	   with	   different	   viral	   coat	  proteins.	  Once	  a	  cell	  is	  infected	  with	  a	  virus	  of	  a	  certain	  subtype,	  further	  infection	  of	  the	  cell	  by	  cells	  with	  the	  same	  viral	  coats	  is	  prevented.	  Infection	  with	  viruses	  of	   a	   different	   subclass	   is	   however	   still	   possible,	  which	   allows	  multiple	   viruses	  with	   different	   coats	   to	   infect	   the	   same	   cell.	   Furthermore	   a	   more	   efficient	  polymerase,	   the	   Bryan	   high-­‐titer	   (BP)	  was	   introduced	   into	   the	   RCAS	   vector	   to	  increase	  the	  viral	  titer	  (RCASBP).	  In	  order	  to	  monitor	  the	  efficiency	  of	  our	  viral	  injections	  we	  developed	  a	  system	  based	   on	   viruses	   with	   different	   coats.	   These	   viral	   coat	   proteins	   are	   of	   critical	  importance	  for	  the	  infection	  as	  they	  are	  responsible	  for	  the	  interaction	  with	  the	  cellular	  receptors.	  Importantly,	  two	  different	  viruses	  with	  the	  same	  coat	  protein	  cannot	   infect	   the	   same	   cell.	   However,	   two	   viruses	   with	   different	   viral	   coat	  proteins	   van	   bind	   to	   different	   cellular	   receptors	   and	   therefore	   infect	   the	   same	  cell.	  Currently,	  we	  use	  two	  subtypes	  of	  the	  RCAS	  virus:	  RCASBPA	  and	  RCASBPB.	  With	   a	   RCASBPB-­‐GFP	   virus	   present	   in	   the	   lab,	   this	   allows	   us	   to	   co-­‐inject	   the	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RCASBPA	   viruses	   with	   the	   RCASBPB-­‐GFP	   virus	   in	   order	   to	   control	   for	   the	  injection	   efficacy.	   Importantly,	   the	   cloning	   of	   the	   gene	   of	   interest	   in	   the	   RCAS	  vector	   must	   be	   in	   frame	   with	   the	   open	   reading	   frame	   of	   the	   viral	   genes.	  Therefore,	  a	  shuttle	  vector,	  pSLAX12,	  is	  used.	  This	  is	  a	  small,	  high	  copy	  number	  plasmid	   that	   provides	   ClaI	   restriction	   sites	   to	   use	   for	   cloning	   into	   RCAS.	   To	  ensure	  the	  ORF	  of	  the	  gene	  of	  interest	  is	  similar	  to	  the	  ORF	  of	  the	  virus,	  the	  ORF	  has	  to	  be	  subcloned	  in	  the	  NcoI	  site	  of	  the	  multiple	  cloning	  site	  of	  the	  pSLAX12	  vector	  (Fig	  3.1).	   	  
	  
Figure	  3.1:	  Schematic	  representation	  of	  the	  cloning	  strategy	  and	  multiple	  cloning	  site	  of	  pSLAX12	  Downstream	  of	  the	  gag,	  pol,	  env,	  the	  gene	  of	  interest	  can	  be	  cloned	  in	  to	  the	  RCAS	  vector	  using	  the	  ClaI	  site.	  The	  pSLAX	  vector	  permits	  cloning	  of	  the	  gene	  of	   interest	   in	  between	  two	  ClaI	  sites.	  Ideally	  the	  translation	  start	  site	  of	  the	  gene	  of	  interest	  uses	  the	  ATG	  of	  the	  NcoI	  restriction	  site.	  Alternatively,	  the	  ATG	  of	  the	  gene	  must	  be	  in	  frame	  with	  the	  ATG	  of	  the	  NcoI	  site.	  	  
3.1.3	  The	  mouse	  model	  As	  the	   favorite	  model	   for	  over	  100	  years	   the	  mouse	  model	  has	  proven	  to	  be	  of	  great	  importance	  in	  the	  field	  of	  biomedical	  research.	  Just	  like	  humans,	  mice	  are	  mammals,	   in	  contrast	  to	  yeast,	  worms,	  fruitflies,	  zebrafish	  and	  frogs.	  With	  their	  physiology	   closely	   resembling	   that	   of	   humans,	   they	   make	   excellent	   models	   to	  study	  different	  processes	  of	  the	  immune,	  nervous	  and	  skeletal	  system	  to	  mention	  a	   few.	   In	   addition,	   mice	   also	   develop	   diseases	   relevant	   to	   humans	   like	  atherosclerosis,	   diabetes,	   osteoporosis	   and	   cancer.	   Furthermore,	   other	  
  T3 primer 
ATT  AAC  CCT  CAC  TAA  AGG  GAA  CAA  AAG  CTG  GAG 
        ClaI   
CTC  ATC  GAT  TCT  AGA  CCA  CTG  TGG  CCA  GGC GGT 
          NcoI 
AGC  TGG  GAC  GTG  CAG  CCG  ACC  ACC  ATG  GCC  ATG 
 
ATT  ACG AAT  TCG  AGC  TCG  CCC  GGG GAT  CCT  CTA 
         ClaI 
GAG  TCG  ACC  TGC  AGC  CCA  AGC  TTA  TCG  ATA  CCG 
 
TCG  ACC  GTC  GAC  CTC  GAG  GGG GGG CCC  GGT  ACC 
     T7 primer 
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conditions	  like	  Alzheimer’s	  disease	  can	  be	  induced	  in	  mice	  in	  order	  to	  study	  its	  onset	  and	  progression.	  Before,	  mice	  were	  (exposed	  to	  DNA	  damaging	  chemicals	  and)	  bred	   in	  order	   to	  generate	  offspring	  with	  a	  particular	   trait.	  Later	  however,	  innovative	   genetic	   techniques	   were	   used	   to	   generate	   a	   genetically	   modified	  mouse	   model	   that	   can	   be	   used	   to	   study	   the	   function	   of	   a	   gene	   or	   a	   specific	  condition.	  Currently,	  with	  the	  international	  research	  community	  using	  the	  mouse	  as	  a	  model	  for	  their	  research,	  over	  1000	  transgenic	  mouse	  models	  are	  available	  world-­‐wide.	  	  
3.2	  Experimental	  procedures	  
3.2.1	  Zebrafish	  care	  &	  manipulations	  Adult	   zebrafish	   (Danio	   rerio)	   were	   maintained	   at	   28°C,	   on	   a	   14/10	   hour,	  light/dark	   cycle	   under	   standard	   aquaculture	   conditions	   as	   described	  (www.zfin.org).	  All	   experiments	  were	  performed	  using	  embryos	  obtained	   from	  random	  matings	  of	  the	  wild	  type	  AB	  strain,	  the	  Tg(mpx:GFP)i114,	  the	  Tg(fli:eGFP)y1	  or	  the	  Tg(myl7:GFP)	  transgenic	  line	  (Lawson	  and	  Weinstein,	  2002;	  Huang	  et	  al.,	  2003;	  Gray	  et	  al.,	  2011).	  Embryos	  were	  kept	   in	  embryo	  medium	  and	  staged	  by	  hours	  post-­‐fertilization,	  the	  number	  of	  somites	  (somite	  stage	  or	  ss)	  or	  the	  onset	  of	  circulation	  according	  to	  defined	  criteria.	  	  An	   ATG	   and	   a	   SPLICE	   morpholino	   (MO)	   against	   smoc2	   were	   designed	   and	  purchased	   from	   GeneTools	   (ATG-­‐MO:	   5’-­‐CGCATCCTCGCAGCTCCCCAGAAGC-­‐3’;	  SPLICE-­‐MO:	  5’-­‐AAGGTGTTGTGACCCACCGTGAGCG-­‐3’).	  MOs	  were	  resuspended	  at	  a	  stock	  concentration	  of	  2mM.	  The	  working	  solution	  consists	  of	  0.4	  mM	  (3.5	  ng)	  and	  0.05	  mM	  p53	  MO	  (0.39	  ng;	  p53	  MO:	  5’-­‐GCGCCATTGCTTTGCAAGAATTG-­‐3’).	  RT-­‐PCR	   as	   a	   control	   for	   the	   splicing	   of	   the	   first	   exon	  was	   performed	  with	   the	  primers	   indicated	   in	   Figure	   4.7	   (primer	   F:	   5’-­‐GATGCGCGTATCGGTGCTG-­‐3’;	  primer	  R:	  5’-­‐	  CTCTGCAACACACTTGGGG-­‐3’).	  EST	   analysis	   for	   determination	   of	   the	   ORF	   of	   smoc2	   was	   performed	   using	   the	  primers	  in	  Table	  3.1.	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Clone	   Forward	  primer	  (5'	  -­‐	  3')	   Reverse	  primer	  (5'	  -­‐	  3')	  O-­‐Smoc2	  	   ATGCGCGTATCGGTGCTG	   GAATTCAGGGGGGTTTTTGGTGAT	  B-­‐Smoc2	   GCCTTGTTTCTTTGACAGGTTCAGTTTAC	  N-­‐Smoc2	  1	   GGCCTTGACAAATGCAACATGTAATAC	  N-­‐Smoc2	  2	   CCCGTTCCATGTGTGGTACAGG	  
Table	  3.1:	  Primer	  sequences	  used	  for	  cloning.	  	  The	  full-­‐length	  ORF	  of	  smoc2	  was	  cloned	  in	  the	  pCS2+	  expression	  vector	  (smoc2	  ORF-­‐F:	   5’-­‐TATATAATCGATATGCGCGTATCGGTG-­‐3’;	   smoc2	   ORF-­‐R:	   5’-­‐CTAGCCTTGTTTCTTTGACAGGTTCAG-­‐3’).	   Capped	   mRNA	   was	   generated	   using	  the	   mMESSAGE	   mMACHINE	   SP6	   Kit	   (Ambion)	   according	   to	   manufacturer’s	  protocol.	  Diluted	  MO	  or	  diluted	  mRNA	  was	  injected	  in	  one-­‐cell	  stage	  embryos	  in	  a	  volume	  of	  1	  nl.	   Injected	  embryos	  were	  maintained	  at	  28.5	  °C	  and	  analyzed	  at	  the	   appropriate	   stage.	   Images	   were	   acquired	   with	   DMR	   Leica	   and	   Stereo	  Discovery	  V8	  (Zeiss)	  microscopes.	  	  
3.2.2	  Chicken	  care	  &	  manipulations	  Fertilized	  White	  Leghorn	  eggs	  (Poel-­‐Houben,	  Halle,	  Belgium)	  were	  incubated	  in	  a	  humidified	  incubator	  at	  38°C	  for	  approximately	  48	  hours.	  Staging	  was	  performed	  according	   to	   the	   criteria	   of	   Hamburger-­‐Hamilton	   (Hamburger	   and	   Hamilton,	  1992).	   2-­‐3	   ml	   of	   albumin	   was	   removed	   to	   lower	   the	   embryo	   from	   the	   upper	  surface	   and	   prevent	   damaging	   of	   the	   embryo	   during	   the	   manipulations.	   By	  cutting	   a	   ‘window’	   in	   the	   upper	   surface	   of	   the	   shell	   the	   embryo	  was	   accessed.	  The	   lateral	   plate	   mesoderm	   of	   the	   right	   hindlimb	   was	   targeted	   by	   injecting	  multiple	  times	  with	  high-­‐titer	  viral	  supernatans	  suplemented	  with	  1/40	  1%	  Fast	  Greeen	   solution	   (Sigma-­‐Aldrich)	   in	  PBS.	  After	   adding	   an	   antibiotic/antimycotic	  solution,	   the	   eggs	   were	   sealed	   with	   clear	   tape	   and	   incubated	   until	   the	   stage	  required.	  	  	  
3.2.3	  Mouse	  care	  
Smoc2	  heterozygote	  mice	  were	  purchased	  from	  TIGM	  and	  crossed	  into	  the	  CD1	  background.	  Mouse	  colonies	  were	  housed	   in	  a	   conventional	  animal	   facility	  and	  maintained	  according	  to	  Animal	  Welfare	  Guidelines.	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3.2.4	  Whole-­‐mount	  in	  situ	  hybridization	  (WISH)	  All	   whole-­‐mount	   in	   situ	   hybridization	   (WISH)	   analyses	   were	   performed	   using	  digoxygenin-­‐labelled	   anti-­‐sense	   RNA	   probes,	   that	   were	   generated	   from	  linearized	  plasmids	  using	  SP6,	  T3	  or	  T7	  polymerase	  and	  a	  DIG	  RNA	  labeling	  mix	  (Roche	  Applied	  Science,	  manufacturers	  protocol).	  Subsequently	  the	  probes	  were	  purified	   using	   the	   microspin	   columns	   P-­‐30	   (Bio-­‐Rad).	   All	   but	   the	   smoc1	   and	  
smoc2	  probes	  were	  generous	  gifts	  from	  other	  labs	  (Table	  3.2).	  	  
 
Probe	   Source	   Probe	   Source	  
ntl	  
C.	  Houart	  (London)	  
flt4	   S.	  Schulte-­‐Merker	  (Leiden)	  pcdh8	   dll4	  
myod	   vegfc	  
chd	   draculin	   T.	  Takahashi	  (Manchester)	  
gata2	   hbbe1.1	  
runx1	   K.	  Crosier	  (Auckland)	   gata1	   C.	  Esguerra	  (Leuven)	  ikaros	   R.	  Patient	  (Oxford)	   nkx2.5	  c-­‐myb	   vox	  
lmo2	   vent	  
irf8	   Z.	  Wen	  (Hong	  Kong)	   krox20	   W.	  Annaert	  (Leuven)	  csf1ra	   chd	   C.	  Houart	  (London)	  c/ebp1	   pcdh8	  
tal1	   T.	  Evans	  (New	  York)	   myod	  
gata2	   ntl	  
spi1b	   N.	  Itoh	  (Kyoto)	   dHAND	   V.	  Zappavigna	  (Modena)	  
mpx	   SHH	   M.	  Logan	  (London)	  flk1	   M.	  Dewerchin	  (Leuven)	   BMP2	  
fli1	   FGF8	  
Table	  3.2:	  Probes	  used	  in	  this	  study	  and	  their	  sources	  Zebrafish	  probes	  in	  blue	  and	  chicken	  probes	  in	  yellow	  	  For	  smoc2,	  the	  ORF	  and	  the	  3’	  UTR	  was	  cloned	  in	  the	  pCR-­‐Script	  vector	  using	  the	  following	  primers:	  -­‐ smoc2	  probe	  S:	  5’	  –	  GATGCGCGTATCGGTGCTG	  –	  3’	  -­‐ smoc2	  probe	  AS:	  5’	  –	  GGCCTTGACAAATGCAACATGTAATAC	  –	  3’	  Dependent	  on	  the	  orientation	  of	  the	  amplified	  fragment,	  either	  a	  probe	  of	  the	  5’	  coding	  sequence	  or	  a	  probe	  of	  the	  3’	  UTR	  was	  generated.	  	  For	  smoc1,	  the	  following	  primers	  were	  used	  to	  clone	  the	  3’	  coding	  sequence:	  -­‐ smoc1	  probe	  S:	  5’	  –	  ATGATGGTTCCAAGCCCACACC	  –	  3’	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-­‐ smoc1	  probe	  AS:	  5’	  –	  GCGACCTTAACAAGGACAAGACCATC	  –	  3’	  	  3.2.4.1	  Zebrafish	  WISH	  was	   performed	   as	   described	   by	   the	   group	   of	   Thisse	   (Thisse	   and	   Thisse,	  2008).	  	  3.2.4.2	  Chicken	  WISH	  was	  performed	  according	  to	  (Salsi	  et	  al.,	  2008)	  	  
3.2.5	  Skeletal	  staining	  Skeletal	   staining	   was	   performed	   using	   Alcian	   Blue	   (8GX,	   Sigma-­‐Aldrich)	   and	  Alizarin	  Red	   (Sigma-­‐Aldrich)	   to	   stain	   cartilage	   and	  bone	   respectively.	  Embryos	  were	  collected	  and	  the	  limbs	  were	  isolated,	  fixed	  and	  dehydrated	  in	  95%	  ethanol	  for	  3-­‐5	  days.	  First	  the	  limbs	  were	  stained	  with	  Alcian	  Blue	  solution	  (20%	  glacial	  acetic	   acid,	   80%	   ethanol	   and	   150	  mg/ml	   Alcian	   Blue)	   for	   24	   hours.	   After	   two	  consecutive	  washes	  with	  95%	  ethanol	  for	  2	  days,	  the	  limbs	  were	  cleared	  in	  1%	  KOH	   for	  30-­‐60	  minutes.	  Next,	  all	  mineralized	   tissue,	   like	   the	  bone,	  was	  stained	  with	   Alizarin	   Red	   solution	   (1%	   KOH	   with	   50	   mg/ml)	   for	   4-­‐5	   hours.	   After	  additional	   clearing	   in	  1%	  KOH	   for	  12	  hours	  at	  4°C,	   they	  were	  passed	  every	  24	  hours	  to	  a	  solution	  with	  increasing	  ratios	  of	  1%	  KOH	  and	  glycerol	  (80:20,	  60:40,	  40:60,	  20:80).	  	  
3.2.6	  Immunohistochemistry	  P-­‐SMAD	  Embryonic	   zebrafish	  were	   fixed	  O/N	   in	  4%	  PFA	  and	  washed	  multiple	   times	   in	  PBST	   supplemented	   with	   1%	   DMSO.	   After	   blocking	   in	   blocking	   buffer	   (10%	  Normal	  Donkey	  Serum	  in	  PBST)	  for	  1	  hour,	   the	  embryos	  are	   incubated	  O/N	  on	  the	   rocking	   plate	   in	   the	   antibody	   solution	   (1/300	   diluted	   P-­‐SMAD	   1/5/8	  antibody	   (Cell	   Signaling,	   9511S)	   in	   blocking	   solution).	   Subsequently,	   the	  embryos	  are	  washed	   three	   times	   for	  an	  hour	  on	   the	   rocking	  plate	  and	  blocked	  again	  in	  blocking	  buffer	  for	  1	  hour.	  The	  secondary	  antibody	  is	  applied	  O/N	  at	  4°C	  (1/500	   donkey	   anti	   rabbit	   Alexa	   488/555	   (Invitrogen).	   Finally,	   unbound	  secondary	   antibodies	   are	   removed	   by	  washing	   three	   times	   for	   1	   hour	   in	   0.3%	  Triton-­‐100	  in	  PBS.	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3.2.7	  RNA	  extraction	  cDNA	  synthesis	  qPCR	  Embryos	  at	  12	  or	  20	  ss	  were	  fixed	  gently	  with	  1%	  trichloroacetic	  acid	  (TCA)	  on	  ice	  for	  10	  min,	  followed	  by	  dissection	  of	  the	  anterior	  part	  of	  the	  fish	  by	  cutting	  at	  the	   level	  of	   the	  most	  anterior	  somites	  (Law	  and	  Sargent,	  2013).	  Older	  embryos	  were	  clipped	  at	   the	  most	   rostral	  part	  of	   the	  yolk	  sac	  extension.	  Total	  RNA	  was	  isolated	   from	   10-­‐15	   dissected	   stage-­‐matched	   pooled	   embryos	   using	   the	   High	  Pure	  RNA	  Tissue	  Kit	   (Roche	  Applied	  Science;	  manufacturers	  protocol).	  At	   least	  four	   RNA	   isolations	   were	   performed	   per	   condition	   and	   subsequently	   reverse	  transcribed	   using	   Primescript	   RT	   Reagent	   (Takara;	   manufacturers	   protocol).	  Real-­‐time	  PCR	  was	  performed	  in	  duplicate	  with	  gene	  specific	  primers	  (Table	  3.3)	  with	  SYBR	  Premix	  Ex	  Taq	  II	  (Takara;	  manufacturers	  protocol)	  using	  Rotor-­‐gene	  6000	  detection	   system	  (Corbett	  Research,	  Westburg).	   Samples	  were	   confirmed	  to	   be	   anterior	   by	   checking	   anterior	   six3b	   expression	   and	   posterior	   charon	  expression.	   Gene	   expression	  was	  normalized	   to	   the	   housekeeping	   gene	  β-­‐actin	  and	  presented	  as	  a	  ratio	  to	  control	  embryos.	  The	  significance	  of	  the	  difference	  in	  expression	  was	  analyzed	  using	  the	  Student’s	  T-­‐test.	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Gene	   Forward	  primer	  (5'	  -­‐	  3')	   Reverse	  primer	  (5'	  -­‐	  3')	  
β-­‐actin	   TGCCCCTCGTGCTGTTTT	   TCCCATGCCAACCATCACT	  
alk8	   GCATTGCAGCTAAAGGATCCAA	   TCCTCAAGTGACTCTCAGCG	  
bmp2b	   CGACTCTCTGTCGTGGGATA	   TGATCAGTCAGTTCCGGAGG	  
bmp4	   GGCCTGCAAAGGCGTCCCAG	   CAGCTCCTCCAGGTGCTCTTCAT	  
c/ebpα	   GAGTACAGGCTGAGGAGGGA	   ACATTGCGCATTTTCGCCTT	  
c/ebp1	   TGCACATACACAGGATTTTGCT	   CCGGTACTCAGCACTGTCTT	  
c-­‐fos	   CAACTGTCACGGCGATCTCT	   GCCACAGAGGAGATCATGGG	  
charon	  	   AAAGTGGTGCACAAAAGCGA	   CGTTATGCGCTGTGTAAAGGG	  
chd	   GCTGTCCCATCTGTGAAGAGAA	   GTTCCAGGTGCGTGCATTTT	  
ctsk	   AGGCCATCGACCGTTTCAAT	   CCCATTCTGACCTGAGCGAT	  
ets1	   ACAGCGGATCTTGTTGAGGG	   TGTCCTCAAAGAATAGACGCCA	  
gata1	   GACTGACCTACTGCCATCGT	   AGACTTGGCGAACTGGACTG	  
gata2	   AAACTCCACAACGTCAACAGG	   CGAAACCCTCACCAGATCGT	  
gata4	   CACTTCGACAGCTCCGTACT	   CCTCGCAGATCATCAAAAACTCTAA	  
gata5	   CTGCCTGTGTCAGAAAACGC	   AACTGTGTCGATGCCTGTGT	  
gata6	   ACACTTTCTCTGCAACGCCT	   GAGGAAGACATGCGCTTCTG	  
ikaros	   CACAGAGGTTTGTGGGAGAGA	   ATTGCACTGTTGATGGCCTG	  
irf8	  	   TCCATTTTCAAAGCGTGGGC	   AGCGCAATCTGGTCTTCCAT	  
lmo2	  	   GGGACGCAGGCTTTACTACA	   CGTCCTGACCAAACAGTCTGA	  
mpx	   TTGTGCTCTTTCAGTGGGGG	   ACTTGTAAGCAGCGTCCACTA	  
nfatc	   ACCTGCCCACAAATGTTCCA	   TGAAGAGGCGCACATACCTG	  
rRNA	  (18S)	   CCTGCGGCTTAATTTGACTC	   GACAAATCGCTCCACCAACT	  
runx1	   AATCCTACCCTGCACCAACG	   CCTTCGCTCTGATTGGGGAG	  
six3b	   GCTGCCAAAAACAGGCTTCAG	   CAGCCCGATTCTGACATGGAG	  
spi1b	   AGTCAGAACGATCACTCTTGGG	   GTGACTGCACGCTTTGTAGC	  
tal1	   AAATCAACGATGGTTCGCAGC	   GTTCACATTCTGCTGTCGCC	  
ved	   CACACACACGAGTCTGGCTTCAG	   CGCCGGCCACTAGAGGGAGA	  
vox	   CTCGGCCTGTCGGAAACACAGATCA	   GGGAACGGGAGCCGCTGTCT	  
Table	  3.3:	  Primer	  sequences	  used	  for	  qPCR	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4.1	  Cloning	  of	  the	  zebrafish	  smoc2	  sequence	  	  	  We	  cloned	  zebrafish	  smoc2	  by	  analyzing	  available	  EST	  sequences	  and	  designing	  primers	   flanking	   the	   ORF.	   The	   complete	   ORF	  was	   then	   cloned	   into	   the	   pCS2+	  expression	   vector,	   which	   allows	   for	   the	   in	   vitro	   synthesis	   of	   polyadenylated	  mRNA.	  The	  sequence	  of	  this	  clone	  was	  compared	  to	  the	  online	  available	  data	  in	  order	   to	   detect	   potential	   point	   mutations	   introduced	   during	   PCR	   or	   cloning.	  Despite	  the	  fully	  sequenced	  zebrafish	  genome,	  the	  annotation	  of	  the	  genes	  in	  the	  database	   was	   and	   still	   is	   incomplete.	   Abnormalities	   in	   our	   clone	   were	   left	  undetected	  until	  April	  2012,	  with	  the	  publication	  of	  Bloch-­‐Zupan	  on	  craniofacial	  defects	  in	  smoc2	  morphants	  and	  the	  submission	  of	  the	  smoc2	  mRNA	  sequence	  on	  the	   NCBI	  website	   (Thisse,	   2001;	   Bloch-­‐Zupan	   et	   al.,	   2011).	   Comparison	   of	   the	  amino	  acid	  sequence	  of	  our	  clone	  (O-­‐Smoc2)	  with	  the	  clone	  of	  Bloch-­‐Zupan	  (B-­‐Smoc2)	   resulted	   in	   the	   identification	  of	   six	  point	  mutations	  of	  which	   five	  were	  located	  within	  the	  different	  domains	  of	  Smoc2.	  An	  additional	  stretch	  of	  37	  amino	  acids	  was	  found	  at	  the	  3’	  end	  of	  the	  gene,	  downstream	  of	  exon	  11,	  resulting	  in	  a	  sequence	  difference	  of	  over	  9%	  (Fig	  4.1).	  	  	  
	  
Figure	  4.1:	  Sequence	  alignment	  of	  different	  zebrafish	  Smoc2	  clones	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Comparison	   of	   the	   O-­‐Smoc2	   and	   B-­‐Smoc2	   clone	   indicated	   over	   9%	   difference	   in	   amino	   acid	   identity.	  Indicated	  in	  red	  are	  the	  residues	  that	  are	  different:	  six	  point	  mutations	  of	  which	  five	  are	  located	  in	  the	  SP,	  TY2	  and	  EC	  domain;	  a	  stretch	  of	  37	  amino	  acids	  at	  the	  3’	  end	  of	  the	  ORF.	  	  In-­‐depth	  analysis	  of	  this	  alternative	  3’	  end,	  revealed	  that	  it	  partially	  consisted	  of	  a	  pCS2+	   sequence	   (orange),	   and	   two	   smoc2	   genomic	  DNA	   fragments	   (blue	  and	  purple)	  (Fig	  4.2).	  	  	  
	  
Figure	  4.2:	  Schematic	  representation	  of	  the	  different	  Smoc2	  clones	  The	   lab	   clone	   contained	   six	   point	   mutations	   dispersed	   throughout	   the	   gene.	   Four	   different	   stretches	   of	  amino	   acids	   were	   identified	   (blue,	   purple,	   orange	   and	   green).	   A	   new	   EST	   assembly	   resulted	   in	   the	  identification	  of	   two	  overlapping	  contigs	   that	  did	  not	   contain	  any	  point	  mutation,	  nor	   the	  blue,	  purple	  or	  orange	  stretch	  of	  amino	  acids.	  Based	  on	  the	  contigs,	  new	  primers	  (I-­‐IV)	  were	  designed.	  	  	  The	   blue	   domain	   was	   also	   found	   in	   the	   publically	   available	   clone	   (accession	  number:	   JQ085591)	   and	   in	   the	   genomic	   DNA	   database	   (accession	   number:	  FR649726.1).	   The	   purple	   domain	   however	   was	   only	   found	   in	   the	   genomic	  sequence.	   The	   integration	   of	   these	   domains	   could	   be	   due	   to	   an	   alternative	  splicing	  event.	  Therefore,	  we	  used	  online	  available	  tools	  like	  Netgene2,	  ASSP	  and	  Human	  Splicing	  Finder,	  to	  analyze	  the	  splicing	  events	  of	  exon	  11	  (Brunak	  et	  al.,	  1991;	  Wang	  and	  Marin,	  2006;	  Desmet	  et	  al.,	  2009).	  Our	  analysis	   indicated	   that	  the	   blue	   domain	   was	   flanked	   by	   two	   splice	   donor	   sites,	   whereas	   the	   purple	  domain	  was	  not	  (Fig	  4.3A).	  So	  indeed,	  the	  integration	  of	  the	  blue	  domain	  in	  the	  
smoc2	  ORF	  could	  be	  due	  to	  an	  alternative	  splicing	  event.	  This	  domain	  was	  also	  picked	  up	  by	   the	   group	  of	  Dolfus	   (Bloch-­‐Zupan	  et	   al.,	   2011).	   Interestingly,	   this	  group	   submitted	   this	   clone	   to	   the	  NCBI	  website,	   but	   published	   and	  designed	   a	  MO	  in	  the	  same	  area	  based	  on	  the	  clone	  without	  the	  blue	  domain	  (Bloch-­‐Zupan	  et	  al.,	  2011).	  Using	   the	  online	  splicing	  analysis	   tools,	  a	  score	  was	  generated	   for	  the	  two	  splice	  donor	  sites	  of	  exon	  11.	  As	  the	  score	  for	  splice	  donor	  site	  A	  (red)	  was	  higher	  than	  the	  score	  for	  site	  B	  (yellow),	  it	  is	  therefore	  more	  likely	  to	  be	  the	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primary	  splice	  donor	  site	  (Fig	  4.3B).	  Yet	  it	  is	  important	  to	  mention	  that	  the	  score	  for	   site	   B	   is	   comparable	   to	   the	   score	   of	   other	   smoc2	   exon	   splice	   donor	   sites,	  which	  suggests	  that	  it	  can	  not	  be	  excluded	  that	  the	  splicosoom	  uses	  site	  B	  instead	  of	  site	  A.	  
	   	  
Figure	  4.3	  Splice	  donor	  site	  analysis	  A.	  Schematic	   representation	  of	   the	  genomic	   sequence	  of	   exon	  11	  with	   its	  blue	  domain,	   intron	  11	  and	   the	  green	   exon	   12.	   2	   splice	   donor	   sites	   were	   detected	   for	   exon	   11.	   B.	   Using	   the	   Human	   Splicing	   Finder,	   we	  analyzed	  the	  donor	  splice	  sites	  for	  all	  exons.	  	  Tracing	  back	  the	  cloning	  strategy	  of	  previous	  lab	  members,	  an	  antisense	  primer	  was	  found	  that	  complemented	  the	  3’	  end	  of	  the	  purple	  domain.	  So	  we	  conclude	  that	   the	   integration	   of	   the	   purple	   domain	   in	   the	   ORF	   of	   smoc2	   is	   due	   to	   an	  incorrect	  primer	  design.	  The	  integration	  of	  the	  orange	  domain,	  which	  was	  part	  of	  the	   pCS2+	   multiple	   cloning	   site,	   was	   most	   likely	   due	   to	   incorrect	   use	   of	  restriction	  enzymes	  and	  ligases.	  	  	  The	   biological	   consequences	   of	   these	   sequence	   alterations	   are	   unknown	   but	  could	  potentially	   influence,	  positively	  or	  negatively,	   the	   function	  of	   the	  protein	  by	   causing	   different	   folding	   properties,	   hence	   changing	   the	   interaction	   with	  other	   proteins	   or	   with	   its	   own	   domains.	   Furthermore,	   these	   mutations	   could	  affect	  the	  stability	  of	  the	  mRNA	  and	  therefore	  the	  amount	  of	  protein	  generated.	  Therefore	  we	  decided	  to	  reanalyze	  the	  ESTs	  and	  design	  different	  new	  primers	  (I-­‐IV)	  to	  reclone	  zebrafish	  smoc2	  in	  order	  to	  ensure	  that	  we	  were	  working	  with	  the	  correct	  and	  biologically	  relevant	  ORF	  (Fig	  4.2).	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  Our	   newly	   generated	   contigs	   did	   not	   contain	   point	   mutations	   or	   any	   of	   the	  domains	  indicated	  in	  blue,	  purple	  or	  orange	  (Fig	  4.2).	  Using	  the	  primer	  sets	  II-­‐IV,	  amplicons	  were	  generated,	  whereas	  the	  use	  of	  primer	  set	   I	  did	  not	  result	   in	  an	  amplified	   fragment,	   suggesting	   that	   this	   sequence	   information	   was	   incorrect.	  Cloning	  of	  this	  new	  smoc2	  ORF	  in	  pCS2+	  (N-­‐Smoc2)	  and	  subsequent	  sequencing	  indicated	   that	   no	  more	   point	  mutations	  were	   present.	   As	   anticipated,	   the	   blue	  domain,	  found	  in	  the	  O-­‐Smoc2	  protein	  and	  the	  B-­‐Smoc2	  protein,	  was	  not	  found	  in	  the	  N-­‐Smoc2	  protein.	  	  	  Unfortunately,	   the	   ENSEMBL	   database	   is	   not	   100%	   complete	   and	   correct.	   For	  zebrafish	   smoc2,	   two	   different	   transcripts	   were	   found.	   Each	   of	   them	   matches	  with	   either	   the	  5’	   or	   the	  3’	   end	  of	   our	   clone.	  Our	  newly	   generated	   clone	   could	  therefore	   not	   be	   compared	   to	   the	   database,	   not	   could	   the	   splicing	   events	   be	  assessed.	   In	   addition,	   the	   annotation	   of	   the	   different	   exons	   of	   smoc2	   is	  incomplete.	   Further	   optimization	   of	   the	   publically	   available	   zebrafish	   data	   is	  required	  to	  prevent	  problems	  like	  encountered	  during	  this	  project.	  	  
	  
4.2	  Sequence	  and	  expression	  analysis	  during	  zebrafish	  
development	  	  
Remark:	  The	  identification	  of	  the	  point	  mutations	  and	  the	  difference	  in	  the	  3’	  end	  of	  the	  ORF	   was	   done	   after	   a	   number	   of	   experiments	   were	   performed	   with	   this	   O-­‐Smoc2	   clone.	   After	   cloning	   the	   N-­‐Smoc2	   clone,	   these	   experiments	   were	  repeated.	   Despite	   the	   9%	   difference	   in	   amino	   acid	   identity,	   no	   different	  overexpression	  phenotypes	  could	  be	  detected	  with	  this	  correct	  N-­‐Smoc2	  clone.	  Therefore,	  the	  overexpression	  data	  obtained	  with	  the	  O-­‐Smoc2	  clone	  were	  still	  included	  and	  are	   still	   considered	   to	   be	   relevant.	  Yet,	  we	   are	   aware	   of	   the	   fact	  that	   the	   data	   on	   the	   O-­‐Smoc2	   clone	   could	   be	   biased	   due	   to	   the	   change	   in	  sequence.	  For	  the	  sequence	  analysis,	  the	  expression	  analysis,	  the	  domain	  study	  and	  the	  rescue	  of	  the	  morpholino	  phenotypes,	  the	  N-­‐Smoc2	  clone	  was	  used.	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Alignment	   of	   the	   protein	   sequence	   of	   zebrafish	   Smoc2	   revealed	   an	   identical	  organization	  of	  the	  different	  domains	  across	  species.	  Within	  the	  FS,	  TY,	  SMOC,	  EC	  domains	  the	  conservation	  is	  very	  high	  (55-­‐80%	  identity	  to	  human	  SMOC2),	  while	  in	   the	   SP	  domain	   and	   the	  C	   terminal	  part	   the	   conservation	   is	  much	   lower	   (Fig	  4.4).	  	  	  
	  
Figure	  4.4:	  Sequence	  alignment	  of	  Smoc2	  Amino	   acid	   sequence	   alignment	   (ClustalW)	   of	   Smoc2	   homologs	   reveals	   a	   high	   degree	   of	   sequence	  conservation	  and	  similar	  domain	  organization	  (green:	  identical	  residue;	  purple:	  conserved	  residue;	  yellow:	  similar	  residue).	  The	  signal	  peptide	   is	   indicated	   in	   light	  blue,	   the	  Follistatin-­‐like	  domain	   in	  dark	  blue,	   two	  Thyroglobulin	   domains	   flanking	   the	   putative	   SMOC	   domain	   in	   red	   and	   the	   extracellular	   calcium	   binding	  domain	  in	  orange,	  with	  the	  EF-­‐hand	  motifs	  in	  brown.	  	  To	   determine	   the	   spatiotemporal	   pattern	   of	   smoc2	   mRNA	   expression	   during	  zebrafish	  development,	  we	  performed	  whole	  mount	  in-­‐situ	  hybridization	  (WISH)	  using	   two	   non-­‐overlapping	   probes.	   During	   pregastrulation	   stages,	   smoc2	  expression	  was	  not	  spatially	  restricted	  (Fig	  4.5).	  During	  segmentation	  and	  later	  stages	   of	   development	   however,	   the	   expression	   pattern	   became	   restricted	   to	  anterior	   structures,	   with	   a	   predominant	   expression	   in	   the	   retina,	   notochord,	  anterior	   somites,	   lateral	   hindbrain,	   lateral	   epidermis,	   cerebellum,	   dorsal	  midbrain,	   telencephalon,	   and	   diencephalon.	   Furthermore,	   an	   additional	  expression	  pattern	   can	  be	   seen	  at	   later	   stages	   in	   the	   epidermis	  of	   the	   tail	   (see	  inset	   at	   30	   hpf).	   This	   smoc2	   expression	   pattern	   is	   in	   accordance	   with	   the	  available	  online	  data	  (www.zfin.org)	  (Thisse,	  2001).	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Figure	  4.5:	  Expression	  analysis	  of	  smoc2	  A-­‐I.	   Expression	   pattern	   of	   smoc2	   during	   the	   indicated	   stages	   of	   zebrafish	   development.	   The	   initial	  ubiquitous	  expression	  pattern	  becomes	  more	  anteriorly	  restricted	  as	  development	  progresses,	  although	  a	  caudal	  epidermal	  expression	  appears	  at	   later	  stages	  (see	   inset).	  From	  somitogenesis	  onwards,	   transcripts	  are	  detected	  in	  anterior	  somites	  (as),	  anterior	  and	  ventral	  retina	  (r),	  dorsal	  diencephalon	  (d),	  telencephalon	  (t),	  dorsal	  midbrain	  (dm),	  lateral	  hindbrain	  (lh),	  cerebellum	  (c)	  and	  the	  notochord	  (n).	  	  	  To	  ensure	  the	  expression	  pattern	  that	  is	  shown	  in	  Fig	  4.5	  was	  specific	  for	  smoc2	  and	  not	  smoc1	  transcripts,	  the	  expression	  patterns	  of	  both	  genes	  were	  compared	  (Fig	  4.6).	  At	  the	  onset	  of	  blood	  cell	  circulation,	  the	  expression	  pattern	  of	  smoc1	  mRNA	   didn’t	   overlap	   with	   the	   expression	   pattern	   of	   smoc2	   mRNA.	   These	  expression	  domains	  were	  in	  line	  with	  the	  online	  available	  data	  and	  allowed	  us	  to	  conclude	   that	   the	   smoc2	   probe	   is	   specific	   for	   the	   detection	   of	   the	   smoc2	  transcripts	  (Thisse,	  2001).	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Figure	  4.6:	  Differential	  expression	  of	  smoc1	  and	  smoc2	  27	  hpf;	  lateral	  view,	  anterior	  to	  the	  left.	  smoc1	  (A)	  and	  smoc2	  (B)	  transcripts	  were	  found	  in	  different	  tissues	  	  Additionally,	   we	   performed	   RT-­‐PCR	   analysis	   with	   smoc2	   specific	   primers	   at	  different	  developmental	  stages.	  Prior	  mid-­‐blastula	  stage,	  we	  could	  detect	  smoc2	  mRNA	   indicating	   that	  maternal	   smoc2	  mRNA	  was	  present	   in	   the	  early	  embryo.	  After	  zygotic	  transcription	  was	  initiated,	  smoc2	  mRNA	  continued	  to	  be	  expressed	  throughout	  all	  further	  stages	  analyzed	  (Fig	  4.7).	  	  
	  
Figure	  4.7:	  smoc2	  is	  expressed	  throughout	  all	  stages	  of	  zebrafish	  development	  RT-­‐PCR	   indicated	   smoc2	  mRNA	   is	   present	   in	   the	   embryo	   from	  early	   stages	   onwards	   and	   continues	   to	   be	  expressed	  after	  the	  mid-­‐blastula	  transition.	  	  Based	   on	   the	   sequence	   and	   expression	   analysis,	   we	   conclude	   that	   the	   smoc2	  sequence	   is	   evolutionary	   conserved	   with	   an	   identical	   domain	   organization	  across	   species	   and	   a	   high	   degree	   of	   amino	   acid	   sequence	   conservation.	   In	  addition,	  maternal	  smoc2	  mRNA	  is	  present	  before	  mid-­‐blastula	  transition.	  During	  later	  stages	  of	  development,	  smoc2	  is	  expressed	  in	  a	  ubiquitous	  way.	  From	  mid-­‐segmentation	   stages	   onwards,	   the	   expression	   becomes	   anteriorly	   restricted.	  Further	   experiments	   are	   required	   to	   determine	   the	   function	   of	   Smoc2	   during	  zebrafish	  development.	  	  
4.3	  smoc2	  loss	  of	  function	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Two	   different	   morpholinos	   (MO)	   were	   used	   to	   perform	   the	   loss-­‐of-­‐function	  experiments.	  An	  ATG-­‐MO,	   targeting	   the	   translation	  start	   site	  and	  a	  SPLICE-­‐MO,	  targeting	   the	   first	   exon-­‐intron	   boundary,	   prevents	   proper	   splicing	   of	   the	   pre-­‐mRNA	  (Fig	  4.8A).	  As	  a	  control	  for	  the	  splicing	  of	  intron	  1,	  an	  RT-­‐PCR	  analysis	  was	  performed	  24	  hours	  after	  injection	  with	  the	  SPLICE-­‐MO	  (Fig	  4.8B).	  With	  the	  first	  intron	  of	  smoc2	  spanning	  over	  50	  kb,	  no	  amplicon	  could	  be	  generated,	  using	  the	  primers	  F	  and	  R	  annotated	   in	  blue	   in	  Fig	  4.8A.	  Co-­‐injection	  with	   smoc2	  mRNA,	  where	  splicing	  already	  occurred,	  did	  allow	  for	  the	  amplification	  of	  the	  fragment	  as	  in	  the	  control	  conditions	  (Fig	  4.8B).	  The	  morpholinos	  were	  co-­‐injected	  with	  a	  
p53-­‐MO	   to	   prevent	   off-­‐targeting	   effects	   and	   the	   associated	   activation	   of	   p53-­‐mediated	   apoptosis	   (Robu	   et	   al.,	   2007).	   Both	   the	   injection	  of	   1	   nl	   of	  ATG-­‐	   (0.4	  mM,	  3.5	  ng)	  or	  the	  SPLICE-­‐MO	  (0.4	  mM,	  3.6	  ng)	  resulted	  in	  the	  same	  phenotype.	  For	  all	  subsequent	  experiments,	  the	  ATG-­‐MO	  was	  used.	  
	  
Figure	  4.8:	  smoc2	  loss-­‐of-­‐function	  strategy	  A.	  Diagram	  illustrating	  the	  MO	  and	  primer	  design.	  B.	  RT-­‐PCR	  using	  primers	  F	  and	  R	  indicated	  in	  A	  to	  analyze	  the	  splicing	  of	  intron	  1.	  	  
4.3.1	  smoc2	  knock	  down	  results	  in	  a	  mild	  ventralization	  Morphological	   analysis	   of	   morphant	   embryos	   at	   bud	   stage	   did	   not	   reveal	  apparent	   phenotypic	   abnormalities	   (Fig	   4.9A-­‐B).	   The	   first	   observable	  phenotypes	  in	  the	  morphants	  were	  detected	  during	  somitogenesis.	  At	  15	  ss,	  the	  posterior	   structures	   appeared	   compressed	  and	   reduced	   in	   length,	   and	  also	   the	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somites	   lost	   their	   typical	   chevron	   pattern	   (Fig	   4.9C-­‐D).	   In	   general,	   the	  development	  of	  the	  morphants	  was	  delayed	  as	  compared	  to	  the	  control	  embryos.	  The	   time	   point	   when	   the	   first	   blood	   cells	   entered	   the	   circulation	   and	   started	  flowing	  through	  the	  dorsal	  aorta	  and	  the	  posterior	  cardinal	  vein	  was	  delayed	  by	  2-­‐3	  hours	  (around	  29-­‐30	  hpf	   in	   the	  morphants	  versus	  26-­‐28	  hpf	   in	   the	  control	  embryos).	  At	  that	  moment,	  the	  location	  of	  the	  heart,	  development	  of	  the	  ear	  and	  initiation	  of	  the	  pigmentation	  of	  the	  eye	  were	  the	  same	  in	  control	  and	  morphant	  embryos.	  Therefore,	  and	  to	  correct	  for	  heterochronicity,	  the	  time	  point	  when	  the	  first	   blood	   cells	   started	   circulating	   was	   chosen	   to	   be	   a	   proper	   landmark	   for	  staging	  the	  embryos	  and	  comparing	  their	  phenotypes.	  	  At	  the	  onset	  of	  blood	  cell	  circulation,	  the	  yolk	  sac	  extension	  (YSE)	  of	  the	  ATG-­‐MO	  or	  SPLICE-­‐MO	  injected	  embryos	  appeared	  reduced	  in	  length	  (Fig	  4.9E-­‐G:	  colored	  lines)	  and	  the	  tail	  was	  kinked	  (Fig	  4.9E-­‐G).	  Posterior	  from	  the	  YSE,	  the	  posterior	  blood	   islands	   (PBI)	   appeared	   to	   be	   enlarged	   and	   denser	   in	   the	   morphants	   as	  compared	   to	   the	   control	   embryos	   (Fig	   4.9E-­‐G).	   Closer	   investigation	   and	  measurement	   of	   the	   surface	   area	   of	   the	   PBI	   indicated	   a	   significant	   increase	   in	  their	   size	   in	   morphant	   embryos	   (Fig	   4.9H-­‐J).	   As	   development	   progressed,	   the	  morphant	   defects	   became	   more	   pronounced	   with	   heart	   and	   yolk	   sac	   edema,	  heart	   defects	   similar	   to	   the	   heartstring	   phenotype	   (Garrity	   et	   al.,	   2002)	   and	   a	  compression	   of	   the	   anterior	   head	   structures	   along	   the	   anterior	   posterior	   axis	  (data	  not	  shown).	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Figure	  4.9:	  smoc2	  morphants	  present	  a	  mild	  ventralization	  defect	  A-­‐I.	   Lateral	   view	   of	   control	   embryos	   (A,	   C,	   E,	   H)	   and	   smoc2	   morphants	   (B,	   D,	   F,	   G,	   I)	   at	   bud	   stage	   (A-­‐B;	  anterior	  to	  the	  top),	  15	  ss	  (C-­‐D;	  anterior	  to	  the	  top)	  and	  the	  onset	  of	  circulation	  (E-­‐I;	  anterior	  to	  the	   left).	  
smoc2	  morphants	  presented	  anterior-­‐posterior	  outgrowth	  defects	  (C-­‐I),	  loss	  of	  ‘v-­‐shaped’	  somites	  (compare	  red	  lines	  in	  C-­‐D),	  shortened	  yolk	  extension	  (compare	  colored	  lines	  in	  E-­‐G),	  a	  downward	  curvature	  of	  the	  tail	  and	  denser	  and	  expanded	  blood	  islands	  (delineated	  with	  black	  dotted	  lines	  in	  E,G	  and	  magnification	  of	  the	  dotted	   region	   in	   H	   and	   I).	   J.	   Quantification	   of	   the	   surface	   of	   the	   PBI	   of	   control	   embryos	   (n=20),	   ATG	  morphants	  (n=29;	  *	  p<0.05)	  and	  SPLICE	  morphants	  (n=18;	  *	  p<0.05).	  	  To	   analyze	   the	   specificity	   of	   the	  MO,	   we	   performed	   a	   rescue	   experiment	  with	  
smoc2	  mRNA.	  As	  our	  ATG-­‐MO	  only	  binds	  to	  the	  first	  five	  bases	  of	  the	  ORF,	  and	  is	  therefore	  unable	  to	  block	  translation	  of	  the	  in	  vitro	  synthesized	  mRNA,	  we	  could	  use	   the	   latter	   to	   restore	   the	   levels	   of	   smoc2	   (Fig4.10A-­‐D).	   Co-­‐injection	   of	   the	  
smoc2	  ATG-­‐MO	  with	  smoc2	  mRNA	  at	  the	  one-­‐cell	  stage	  embryo	  resulted	  in	  a	  dose	  dependent	   rescue	   of	   the	   morphant	   phenotype	   at	   the	   onset	   of	   blood	   cell	  circulation.	   Up	   to	   63%	   of	   the	   embryos	   lacked	   morphant	   specific	   defects	   after	  injection	  with	   200	  pg	   of	   smoc2	  mRNA	   (Fig	   4.10E).	   Attempts	   to	   obtain	   a	   100%	  rescue,	  with	   a	   higher	   concentration	  of	   smoc2	  mRNA,	  were	  unsuccessful	   due	   to	  the	  high	  number	  of	  early	  gastrulation	  defects	   induced	  by	  the	  smoc2	  mRNA	  (Fig	  4.10C-­‐D)	   (Vuilleumier	   et	   al.,	   2010).	   Co-­‐injection	   of	   the	   SPLICE-­‐MO	  with	   smoc2	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mRNA	   resulted	   in	   a	   similar	   trend,	   although	   more	   embryos	   presented	   early	  gastrulation	  defects	  (data	  not	  shown).	  This	  was	  probably	  due	  to	  the	  late	  action	  of	  the	   SPLICE-­‐MO	   and	   the	   presence	   of	   the	  maternal	   smoc2	  mRNA.	   Therefore	   the	  amount	   of	   functional	   Smoc2	   accumulates,	   which	   results	   in	   more	   dorsalized	  defects.	  	   	  
	  
Figure	  4.10:	  Co-­‐injection	  of	  smoc2	  ATG-­‐morphants	  with	  smoc2	  mRNA	  rescues	  the	  MO	  phenotypes	  A-­‐D.	  Different	  phenotypes	  after	  co-­‐injection	  of	  smoc2	  ATG-­‐MO	  (0.4mM)	  and	  smoc2	  mRNA	  (200	  pg).	  A	  subset	  of	  embryos	  presented	  dorsalized	  phenotypes	  (C-­‐D).	  Success	  of	  injection	  is	  monitored	  in	  insets.	  E.	  Injection	  of	   increasing	   concentrations	   of	   smoc2	   mRNA	   resulted	   in	   a	   higher	   percentage	   of	   embryos	   without	   the	  morphant	  phenotype.	  	  Together,	   we	   showed	   that	   smoc2	   morphants	   displayed	   a	   mild	   ventralization	  defect	  with	  an	  apparent	  increase	  in	  the	  size	  of	  the	  PBI.	  This	  defect	  was	  shown	  to	  be	  specifically	  induced	  by	  the	  silencing	  of	  smoc2.	  	  
4.3.2	  Molecular	  analysis	  of	  the	  PBI	  defect	  in	  the	  smoc2	  morphants	  To	  confirm	  our	  morphological	  observation	  that	  the	  morphants	  had	  an	  expanded	  PBI,	   we	   performed	   WISH	   analysis	   using	   several	   PBI	   markers	   (gata1,	   ikaros,	  
draculin	  (Fig	  4.11A-­‐F)	  and	  hbbe1.1	  (data	  not	  shown))	  at	  the	  time	  point	  when	  the	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first	  blood	   cells	   started	   flowing	  and	   could	   show	   that	   the	   transcription	  of	   these	  markers	   was	   apparently	   upregulated	   in	   the	   morphants	   and	   confirmed	   the	  morphological	   observation	   of	   the	   increase	   in	   the	   size	   of	   the	   PBI	   (Fig	   4.11A-­‐F).	  Interestingly,	  mpx,	   a	  marker	   for	   both	   the	   posterior	   and	   the	   anterior	   or	   rostral	  blood	   islands	  (RBI),	  appeared	  downregulated	   in	  smoc2	  ATG	  morphants	   in	  both	  populations	  of	  blood	  cell	  progenitors	  (Fig	  4.11G-­‐H)	  and	  co-­‐injection	  with	  smoc2	  mRNA	  rescued	  the	  loss	  of	  mpx	  transcripts	  in	  both	  the	  RBI	  and	  the	  PBI	  (Fig	  4.11J).	  This	   loss	  and	  rescue	  of	  mpx	  expression	  was	  also	  seen	  in	  the	  SPLICE	  morphants	  (Fig	  4.11I,	  K)	  indicating	  that	  both	  smoc2	  morpholinos	  act	  specifically	  on	  the	  same	  transcript	  resulting	  in	  similar	  morphological	  and	  molecular	  phenotypes.	  	  	  
	  
Figure	  4.11:	  smoc2	  morphants	  display	  an	  enlarged	  PBI	  and	  a	  reduced	  expression	  of	  mpx.	  Lateral	  view	  of	  control	  embryos	  (A,	  C,	  E,	  G),	  smoc2	  morphants	  (B,	  D,	  F,	  H,	  I),	  and	  rescued	  morphants	  ((J,	  K)	  at	  the	   onset	   of	   blood	   cell	   circulation.	   Analysis	   of	   the	   expression	   pattern	   of	   the	   PBI	   markers	   gata1	   (A-­‐B),	  
draculin	  (C-­‐D)	  and	  ikaros	  (E-­‐F).	  The	  neutrophil	  specific	  marker	  mpx	  (G-­‐K)	  indicates	  an	  enlarged	  PBI	  with	  a	  reduction	   in	  mpx	  expression	   in	  both	  the	  PBI	  and	  the	  RBI.	  This	  signal	  was	  restored	  upon	  co-­‐injection	  with	  
smoc2	  mRNA.	  	  The	   apparent	  morphological	   enlargement	   of	   the	  PBI	   is	   therefore	   supported	  by	  the	  results	  of	  the	  WISH	  analysis.	  Similar	  PBI	  phenotypes	  were	  seen	  in	  zebrafish	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embryos	  where	   the	   levels	  of	  Bmp	  signaling	  were	  altered	   (Dal-­‐Pra	  et	  al.,	  2006).	  Therefore,	  we	   investigated	  whether	  an	  early	  defect	   in	  dorso-­‐ventral	  patterning	  caused	   this	  phenotype	  by	  analyzing	   the	  expression	  of	  chordin,	   at	   this	   stage	   the	  dominant	   Bmp	   antagonist,	   vox	   and	   vent,	   two	   Bmp	   target	   genes,	   and	   the	  phosphorylation	  status	  of	  the	  Smad1/5/8	  proteins,	  the	  intracellular	  mediators	  of	  Bmp	  signaling	  (Imai	  et	  al.,	  2001;	  Gilardelli	  et	  al.,	  2004).	  Detecting	  a	  change	  in	  the	  
smoc2	  morphants	  could	  provide	  us	  with	  a	  molecular	  mechanism	  that	   is	  needed	  to	  determine	  the	  function	  of	  Smoc2.	  Yet,	  when	  comparing	  the	  control	  embryos	  to	  the	   smoc2	   morphants,	   no	   change	   could	   be	   detected	   in	   either	   the	   expression	  domains	   or	   levels	   of	   chordin,	   vox	   or	   vent,	   or	   the	   activation	   of	   the	   Smad1/5/8	  proteins	  (Fig	  4.12).	  	   	  
	  
Figure	  4.12:	  smoc2	  knockdown	  does	  not	  result	  in	  early	  dorso-­‐ventral	  patterning	  defects.	  A-­‐D,	  E,	  F,	   I-­‐L,	  M-­‐P.	  Animal	  view,	  dorsal	   to	   the	   right.	  G,	  H.	  Lateral	   view,	  dorsal	   to	   the	   right.	  A-­‐D,	   I-­‐P.	  WISH	  analysis	   for	   the	  extracellular	  Bmp	   inhibitor	   chd	   (A-­‐D)	  and	   the	  Bmp	   target	  genes	  vox	   (I-­‐L)	  and	  vent	   (M-­‐P)	  (n≥19).	  E-­‐H.	  Immunostaining	  for	  phosphorylated	  Smad1/5/8	  proteins	  (n≥23).	  	  The	   enlargement	   of	   the	   PBI	   could	   not	   be	   attributed	   to	   a	   change	   in	   early	   Bmp	  signaling.	  However,	  this	  defect	  could	  be	  caused	  by	  the	  impaired	  axial	  outgrowth,	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meaning	   this	   could	   be	   a	   secondary	   defect.	   Therefore,	   and	   as	   smoc2	   was	  predominantly	   expressed	   in	   the	   anterior	   half	   of	   the	   zebrafish	   and	   as	   there	  appears	   to	  be	  a	  defect	   in	   the	  RBI,	  next	   to	   the	  defect	   in	   the	  PBI,	  we	   focused	  our	  attention	  on	  the	  anterior	  domain.	  	  The	   anterior	   lateral	   plate	   mesoderm	   is	   the	   primary	   site	   for	   embryonic	  myelopoiesis.	   As	   smoc2	   dependent	   regulation	   of	   these	   myeloid	   cells	   is	   only	  possible	  when	  smoc2	  is	  expressed	  in	  the	  proximity	  of	  myeloid	  regulatory	  genes,	  we	   analyzed	   the	   expression	   pattern	   of	   smoc2	   in	   relation	   to	   the	   expression	  pattern	  of	   tal1	   and	   spi1b,	   two	   regulatory	   genes	   required	   for	   the	   induction	   and	  differentiation	   of	   the	   myeloid	   lineage.	   As	   the	   protocol	   for	   dual	   colored	   WISH	  analysis	  was	  not	  optimized	  in	  the	  lab,	  we	  performed	  this	  expression	  analysis	  in	  relation	  to	  krox20,	  the	  marker	  for	  rhombomere	  3	  and	  5	  (Fig	  4.13)	  (Thisse,	  2001).	  At	  the	  5	  ss,	  a	  weak	  but	  apparent	  smoc2	  expression	  in	  the	  anterior	  lateral	  domain	  could	  be	  detected	  in	  proximity	  of	  tal1	  and	  spi1b	  expression	  (arrow	  in	  Fig	  4.13C).	  According	   to	   the	  publically	  available	  data	  of	  Thisse,	   this	  anterior	  expression	  of	  
smoc2	  is	  restricted	  to	  the	  epidermis	  (Thisse,	  2001).	  Additional	  marker	  analysis	  is	  required	  to	  confirm	  this.	   	  
	  
Figure	  4.13:	  smoc2	  is	  expressed	  in	  the	  proximity	  of	  tal1	  and	  spi1b	  expressing	  cells.	  Dorsal	  views,	  anterior	  to	  the	  top	  of	  uninjected	  embryos	  at	  5	  ss.	  Analysis	  of	  the	  expression	  pattern	  of	  tal1	  (A),	  
spi1b	  (B)	  and	  smoc2	  (C)	  in	  relation	  to	  krox20	  (rhombomere	  3	  and	  5)	  (n≥20).	  	  Together,	  we	  have	  shown	  that	  our	  morphological	  observation	  of	  an	  enlarged	  PBI	  was	   confirmed	   by	   the	   molecular	   analysis	   of	   PBI	   markers.	   These	   defects	   were	  shown	   not	   to	   be	   induced	   by	   a	   defective	   DV	   patterning	   at	   earlier	   stages	   of	  development.	   In	   addition,	   we	   detected	   an	   additional	   defect	   for	   the	   myeloid	  marker	  mpx	  in	  both	  the	  RBI	  as	  the	  PBI	  and	  we	  showed	  that	  smoc2	  was	  expressed	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in	   close	   proximity	   of	   the	   hematopoietic	   regulatory	   genes	   tal1	   and	   spi1b	   in	   the	  ALPM,	  which	  suggests	  that	  smoc2	  could	  affect	  their	  function.	  	  
4.3.3	  smoc2	  modulates	  early	  embryonic	  myelopoiesis	  	  To	  further	  explore	  the	  anterior	  myeloid	  defect,	  we	  investigated	  the	  status	  of	  the	  hemangioblast	  in	  smoc2	  morphants	  by	  analyzing	  the	  expression	  of	  tal1,	  lmo2	  and	  
gata2,	   the	   molecular	   markers	   for	   these	   precursor	   cells	   (Fig	   4.14A-­‐L)	   in	   the	  ALPM.	  At	  12	  ss,	  WISH	  analysis	   indicated	  a	  reduced	  expression	   level	  without	  an	  apparent	   change	   in	   the	   size	   of	   the	   domain	   of	   tal1.	   The	   qPCR	   analysis	   on	   RNA	  isolated	  from	  the	  anterior	  tissues	  confirmed	  the	  reduction	  in	  the	  expression	  level	  of	  tal1	  mRNA.	  This	  reduction	  could	  be	  rescued	  by	  co-­‐injection	  with	  smoc2	  mRNA	  supporting	   the	   notion	   that	   the	   tal1	   phenotype	   was	   specifically	   induced	   upon	  knockdown	  of	  smoc2	  (Fig	  4.14A-­‐D).	  The	  expression	  of	  lmo2	  was	  also	  significantly	  reduced	   upon	   reduction	   of	   the	   levels	   of	   smoc2	   (Fig	   4.14E-­‐H).	   However,	   no	  significant	  change	   in	  expression	   levels	  of	  gata2	  could	  be	  detected	  (Fig	  4.14I-­‐L).	  Nevertheless,	   the	   significant	   reduction	   in	   tal1	   and	   lmo2	   expression	   in	   smoc2	  morphants	   supports	   the	   requirement	   for	   Smoc2	   during	   hemangioblast	  development	  in	  the	  ALPM.	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Figure	  4.14:	  smoc2	  morphants	  display	  hemangioblast	  defects	  at	  12	  ss	  A-­‐C,	  E-­‐G,	  I-­‐K.	  Dorsal	  view	  of	  anterior	  lateral	  plate	  mesoderm;	  anterior	  to	  the	  top.	  WISH	  analysis	  for	  tal1	  (A-­‐C),	  lmo2	  (E-­‐G),	  gata2	  (I-­‐K)	  of	  control	  embryos,	  ATG	  morphants	  and	  rescue	  embryos	  at	  12	  ss	  (n≥12)..	  D,	  H,	  L.	  Quantification	  of	  changes	  in	  expression	  levels	  by	  qPCR.	  Values	  plotted	  as	  mean	  ±	  SEM;	  n≥4;	  *	  p<0.05.	  	  Within	  the	  myelopoietic	  lineage,	  the	  hemangioblasts	  develop	  into	  spi1b	  positive	  granulocyte-­‐myeloid	  progenitors.	  In	  the	  ALPM,	  spi1b	   induces	  its	  own	  repressor,	  
runx1,	   thereby	   creating	   a	   negative	   regulatory	   loop	   (Jin	   et	   al.,	   2012).	  WISH	  and	  qPCR	  analysis	  for	  spi1b	  and	  runx1	  at	  12	  ss	  showed	  a	  reduction	  in	  the	  expression	  domain	  and	  levels	  of	  both	  markers	  upon	  injection	  with	  smoc2	  MO	  (Fig	  4.15A-­‐H).	  For	   spi1b	   and	   runx1,	   the	   expression	   could	   be	   restored	   by	   co-­‐injecting	   smoc2	  mRNA.	   The	   expression	   of	   another	   early	   myeloid	   marker,	   c-­‐myb,	   apparently	  changed	  when	  analyzed	  by	  WISH	  but	  the	  quantification	  by	  qPCR	  did	  not	  support	  that	  observation	  (Fig	  4.15I-­‐L).	  	  
	  	  
Figure	  4.15:	  smoc2	  morphants	  display	  defects	  in	  embryonic	  hematopoiesis	  at	  12	  ss	  A-­‐C,	  E-­‐G,	  I-­‐K.	  Dorsal	  view	  of	  anterior	  lateral	  plate	  mesoderm;	  anterior	  to	  the	  top.	  WISH	  analysis	  for	  spi1b	  (A-­‐C),	  runx1	  (E-­‐G),	  c-­‐myb	  (I-­‐K)	  of	  control	  embryos,	  ATG	  morphants	  and	  rescue	  embryos	  at	  12	  ss	  (n≥12).	  	  D,	  H,	  L.	  Quantification	  of	  changes	  in	  expression	  levels	  by	  qPCR.	  Values	  plotted	  as	  mean	  ±	  SEM;	  n≥4;	  *	  p<0.05.	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At	  18	  ss,	  the	  hemangioblast	  marker	  tal1	  did	  not	  change	  anymore,	  whereas	  lmo2	  still	   did	   significantly	   (Fig	   4.16A-­‐H).	   Similarly,	   the	   granulocyte-­‐macrophage	  progenitor	   specific	   spi1b	   expression	   was	   still	   downregulated	   in	   the	   smoc2	  morphants	   (Fig	   4.16I-­‐L).	   In	   addition,	   runx1	   and	   c-­‐myb	   showed	   a	   significant	  reduction	   in	   their	  expression	   in	   the	  smoc2	  morphants	  both	  by	  WISH	  and	  qPCR	  (Fig	   4.16M-­‐T).	   Co-­‐injection	   with	   smoc2	   mRNA	   resulted	   in	   a	   significant	  restoration	  of	  the	  expression	  levels	  of	  all	  markers,	  except	  lmo2	  (Fig	  4.16D,	  H,	  L,	  P,	  T).	  	   	  
	  
Figure	  4.16:	  smoc2	  morphants	  display	  defects	  in	  embryonic	  hematopoiesis	  at	  20	  ss	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A-­‐C,	  E-­‐G,	  I-­‐K,	  M-­‐O,	  Q-­‐S.	  Dorsal	  view	  of	  anterior	  lateral	  plate	  mesoderm;	  anterior	  to	  the	  top.	  WISH	  analysis	  for	  
tal1	  (A-­‐C),	  lmo2	  (E-­‐G),	  spi1b	  (I-­‐K),	  runx1	  (M-­‐O),	  c-­‐myb	  (Q-­‐S)	  of	  control	  embryos,	  ATG	  morphants	  and	  rescue	  embryos	  at	  20	  ss	  (n≥11).	  D,	  H,	  L,	  P,	  T.	  Quantification	  of	  changes	  in	  expression	  levels	  by	  qPCR.	  Values	  plotted	  as	  mean	  ±	  SEM;	  n≥4;	  *	  p<0.05.	  	  
spi1b	   was	   shown	   previously	   to	   downregulate	   the	   expression	   of	   the	   erythroid	  specific	   gene	   gata1.	  Hence,	   a	   reduction	   of	   Spi1b	   levels	   induced	   ectopic	   gata1	  expression	   in	   the	  ALPM	  at	   24	   hpf	   (Rhodes	   et	   al.,	   2005;	  Monteiro	   et	   al.,	   2011).	  However,	  our	  WISH	  and	  qPCR	  analysis	  did	  not	  indicate	  an	  ectopic	  expression	  of	  this	  erythroid	  marker	  at	  the	  onset	  of	  blood	  cell	  circulation	  (Fig	  4.11A-­‐B	  and	  data	  not	  shown).	  	  In	   summary,	   during	   the	   initial	   stages	   of	   hematopoietic	   development,	   the	  knockdown	   of	   smoc2	   resulted	   in	   defective	   hemangioblast	   and	   myeloid	  progenitor	  development	  in	  the	  ALPM.	  	  	  
4.3.4	  The	  myelopoietic	  defect	   induced	  by	  smoc2	  knockdown	  persists	  until	  
the	  onset	  of	  circulation	  	  At	  the	  end	  of	  segmentation,	  spi1b	  positive	  progenitors	  give	  rise	  to	  irf8	  and	  csf1ra	  expressing	   macrophages	   and	   c/ebp1	   and	   mpx	   expressing	   neutrophils.	   To	  investigate	   the	   effect	   of	   the	   early	   defects	   in	   smoc2	   morphants	   on	   myeloid	  development,	   we	   performed	  WISH	   and	   qPCR	   analysis	   for	   these	  marker	   genes.	  The	   earliest	   myeloid	   marker,	   irf8,	   specific	   for	   developing	   macrophages,	   was	  significantly	  downregulated	  in	  morphants	  at	  18	  ss	  (Fig	  4.17A-­‐D)	  (Li	  et	  al.,	  2011).	  	  At	  the	  moment	  when	  the	  first	  blood	  cells	  start	  circulating,	  the	  macrophage	  defect	  persisted,	  as	   the	  number	  of	  csf1ra	  positive	  cells	  was	  reduced	   in	   the	  morphants	  compared	  to	  the	  control	  or	  the	  rescue	  condition	  (Fig	  4.17E).	  Similar	  results	  were	  found	  when	  analyzing	  the	  irf8,	  c/ebp1	  or	  the	  mpx	  positive	  cells	  (Fig	  4.17F-­‐H).	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Figure	  4.17:	  The	  early	  smoc2	  morphant	  defects	  result	  in	  defective	  myeloid	  development	  	  A-­‐C.	   Dorsal	   view	   of	   anterior	   lateral	   plate	  mesoderm;	   anterior	   to	   the	   top.	  WISH	   analysis	   for	   irf8	   (A-­‐C)	   of	  control	   embryos,	   ATG	   morphants	   and	   rescue	   embryos	   at	   20	   ss	   (n≥11).	   D.	   Quantification	   of	   changes	   in	  expression	  levels	  by	  qPCR.	  Values	  plotted	  as	  mean	  ±	  SEM;	  n≥4;	  *	  p<0.05.	  E-­‐H.	  Lateral	  views	  of	  the	  embryos,	  anterior	  to	  the	  left,	  dorsal	  to	  the	  top,	  at	  the	  onset	  of	  blood	  cell	  circulation.	  Analysis	  of	  the	  expression	  pattern	  of	  the	  macrophage	  marker	  csf1ra	  (E)	  and	  the	  early	  macrophage	  marker	  irf8	  (F),	  the	  early	  neutrophil	  marker	  
c/ebp1	  (G),	  and	  the	  late	  neutrophil	  marker	  mpx	  (H).	  	  	  To	   confirm	   the	   anterior	   myeloid	   defect	   at	   this	   late	   stage,	   qPCR	   analysis	   was	  performed	   on	   the	   anterior	   part	   of	   the	   embryo	   at	   the	   onset	   of	   blood	   cell	  circulation.	  For	  csf1ra,	  no	  quantitative	  analysis	  was	  performed,	  as	  csf1ra	  at	  this	  stage	   also	   marks	   the	   neural	   crest-­‐derived	   pigment	   cells,	   masking	   the	  macrophage	   defect	   (Parichy	   et	   al.,	   2000).	   Although	   the	   WISH	   indicates	   a	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decrease	  in	  the	  number	  of	  irf8	  positive	  cells,	  this	  could	  not	  be	  reproduced	  by	  the	  qPCR	   (Fig	   4.18A).	  However,	   for	   c/ebp1	   and	  mpx	   a	   significant	   decrease	   in	   their	  expression	   levels	   could	   be	   detected	   (Fig	   4.18B-­‐C).	   This	   neutrophil	   defect	  persisted	   until	   later	   stages	   of	   development	   as	   the	   Tg(mpx:GFP)i114	   transgenic	  reporter	  fish,	  used	  to	  study	  neutrophilic	  inflammation,	  still	  showed	  a	  significant	  reduction	   in	   the	   number	   of	   GFP	   positive	   cells	   as	   compared	   to	   the	   control	  embryos	  at	  3	  dpf	  (Fig	  4.18D-­‐E)	  (Gray	  et	  al.,	  2011).	  	  
	  
Figure	  4.18:	  Quantification	  of	  neutrophil	  defect.	  	  qPCR	  analysis	  of	  the	  early	  macrophage	  marker	  irf8	  (A),	  the	  early	  neutrophil	  marker	  c/ebp1	  (B),	  and	  the	  late	  neutrophil	   marker	   mpx	   (C).	   Values	   plotted	   as	   mean	   ±	   SEM;	   n=4;	   *	   p<0.05.	   D-­‐E.	   Visualization	   and	  quantification	  of	  the	  mpx-­‐positive	  cells	  using	  the	  mpx	  reporter	  embryos	  (Tg(mpx:GFP)i114)	  at	  3	  dpf	  and	  the	  quantification	   of	   the	   number	   of	   neutrophils	   in	   the	   ATG	   morphants	   (n=42)	   as	   compared	   to	   the	   control	  embryos	  (n=12;	  *	  p<0.05).	  	  In	   summary,	   the	  defect	   in	  hemangioblast	   and	  myeloid	  progenitor	  development	  resulted	  in	  a	  loss	  of	  neutrophils	  and	  macrophages	  at	  later	  stages	  of	  development.	  	  
4.3.5	  smoc2	  does	  not	  modulate	  early	  cardiovascular	  development	  	  During	   gastrulation,	   the	   interaction	   of	   multiple	   transcription	   factors	   (gata4,	  
gata5,	  gata6,	   tal1,	  nkx2.5	   and	   fli1,	   among	  others)	   induces	  differentiation	  of	   the	  ALPM	   into	   hematopoietic,	   vascular	   and	   cardiac	   progenitors	   (Peterkin	   et	   al.,	  2009).	   qPCR	   analysis	   of	   the	   smoc2	   morphants	   for	   the	   mesodermal	   markers	  
gata4,	   gata5,	   gata6	   and	   ets1	   did	   not	   indicate	   early	   mesodermal	   defects	   (Fig	  4.19).	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Figure	  4.19:	  smoc2	  morphants	  do	  not	  present	  early	  mesodermal	  defects	  qPCR	  analysis	  of	  the	  early	  mesodermal	  markers	  gata4,	  gata5,	  gata6	  and	  ets1.	  	  To	   assess	   possible	   defects	   in	   cardiovascular	   development,	   we	   examined	   the	  effect	  of	  reducing	  smoc2	  levels	  on	  the	  expression	  of	  vascular	  and	  cardiac	  markers	  (Fig	   4.20A-­‐R’).	   Consistent	   with	   our	   morphological	   observations,	   no	   ectopic	   or	  loss	   of	   expression	   was	   seen	   in	   the	   expression	   pattern	   of	   the	   cardiac	   marker	  
nkx2.5	   at	  12	  ss	  and	  20	  ss	   (Fig	  4.20A-­‐D)	  or	   the	  vascular	  markers	   (fli,	  vegfc,	   flt4,	  
flk1,	  dll4)	  at	  12	  ss,	  20	  ss	  and	  at	  the	  onset	  of	  blood	  cell	  circulation	  (Fig	  4.20E-­‐R’)	  (Chen	  and	  Fishman,	  1996;	  Thompson	  et	  al.,	  1998;	  Ober	  et	  al.,	  2004;	  Hofmann	  and	  Luisa	   Iruela-­‐Arispe,	   2007).	   Also,	   the	   analysis	   of	   the	   vascular	  Tg(fli:eGFP)y1	   and	  the	   cardiac	  Tg(myl7:GFP)	   reporter	   line	   at	   24	   and	   50	   hpf,	   respectively,	   did	   not	  indicate	  a	  defect	   in	  cardiac	  or	  vascular	  development	  (Fig	  4.20Q-­‐R’	  and	  data	  not	  shown)	  (Lawson	  and	  Weinstein,	  2002;	  Huang	  et	  al.,	  2003).	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Figure	  4.20:	  smoc2	  morphants	  do	  not	  display	  cardiovascular	  defects	  Dorsal	   (A-­‐D:	   anterior	   to	   the	   top;	   E-­‐H:	   anterior	   to	   the	   left)	   and	   lateral	   view	   (I-­‐P;	   anterior	   to	   the	   left)	   of	  embryos	  at	  12	  ss	  (A-­‐B,	  E-­‐F),	  20	  ss	  (C-­‐D,	  G-­‐H),	  the	  onset	  of	  circulation	  (I-­‐P)	  and	  50	  hpf	  (Q-­‐R’).	  Analysis	  of	  the	  expression	  pattern	  of	  the	  early	  cardiac	  marker	  nkx2.5	  (A-­‐D),	  the	  vascular	  marker	  fli	  (E-­‐H),	  the	  dorsal	  aorta	  marker	  vegfc	  (I-­‐J),	  the	  marker	  for	  all	  venous	  and	  arterial	  cells	  flt4	  (K-­‐L),	  the	  endothelial	  marker	  flk1	  (M-­‐N)	  and	  the	  arterial	  marker	  dll4	  (O-­‐P)	  (n≥14)..	  (Q-­‐R’)	  Vasculature	  in	  fli	  reporter	  embryos	  (Tg(fli:eGFP)y1)	  at	  50	  hpf	  (n≥11).	  	  In	  summary,	  Smoc2	  deficiency	  did	  not	  influence	  the	  differentiation	  or	  outgrowth	  of	  the	  cardiovascular	  system.	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4.3.6	  smoc2	  affects	  the	  expression	  of	  Bmp	  target	  genes	  in	  the	  ALPM	  during	  
embryonic	  myelopoiesis	  	  It	   has	   been	   reported	   that	   Alk8-­‐mediated	   Bmp	   signaling	   is	   required	   for	   rostral	  
spi1b	  expression	  and	  the	  subsequent	  specification	  of	  myeloid	  progenitor	  cells	  in	  the	   RBI	   (Hogan	   et	   al.,	   2006).	   Therefore	  we	   performed	   a	   qPCR	   analysis	   on	   the	  ALPM	   at	   12	   ss	   to	   evaluate	   the	   effect	   of	   smoc2	   knockdown	   on	  members	   of	   the	  Bmp	   signaling	   cascade	   (Fig	   4.21A).	   The	   expression	   level	   of	   the	   ligands	   bmp2b	  and	  bmp4	  did	  not	  change	  significantly.	  Neither	  did	  the	  expression	  of	  extracellular	  Bmp	  inhibitor,	  chd,	  nor	  the	  Bmp	  type	  I	  receptor	  alk8.	  However,	  the	  expression	  of	  the	  Bmp	  target	  genes	  vox	  and	  ved,	  was	  significantly	  downregulated	  in	  the	  smoc2	  morphants	  (Imai	  et	  al.,	  2001;	  Gilardelli	  et	  al.,	  2004).	  This	  reduction	  was	  partially	  rescued	  by	  co-­‐injection	  of	  smoc2	  mRNA	  supporting	   the	  observation	   that	  smoc2	  knockdown	   could	   affect	   Bmp	   signaling	  without	   affecting	   the	   expression	   of	   the	  ligands,	   the	  receptor	  or	   its	  extracellular	   inhibitors.	  To	  confirm	  the	  qPCR	  result,	  we	  performed	  a	  WISH	  analysis	  for	  vox	  (Fig	  4.21B-­‐C).	  At	  12	  ss,	  the	  expression	  of	  
vox	  in	  the	  anterior,	  and	  medial	  structures	  appeared	  to	  be	  reduced	  upon	  injection	  with	   the	   smoc2	  ATG-­‐MO.	  Furthermore,	   the	  gradient	  at	   the	  posterior	  end	  of	   the	  embryo	   appears	   to	   be	   steeper	   when	   compared	   to	   the	   control	   condition	   (Fig	  4.21B).	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Figure	  4.21:	  smoc2	  modulates	  Bmp	  signaling	  in	  the	  ALPM	  at	  12	  ss	  A.	  qPCR	  analysis	  of	  members	  of	  the	  Bmp	  signaling	  cascade	  in	  the	  anterior	  lateral	  plate	  mesoderm	  of	  smoc2	  morphants.	   Values	  plotted	   as	  mean	  ±	   SEM;	  n=4;	   *	   p<0.05.	  B-­‐C.	  WISH	   analysis	   of	  vox	   expression	   at	   12	   ss.	  Lateral	  views,	  anterior	  to	  the	  top	  (B);	  dorsal	  views,	  anterior	  to	  the	  left	  (C)	  (n≥25).	  	  In	   summary,	   our	   results	   suggest	   that	   Smoc2	   functions	   as	   a	  modulator	   of	   Bmp	  signaling	  as	  the	  expression	  levels	  and	  domains	  of	  Bmp	  target	  genes	  appears	  to	  be	  altered	  upon	  injection	  with	  a	  smoc2	  morpholino.	  	  	  
4.3.7	  smoc2	  does	  not	  affect	  the	  expression	  of	  genes	  involved	  in	  
osteoclastogenesis	  	  In	  a	  recent	  publication,	  the	  level	  of	  C/EBPα,	  related	  to	  C/EBP1	  and	  also	  involved	  during	  myelopoiesis,	  was	   shown	   to	   regulate	   the	   commitment	   to	   the	   osteoclast	  lineage	  in	  mice.	  Additionally,	  the	  transcription	  factors	  involved	  in	  the	  transition	  from	   the	  macrophage/monocyte	   lineage	   to	   the	   osteoclast	   lineage,	   Spi1b,	   C-­‐fos,	  
Ctsk	  and	  Nfatc1,	  were	  shown	  to	  be	  downregulated	  in	  the	  C/ebpα	  -­‐/-­‐	  mice	  (Chen	  et	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al.,	  2013).	  Similarly,	  our	  analysis	  indicated	  a	  decrease	  in	  the	  expression	  levels	  of	  
spi1b	  in	  the	  smoc2	  morphants.	  Therefore	  we	  wanted	  to	   investigate	  the	  effect	  of	  
smoc2	  on	  the	  expression	  of	  c/ebpα,	  c-­‐fos,	  ctsk	  and	  nfatc1	  in	  zebrafish	  embryos	  by	  qPCR.	  Importantly,	  at	  the	  stage	  at	  which	  the	  zebrafish	  were	  analyzed	  (the	  onset	  of	   blood	   cell	   circulation),	   no	   cartilage	   or	   bone	   tissue	   is	   formed	   yet.	   However,	  these	  genes	  are	  present	   in	  different	  tissues,	   like	  the	  brain	  and	  the	  heart	  among	  others,	  which	  enables	  us	  to	  still	  evaluate	  the	  effect	  of	  smoc2	  on	  the	  expression	  of	  
c/ebpα,	   c-­‐fos,	   ctsk	   and	   nfatc1	   albeit	   in	   a	   different	   tissue	   context.	   Using	   this	  approach,	  we	  could	  shed	  new	  light	  on	  the	  function	  of	  smoc2	  in	  the	  context	  of	  the	  joint,	   articular	   cartilage,	   and/or	   subchondral	   bone.	   However,	   none	   of	   the	  investigated	  genes	  showed	  a	  significant	  change	  in	  expression	  level	  at	  the	  onset	  of	  blood	  cell	  circulation	  upon	  injection	  of	  the	  smoc2	  MO	  (Fig	  4.22).	  	  
	  
Figure	  4.22:	  qPCR	  analysis	  of	  osteoclast	  related	  transcription	  factors	  c/ebpα,	  c-­‐fos,	  nfatc1	  and	  ctsk	  at	  
the	  onset	  of	  blood	  cell	  circulation.	  	  
4.3.8	  smoc2	  loss-­‐of-­‐function	  influences	  cartilage	  and	  bone	  development	  	  In	   an	   attempt	   to	   compare	   our	   results	   with	   the	   previously	   published	   data	   on	  
smoc2	   morphants,	   we	   performed	   a	   skeletal	   staining	   of	   6	   days	   old	   control	   and	  
smoc2	  morphant	   zebrafish	   embryos.	   Of	   the	   few	  morphants	   that	   survived	   until	  that	  stage,	  the	  majority	  presented	  defects	  in	  the	  skeletal	  elements	  (Fig	  4.23A-­‐D).	  The	   cartilagenous	   elements	   of	   both	   the	   viscerocranium	   and	   the	   neurocranium	  were	  smaller	  and	  appeared	  to	  contain	  less	  proteoglycans	  as	  the	  intensity	  of	  the	  Alcian	  Blue	  staining	  was	  reduced.	  However,	  the	  patterning	  and	  the	  development	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of	   the	  different	  elements	  was	  unaltered.	  Furthermore,	   the	  reduction	   in	  Alizarin	  Red	   staining	   indicated	   that	   the	   ossification	   of	   the	   bones	   was	   reduced.	   The	  pharyngeal	   teeth	   were	   barely	   detectable,	   and	   other	   structures	   of	   both	   the	  viscerocranium	   (cleithrum,	   opercle	   and	   posterior	   branchiostegal	   ray)	   and	   the	  neurocranium	   (notochord	   and	   parasphenoid)	   also	   appeared	   less	   ossified.	   The	  reduced	  development	  of	  the	  pharyngeal	  teeth	  is	  in	  line	  with	  the	  publications	  on	  the	  importance	  of	  smoc2	  during	  craniofacial	  development.	  In	  contrast	  however,	  our	  study	   indicates	   that	   the	  maturation	  of	   the	  cartilage	   is	  affected	  whereas	   the	  data	  from	  the	  Melvin	  study	  suggested	  a	  patterning	  defect.	  	  	  
	  
Figure	  4.23:	  smoc2	  affects	  skeletal	  development	  at	  6	  dpf	  A-­‐D.	   Ventral	   view,	   anterior	   to	   the	   left.	   Cartilagenous	   elements	   are	   stained	   with	   Alcian	   Blue,	   ossified	  endogenous	  and	  dermal	  bones	  by	  Alizarin	  Red.	  p:	  posterior	  branchiostegal	  ray,	  c:	  cleithrum,	  pt,	  pharyngeal	  teeth,	  ps:	  parasphenoid,	  n:	  notochord.	   	  
4.4	  smoc2	  gain	  of	  function	  	  All	  the	  data	  presented	  in	  this	  section	  were	  initially	  obtained	  using	  the	  clone	  with	  the	  incomplete	  3’	  end	  resulting	  in	  an	  incorrect	  very	  C-­‐terminal	  protein	  sequence.	  Once	  the	  correct	  clone	  was	  generated,	  experiments	  were	  repeated	  and	  resulted	  in	   the	   same	   phenotypes	   indicating	   that	   the	   C-­‐terminal	   sequence	   error	   did	   not	  contribute	  to	  the	  observable	  phenotype.	  Camila	  Esguerra	  initially	  performed	  all	  work	   on	   this	   gain	   of	   function	   approach.	   When	   she	   left	   the	   lab,	   I	   adopted	   the	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project	   and	   reproduced	   all	   results.	   All	   presented	   data	   were	   collected	   and	  submitted	  for	  publication	  by	  Camila	  Esguerra	  with	  me	  as	  a	  shared	  first	  author.	  	  
4.4.1	  smoc2	  overexpression	  results	  in	  dorso-­‐ventral	  patterning	  defects	  In	   order	   to	   further	   investigate	   the	   function	   of	   smoc2	   during	   zebrafish	  development,	  in	  vitro	  transcribed	  smoc2	  mRNA	  was	  injected	  into	  the	  yolk	  of	  one-­‐cell	   stage	   zebrafish	   embryos.	   Injection	  with	   200pg	   smoc2	   mRNA	   resulted	   in	   a	  range	  of	  dorsalized	  phenotypes	  at	  24	  hpf	  (class	  I-­‐V,	  with	  class	  V	  being	  the	  most	  severe	   phenotype)	   and	   48	   hpf	   (Fig	   4.24)	   (Little	   and	   Mullins,	   2004).	   The	  incidence	  of	   the	  different	   classes	  was	  dose	  dependent,	   as	   even	  with	   low	  doses	  class	  V	  dorsalized	  embryos	  could	  be	  detected.	  	  	  
	  
Figure	  4.24:	  smoc2	  overexpression	  induced	  dorsalization	  A-­‐B.	  During	  somitogenesis,	  zebrafish	  injected	  with	  smoc2	  mRNA	  acquire	  an	  elongate	  egg	  shape	  (B).	  C-­‐F.	  At	  48	  hpf,	  different	  classes	  of	  dorsalizations	  can	  be	  seen	  (n≥135).	  G-­‐H.	  A	  subset	  of	  the	  embryos	  injected	  with	  
smoc2	  mRNA	  develop	  cyclopia	  and	  synophtalmia.	  Injections	  and	  processing	  by	  C.	  Esguerra.	  	  During	  somitogenesis	  the	  injected	  zebrafish	  embryos	  displayed	  an	  elongated	  egg	  shape,	   indicative	  of	   a	  defective	  dorso-­‐ventral	  patterning	   (Fig	  4.24A-­‐B).	  At	   later	  stages,	  overexpression	  of	  smoc2	  mRNA	  resulted	   in	  defects	   in	  the	  caudal	  part	  of	  the	  zebrafish	  embryo,	  with	  loss	  of	  the	  ventral	  fin,	  shortening,	  curling	  or	  even	  loss	  of	   the	   trunk	   and	   tail	   structures	   (Fig	   4.24C-­‐F).	   Anteriorly,	   the	   fish	   presented	  malformed	  brain	  structures	  and	   in	  some	  severe	  cases	  a	   fusion	  of	   the	  eye	   fields	  resulting	  in	  synophthalmia	  at	  later	  stages	  of	  development	  (Fig	  4.24G-­‐H).	  	  For	  the	  molecular	  characterization	  of	  the	  phenotype	  we	  analyzed	  the	  expression	  pattern	   of	   the	   mesodermal	   markers	   ntl,	  myoD	   and	   pcdh8	   (Fig	   4.25)	   (Schulte-­‐Merker	   et	   al.,	   1994;	  Weinberg	   et	   al.,	   1996;	  Yamamoto	   et	   al.,	   1998).	  All	  marker	  genes	   indicated	   a	   lateral	   expansion	   of	   the	   expression	   domain,	   wider	   axial	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structures	   and	   somites	   stretching	   around	   the	   embryo.	   This	   all	   in	   combination	  with	   a	   defect	   in	   the	   anterior-­‐posterior	   extension	   of	   the	   embryo.	   Both	   of	   these	  defects	   are	   typically	   indicative	   of	   defective	   convergence	   and	   extension	  movements	  (CE	  movements)	  during	  gastrulation	  stages.	  Note	  also	  the	  elongated	  shape	  of	  the	  embryos	  upon	  injection	  with	  smoc2	  mRNA.	  
	  
Figure	  4.25:	  Mesodermal	  patterning	  defects	  when	  smoc2	  is	  overexpressed	  WISH	   analysis	   of	   the	   expression	   pattern	   at	   5-­‐9	   ss	   of	   mesodermal	   markers	   (ntl:	   axial	   mesoderm,	   pcdh8:	  paraxial	  mesoderm,	  myod:	  adaxial	  mesoderm)	  illustrates	  the	  conversion	  defect,	  with	  somites	  stretching	  all	  around	   the	   embryo;	   and	   the	   elongation	   defect	  with	   the	   failure	   of	   the	  mesoderm	   to	  migrate	   towards	   the	  anterior	  part	  of	  the	  embryo	  (n≥52).	  Injections	  and	  processing	  by	  C.	  Esguerra.	  	  
4.4.2	  smoc2	  modulates	  Bmp	  mediated	  signaling	  In	   an	   attempt	   to	   analyze	   the	   dorso-­‐ventral	   patterning	   defects,	   we	   performed	  WISH	   analysis	   for	   the	   predominant	   Bmp	   inhibitor	   during	   pre-­‐gastrula	   stages,	  
chordin	  and	  for	  the	  Bmp	  target	  gene,	  gata2	  (Maeno	  et	  al.,	  1996;	  Schulte-­‐Merker	  et	  al.,	  1997).	  	  A	   mild,	   but	   apparent	   increase	   in	   chd	   expression,	   without	   a	   change	   in	   the	  expression	  domain,	  was	  detected	  in	  the	  embryos	  that	  were	  injected	  with	  smoc2	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mRNA	   at	   shield	   stage.	   Two	   hours	   later,	   at	   70%	   epiboly,	   this	   small	   difference	  could	  not	  be	  detected	  anymore.	  Concomitant	  with	  the	  increase	  in	  chd	  expression	  at	  shield	  stage,	  a	  discrete	  reduction	  in	  the	  expression	  of	  the	  gata2	  was	  seen	  (Fig	  4.26).	   	  
	  
Figure	  4.26:	  smoc2	  overexpression	  mildly	  affects	  dorso-­‐ventral	  patterning	  	  A-­‐F	  Animal	  view,	  dorsal	  to	  the	  right.	  A-­‐D.	  Shield	  stage;	  E-­‐F	  70%	  epiboly.	  WISH	  analysis	  for	  chordin	  (A-­‐B,	  E-­‐F)	  and	  gata2	  (C-­‐D)	  (n≥30).	  Injections	  and	  processing	  by	  C.	  Esguerra.	  	  Since	  the	  chordin	  expression	  analysis	  indicated	  a	  discrete	  increase	  in	  expression,	  we	  attempted	   to	   rescue	   the	   smoc2	  mRNA	   induced	  phenotypes	  by	   reducing	   the	  levels	  of	  chordin,	   using	  a	  chd	  MO.	  Molecular	  analysis	  of	   the	  embryos,	  using	   the	  paraxial	  mesodermal	  marker	  pcdh8,	   indicated	  that	  the	  dorso-­‐ventral	  patterning	  defect	   was	   rescued	   upon	   co-­‐injection	   with	   chd	   MO.	   The	   CE	   defects	   however	  appeared	  to	  be	  still	  present	  (Fig	  4.27).	  Co-­‐injection	  of	  smoc2	  mRNA	  with	  chd	  MO,	  was	  therefore	  unable	  to	  fully	  rescue	  the	  smoc2	  mRNA	  induced	  phenotype.	  	  	  
	  
Figure	  4.27:	  smoc2	  overexpression	  is	  partially	  rescued	  by	  injection	  with	  chd	  MO	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A-­‐C.	  Dorsal	  view,	  anterior	  to	  the	  top.	  WISH	  analysis	  for	  pcdh8	  at	  the	  5-­‐9	  ss	  in	  control,	  smoc2	  mRNA	  injected	  and	  smoc2	  mRNA,	  chd	  MO	  injected	  embryos	  (n≥20).	  Injections	  and	  processing	  by	  C.	  Esguerra.	  	  
4.4.3	  smoc2	  modulates	  wnt5b	  mediated	  signaling	  	  Since	   CE	  movements	   are	  mainly	   regulated	   by	   the	   non-­‐canonical	  Wnt	   signaling	  pathway	  we	  investigated	  the	  effect	  of	  co-­‐injecting	  smoc2	  mRNA	  with	  the	  mRNA	  of	  different	  Wnt	  ligands	  (Rauch	  et	  al.,	  1997;	  Heisenberg	  et	  al.,	  2000;	  Kilian	  et	  al.,	  2003).	  	  Injection	  of	  wnt5b	  resulted	  in	  a	  ventralized	  embryo	  with	  severe	  anterior	  defects,	  a	   loss	  of	  head	  structures,	  an	  enlarged	  yolk	  sac	  extension	  and	  a	  compressed	  tail	  (Fig	  4.28A,	  C)	   (similar	   to	   (Westfall	   et	  al.,	  2003).	   In	   contrast,	   the	  smoc2	   gain-­‐of-­‐function	  resulted	  in	  a	  loss	  of	  the	  dorsal	  structures	  (Fig	  4.28A-­‐B).	  Co-­‐injection	  of	  
smoc2	  and	  wnt5b	  rescued	  these	  defects	  (Fig	  4.28D-­‐I).	  50%	  of	  the	  embryos	  were	  fully	   rescued	   whereas	   the	   other	   50%	   were	   class	   I	   or	   class	   II	   dorsalization	  phenotypes.	   	  
	  
Figure	  4.28:	  Co-­‐injection	  of	  wnt5b	  mRNA	  rescues	  the	  smoc2	  mRNA	  induced	  phenotype	  Injection	  with	  smoc2	  mRNA	  or	  wnt5b	  mRNA	  results	  in	  opposite	  defects	  with	  the	  loss	  of	  posterior	  structures	  and	  the	   loss	  of	  anterior	  structures	  respectively.	  Upon	  co-­‐injection	  of	  smoc2	  and	  wnt5b	  mRNA,	  50%	  of	   the	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zebrafish	  appeared	  normal	  at	  24	  hpf,	  while	  the	  other	  50%	  only	  displayed	  a	  mild	  dorsalization	  with	  (partial)	  loss	  of	  the	  ventral	  fin	  (n≥101).	  Injections	  and	  processing	  by	  C.	  Esguerra.	  	  The	   wnt5b-­‐mediated	   rescue	   was	   shown	   to	   be	   specific	   as	   co-­‐injection	   with	  another	  non-­‐canonical	  wnt	  (wnt11)	  or	  a	  canonical	  wnt	  (wnt8)	  did	  not	  rescue	  the	  morphological	  defects	  of	  smoc2	  overexpressing	  embryos	  (Fig	  4.29).	  Co-­‐injection	  of	   smoc2	   mRNA	   with	   wnt8.1	   or	   wnt11	   resulted	   in	   a	   similar	   distribution	   of	  dorsalized	   phenoytpes,	   indicating	  wnt11	   and	  wnt8.1	   do	   not	   interfere	   with	   the	  
smoc2	  mediated	  signaling	  events.	   	  
	  
Figure	  4.29:	  The	  rescue	  of	  smoc2	  dorsalized	  phenotypes	  is	  specific	  for	  wnt5b	  The	  distribution	  of	  dorsalized	  phenotypes	  induced	  by	  smoc2	  mRNA	  shifts	  to	  less	  severe	  phenotypes	  when	  coinjected	  with	  wnt5b	  (n≥101).	  Co-­‐injection	  with	  wnt11	  (n≥100)	  or	  wnt8.1	  (n≥45)	  does	  not	  have	  the	  same	  effect	  as	   similar	  distribution	  of	   the	  phenotypes	  can	  be	  seen	  as	  with	  single	   smoc2	   injection.	   Injections	  and	  processing	  by	  H.	  Mommaerts.	  	  Molecular	  analysis	  of	  this	  rescue	  was	  done	  by	  performing	  a	  WISH	  analysis	  using	  the	  mesodermal	  marker	  pcdh8,	  which	  confirmed	  our	  observation	  that	  the	  smoc2	  mediated	   phenotype	   could	   be	   rescued	   by	   overexpressing	   wnt5b	   mRNA	   (Fig	  4.30).	  Both	  the	  dorsalization	  of	  the	  embryo	  and	  the	  convergence	  and	  extension	  defects	   were	   rescued,	   as	   the	   embryo	   lost	   its	   egg	   shape	   and	   the	   expression	  pattern	  of	  paraxial	  mesodermal	  cells	  (pcdh8)	  appeared	  normal.	  	  	  
	  	   80	  
	  
Figure	  4.30:	  wnt5b	  rescues	  the	  smoc2	  induced	  dorssalization	  and	  conversion	  and	  extension	  defects	  WISH	  analysis	  of	  pcdh8	  expression,	  1-­‐3	  somite	  stage,	  dorsal	  view,	  anterior	  to	  the	  top.	  Co-­‐injection	  of	  smoc2	  and	  wnt5b	  results	  in	  the	  rescue	  of	  the	  dorsalization	  and	  a	  rescue	  of	  the	  paraxial	  pcdh8	  expression	  pattern	  (n≥25).	  Injections	  and	  processing	  by	  C.	  Esguerra.	  	  
4.5	  Generation	  of	  tools	  to	  study	  the	  function	  of	  Smoc2	  domains	  
in	  zebrafish	  	  As	  moc2	  is	  a	  secreted	  protein,	  it	   is	  likely	  to	  interact	  through	  its	  domain(s)	  with	  matrix	  molecules,	  ligands,	  receptors	  or	  cofactors.	  The	  first	  step	  in	  unraveling	  the	  function	  of	  the	  different	  domains	  is	  the	  generation	  of	  mutant	  clones	  of	  smoc2	  in	  which	   the	  domain	  of	   interest	   is	  deleted.	  We	  systematically	  generated	  clones	   in	  which	  the	  EC	  domain,	  the	  SMOC	  domain	  or	  the	  FS	  domain	  was	  absent.	  Based	  on	  the	  amino	  acid	  sequence,	  primers	  were	  generated	  to	  perform	  a	  series	  of	  PCRs	  to	  remove	  the	  region	  flanked	  by	  the	  middle	  primers	  (Fig	  4.31).	  	  	  
	  
Figure	  4.31:	  Schematic	  representation	  of	  PCR	  strategy	  Subsequent	   PCRs,	   with	   partially	   overlapping	   primers,	   induce	   the	   amplification	   of	   a	   fragment	   in	   which	  domain	  X	  is	  removed.	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We	  generated	  3	  PCR	  fragments	  of	  the	  smoc2	  ORF	  each	  lacking	  a	  specific	  domain	  (Fig	  4.31,	   4.32).	   Subcloning	   them	   in	  pCS2+	  allowed	  us	   to	   generate	   capped	   and	  polyadenylated	  mRNA	  in	  vitro,	  suitable	  for	  injection	  in	  the	  zebrafish.	  	  
	  
Figure	  4.32:	  Schematic	  representation	  of	  the	  different	  Smoc2	  mutants	  	  Preliminary	  injections	  with	  these	  mutant	  constructs	  (Fig	  4.33)	  and	  scoring	  at	  1	  dpf	  indicated	  that	  the	  loss	  of	  these	  domains	  did	  not	  affect	  the	  function	  of	  Smoc2.	  Injected	  embryos	  still	  displayed	  a	  range	  of	  dorsalized	  phenotypes,	  similar	  to	  the	  
smoc2	   wild	   type	   overexpression	   phenotypes.	   Interestingly,	   the	   incidence	   of	  severely	   dorsalized	   embryos	   was	   reduced	   when	   the	   FS	   mutant	   was	  overexpressed	  (Fig	  4.33).	  Whether	  this	  is	  due	  to	  a	  decreased	  mRNA	  stability	  or	  due	   to	  a	  disturbed	   function	  of	   the	  protein	   is	  yet	   to	  be	  determined.	   In	  addition,	  further	   studies	   are	   necessary	   to	   investigate	   the	   effect	   of	   the	   loss	   of	   these	  domains	  on	  the	  rescue	  of	  the	  morphant	  phenotype,	  allowing	  us	  to	  determine	  the	  role	  of	  that	  specific	  domain	  in	  the	  absence	  of	  endogenous	  smoc2.	  	  
	  
Figure	  4.33:	  Scoring	  of	  the	  phenotypes	  after	  overexpressing	  smoc2	  mutants	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The	  function	  of	  Smoc2	  in	  the	  joint	  cannot	  be	  investigated	  in	  the	  zebrafish	  for	  the	  obvious	   reason	   that	   the	   zebrafish	   does	   not	   have	   limbs	   and	   joints,	   similar	   to	  human	   limbs	   and	   joints.	   So	   in	   order	   to	   investigate	   the	   effect	   of	   SMOC2	   on	   the	  development	  of	  cartilage,	  bone	  and	  joints	  we	  turned	  to	  the	  chicken	  limb	  model.	  These	  data	  were	  included	  in	  the	  master	  thesis	  of	  Laura-­‐An	  Guns	  (supervised	  by	  H.M.).	  Previously,	  gain	  of	   function	  approaches	  by	  means	  of	  electroporation,	   retroviral	  infection	  or	   transgenics	  have	  shown	   that	   the	   chicken	  model	  provides	  powerful	  tools	   for	  embryologists	  (Mozdziak	  and	  Petitte,	  2004;	  Funahashi	  and	  Nakamura,	  2008;	   Gordon	   et	   al.,	   2009).	   The	   chicken	  model	   system	   and	   the	   RCAS	   delivery	  system	  were	  fully	  optimized	  in	  the	  lab	  by	  Nathalie	  Brison	  and	  have	  resulted	  in	  a	  few	  successful	  publications	  (Fantini	  et	  al.,	  2009;	  Brison	  et	  al.,	  2012).	  	  	  We	  cloned	  chicken	  SMOC2	  ORF	  by	  PCR	  using	  primers	  that	  were	  based	  on	  online	  available	  ESTs.	  The	  resulting	  fragment	  was	  cloned	  in	  the	  pSLAX12	  shuttle	  vector	  and	  subsequently	  in	  the	  RCASBPA	  viral	  vector.	  Care	  was	  taken	  to	  ensure	  that	  the	  chicken	   SMOC2	   ORF	   was	   in	   frame	   with	   the	   rest	   of	   the	   viral	   genes.	   Next,	   we	  transfected	  DF1	  cells	  in	  vitro	  to	  produce	  and	  collect	  the	  virus.	  Similar	  steps	  were	  undertaken	   to	   clone	   the	   GFP	   ORF	   into	   the	   RCASBPB	   vector.	   Using	   the	   RCAS	  specific	  3C2	  monoclonal	  antibody	  the	  titer	  of	  the	  viruses	  was	  determined	  to	  be	  at	  least	   1x10^8	   cfu.	   RCASBPA-­‐SMOC2	   and	   RCASBPB-­‐GFP	   were	   mixed	   in	   a	   70:30	  ratio	  and	  injected	  in	  the	  prospective	  hindlimb	  of	  a	  HH10	  stage	  chicken	  embryo.	  The	  embryos	  were	  incubated	  until	  stage	  HH22-­‐24	  when	  they	  were	  harvested	  for	  further	  analysis	  of	   the	  phenotype.	  Successful	   injections	  were	  selected	  based	  on	  the	  presence	  of	  a	  unilateral	  GFP	  signal.	  	  	  Preliminary	   morphological	   comparison	   of	   the	   green,	   infected	   limb	   with	   its	  contralateral	   control	   indicated	   an	   outgrowth	   defect	   of	   the	   limb	   in	   10%	   of	   the	  injected	  embryos	  (Fig	  5.1).	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Figure	  5.1:	  Morphology	  of	  RCASBPA-­‐SMOC2	  and	  RCASBPB-­‐GFP	  injected	  embryos	  Dorsal	  view,	  anterior	  to	  the	  top.	  10%	  of	  the	  limbs	  injected	  at	  HH10	  present	  an	  outgrowth	  defect	  at	  HH24-­‐26.	  The	  severity	  of	  the	  defect	  depends	  on	  the	  titer	  of	  the	  virus	  and	  on	  the	  rate	  of	  infection	  with	  the	  RCASBPA-­‐
SMOC2	  virus.	  	  The	  harvested	  limbs	  were	  further	  processed	  for	  molecular	  analysis	  by	  means	  of	  WISH	  for	  genes	  that	  are	  known	  to	  regulate	  the	  outgrowth	  of	  the	  limb	  (Fig	  5.2).	  Using	   in-­‐house	   probes,	   we	   could	   detect	   a	   change	   in	   the	   expression	   of	   FGF8,	  a	  marker	  of	   the	  apical	  ectodermal	  ridge,	   in	   the	  RCASBPA-­‐SMOC2	   injected	   limb	  as	  compared	   to	   the	   uninjected	   contralateral	   control	   (Fig	   5.2D).	   Although	   WISH	  cannot	   be	   used	   for	   the	   quantification	   of	   expression,	   the	   pattern	   appears	   to	   be	  less	   intense.	   Furthermore,	   the	   domain	   of	   expression	   appears	   to	   be	   reduced,	  potentially	  explaining	  the	  reduced	  size	  of	  the	  limb.	  The	   expression	   domains	   of	   the	   other	   available	   probes	   (SHH	   for	   the	   ZPA	   and	  	  
BMP2	  and	  dHAND	  for	  posterior	  mesenchyme)	  were	  unaltered	  when	  SMOC2	  was	  overexpressed	  in	  the	  chicken	  limb	  (Fig	  5.2A-­‐C).	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To	  further	  clarify	  the	  role	  of	  SMOC2	  during	  embryonic	  development,	  we	  used	  the	  mouse	   model	   to	   create	   a	   Smoc2	   null	   mouse.	   The	   generation	   of	   heterozygous	  animals	   was	   outsourced	   to	   the	   Texas	   A&M	   Institute	   for	   Genomic	   Medicine	  (www.tigm.org).	   The	   first	   exon	   of	   Smoc2	   was	   replaced	   by	   a	   LacZ	   cassette,	  thereby	  removing	  the	  translation	  start	  site	  and	  preventing	  the	  proper	  translation	  of	   the	   protein	   (Fig	   6.1A).	   Additional	   downstream	   translation	   start	   sites	   could	  give	  rise	  to	  a	  truncated	  protein.	  However,	  the	  secretion	  of	  a	  potential	  protein	  is	  prevented	   as	   the	   signal	   peptide	   is	   lost.	   Long	   range	   PCR	   was	   performed	   to	  confirm	   the	   replacement	   of	   exon	   1	   with	   the	   LacZ	   cassette	   (personal	  communication	  with	  Andrei	  Golovko,	  TIGM)	  and	  indicated	  that	  in	  all	  samples	  the	  recombination	  event	  has	  taken	  place	  (Fig	  6.1B)	  	  	  
	  
Figure	  6.1:	  Smoc2	  targeting	  strategy	  A.	   Schematic	   representation	   of	   the	   Smoc2	   targeting	   strategy.	   B.	   Long-­‐range	   PCR	   as	   a	   control	   for	   the	  recombination	  with	  the	  primers	  indicated	  in	  A.	  	  Heterozygote	   adult	  mice	   appeared	  healthy	   and	  were	   fertile.	   Crossing	   of	  Smoc2	  heterozygotes	   resulted	   in	   small	   litters	   (7-­‐9	   pups)	   with	   a	   normal	   morphology.	  Genotyping	  of	  these	  pups	  indicated	  that	  only	  wild	  type	  (±30%)	  and	  heterozygous	  mice	  were	  born.	  To	  screen	  for	  subtle	  differences,	   limbs	  of	  Smoc2	  wild	  type	  and	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Smoc2	  heterozygous	  embryos	  were	   isolated	  at	  birth	  and	  processed	   for	   skeletal	  staining	  and	  H&E	  staining	  (Fig	  6.2).	  No	  differences	  in	  size,	  patterning	  or	  staining	  intensity	  were	  detected.	   	  
	  
Figure	  6.2:	  Morphological	  analysis	  of	  Smoc2+/+	  and	  Smoc2+/-­‐	  embryos	  A-­‐D.	  Lateral	  view	  (A-­‐B),	  Dorsal	  view	  (C-­‐D).	  Skeletal	  staining	  of	  Smoc2+/+	  (A,	  C)	  and	  Smoc2+/-­‐	  (B-­‐D)	  hindlimbs	  at	  birth	  (n≥3	  per	  genotype).	  E-­‐F.	  Dorsal	  view.	  H&E	  staining	  of	  paraffin	  sections	  of	  Smoc2+/+	  (E)	  and	  Smoc2+/-­‐	  (F)	  forelimbs	  (n≥2	  per	  genotype).	  	  In	  an	  attempt	  to	  investigate	  Smoc2	  null	  embryos,	  embryos	  were	  collected	  during	  earlier	  stages	  of	  development.	  Systematic	  screening	  indicated	  that	  the	  embryos	  died	  between	  8	  and	  9.5	  dpc.	  Genotyping	  was	  performed	  on	  the	  yolk	  sacs	  of	  these	  early	   stage	   embryos	   and	   confirmed	   the	   presence	   of	   Smoc2	   null	   mice.	   These	  embryos	  displayed	  a	  clear	  delay	   in	  development,	  associated	  with	  defects	   in	  the	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outgrowth	   of	   anterior	   and	   cardiac	   structures.	   Furthermore,	   whereas	   the	   wild	  type	  embryos	  underwent	  axial	  rotation	  at	  8.5	  dpc,	  the	  Smoc2	  null	  mice	  did	  not.	  Once	  the	  Smoc2	  null	  embryos	  were	  isolated	  from	  the	  surrounding	  amnion,	  they	  stretched	  out	  unlike	  the	  wild	  type	  embryos	  that	  retained	  their	  typical	  embryonic	  position	  (Fig	  6.3A-­‐E).	   	  
	  
Figure	  6.3:	  Morphology	  of	  Smoc2+/+	  and	  Smoc2-­‐/-­‐	  embryos	  at	  8.5	  dpc	  A,	  D.	  Lateral	  view	  of	  Smoc2+/+	  embryos.	  B,	  C,	  E.	  Smoc2-­‐/-­‐	  embryos;	  dorsal	  view,	  anterior	  to	  the	  left	  (B);	  lateral	  view,	   anterior	   to	   the	   left	   (C,	   E).	   Smoc2-­‐/-­‐	   embryos	   were	   clearly	   reduced	   in	   size,	   did	   not	   undergo	   axial	  rotation,	   failed	   to	   close	   the	   head	   folds,	   formed	   irregularly	   shaped	   somites	   (blue	   delineation)	   and	   had	  misshapen	  axial	  structures	  (red	  line).	  	  	  In	  addition,	  at	  8.5	  dpc	  the	  development	  of	  the	  blood	  could	  be	  seen	  in	  the	  Smoc2	  wild	   type	  embryos,	  while	   in	   the	  Smoc2	   null	   embryos,	  no	   red	  blood	  pools	  were	  detected.	  This	   is	  probably	  caused	  by	  the	  developmental	  delay,	  and	  at	  this	  point	  cannot	  be	  attributed	  to	  the	  loss	  of	  SMOC2	  (Fig	  6.3A-­‐E).	  	  	  The	  Smoc2	  wild	  type	  and	  knock-­‐out	  embryos	  were	  further	  processed	  for	  paraffin	  embedding	  and	  H&E	  staining.	  Sagittal	  sections	  of	  both	  genotypes	  confirmed	  the	  observation	   of	   anterior	   defects,	   the	   failure	   to	   undergo	   axial	   rotation	   and	   the	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delay	  in	  growth.	  Other	  structures	  like	  the	  somites,	  and	  axial	  structures	  seemed	  to	  develop	   properly,	   although	   these	   structures	   appeared	   misshapen	   (Fig	   6.3A-­‐B	  and	  Fig	  6.4A-­‐B).	   	  
	  
Figure	  6.4:	  Sagittal	  sections	  of	  Smoc2+/+	  and	  Smoc2-­‐/-­‐	  embryos	  at	  8.5	  dpc	  A,	  B.	  Lateral	  view,	  anterior	  to	  the	  top	  of	  Smoc2+/+	  embryo	  (A)	  and	  Smoc2+/+	  embryo	  (B).	  	  In	  conclusion,	  we	  have	  shown	  for	  the	  first	  time	  the	  embryonic	  lethal	  phenotype	  of	  a	  Smoc2	  null	  embryo.	  Our	  first	  analysis	  indicated	  that	  the	  Smoc2	  null	  embryos	  were	   embryonic	   lethal	   and	   might	   present	   mesendodermal	   defects.	   Further	  research	  is	  however	  required	  to	  investigate	  the	  underlying	  cause	  of	  this	  defect.	  	   	  









Chapter	  7:	  	  
Discussion	  
	   	  
	  	   92	  
There	  are	  over	  230	  moveable	  and	  semi-­‐moveable	  joints	  in	  the	  human	  body.	  The	  development	   and	   homeostasis	   of	   each	   and	   every	   one	   of	   them	   requires	   an	  accurate	   spatio-­‐temporal	   control	   of	   signaling	   events	   and	   tissue	   interactions.	  Over	   the	   past	   decades,	   the	   joint	   has	   been	   intensely	   studied	   since	   a	  malfunctioning	   joint	   can	   result	   in	   progressive	   joint	   damage,	   discomfort	   and	   a	  reduced	  quality	  of	  life.	  Despite	  all	  the	  efforts,	  the	  development,	  homeostasis	  and	  the	   onset	   and	  progression	   of	   joint	   degeneration	   are	   far	   from	  being	   completely	  understood.	  Therefore,	  our	  lab	  analyzed	  a	  protein	  extract	  from	  bovine	  articular	  cartilage,	   and	   isolated	   among	   others,	   a	   novel	   protein	   called	   SMOC2.	   Over	   the	  years	   multiple	   groups	   have	   associated	   SMOC2	   with	   many	   developmental	   and	  disease	  processes	  but	  this	  work	  failed	  to	  identify	  a	  clear	  biological	  function	  of	  the	  protein.	  	  In	   an	   attempt	   to	   clarify	   the	   biological	   role	   of	   SMOC2,	   we	   took	   advantage	   of	  different	   well-­‐established	   animal	   models	   and	   used	   them	   to	   investigate	   the	  function	  of	  SMOC2	  in	  a	  simpler	  and	  better-­‐described	  context.	  By	  identifying	  the	  associated	   signaling	   pathway	   and	   assigning	   a	   function	   to	   the	   protein,	   our	   data	  will	  allow	  further	  research	  in	  the	  context	  of	  the	  joint.	  	  In	  this	  thesis,	  we	  focused	  on	  the	  identification	  of	  pathways	  modulated	  by	  smoc2	  using	   the	   zebrafish	  model.	   Additionally,	   we	   performed	   preliminary	   analysis	   of	  the	  function	  of	  SMOC2	  in	  the	  chicken	  limb	  bud	  and	  the	  mouse	  model.	  	  	  
7.1	  Smoc2	  in	  zebrafish	  	  
7.1.1	  smoc2	  loss	  of	  function	  Up	   to	   date,	   zebrafish	   smoc2	   was	   shown	   to	   be	   associated	   with	   tooth	   and	  craniofacial	   defects	   (Bloch-­‐Zupan	   et	   al.,	   2011;	   Melvin	   et	   al.,	   2013).	   We	  reproduced	   some	   aspects	   of	   these	   reported	   defects,	   like	   the	   reduction	   in	  pharyngeal	  teeth.	  However,	  other	  defects	  like	  the	  ceratohyal	  defect	  could	  not	  be	  reproduced.	  Considering	   the	   severe	  defects	   and	   the	  bad	   shape	  of	   the	  embryos,	  we	   were	   puzzled	   by	   the	   discrete	   phenotypes	   at	   the	   stages	   presented	   in	   the	  previously	   published	   papers	   and	   the	   absence	   of	   earlier	   phenotypes.	   Especially	  since	   we	   observed	   smoc2	   transcripts	   during	   earlier	   stages	   of	   development.	  Careful	   analysis	   revealed	   new	   and	   important	   defects	   caused	   by	   silencing	   of	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smoc2	   transcript	   during	   these	   earlier	   stages.	   The	   fact	   that	   we	   were	   able	   to	  reproduce	  some	  of	  the	  late	  defects	  but	  discovered	  new	  ones	  in	  our	  morphants	  is	  not	  completely	  unexpected.	  The	  key	  reason	  may	   lie	   in	   the	  silencing	   technology	  used.	  While	  the	  morpholino	  technology	  has	  been	  essential	  to	  uncover	  function	  of	  many	  zebrafish	  genes,	   it	   is	  known	  to	  produce	  variable	  results	  due	  to	  the	  target	  sequence	   dependent	   efficiency	   and	   non-­‐specific	   effects	   like	   p53-­‐mediated	  apoptosis	  and	  edema.	  Since	  our	  target	  sequences	  differ	  from	  those	  of	  the	  groups	  of	   Bloch-­‐Zupan	   and	   Melvin,	   we	   might	   expect	   phenotypic	   differences	   (Bloch-­‐Zupan	   et	   al.,	   2011;	  Melvin	   et	   al.,	   2013).	   The	   problem	   is	   so	  widely	   known	   that	  several	   journals	   now	   include	   a	   checklist	   for	   the	   experiments	   involving	  morpholinos	   and	   define	   the	   specific	   controls	   required	  (http://cdn.elsevier.com/promis_misc/ydbioguidelinesmorpholinostudies.pdf).	  It	  is	  our	  opinion	  that	  the	  target	  sequences	  chosen	  by	  Bloch-­‐Zupan	  and	  Melvin	  are	  suboptimal.	  In	  the	  study	  of	  Bloch-­‐Zupan	  et	  al.	  two	  different	  MOs	  were	  designed	  against	  either	  the	  splice	  donor	  site	  of	  exon	  10	  or	  a	  splice	  variant	  with	  only	  the	  C-­‐terminal	  EC	  domain	  of	  full-­‐length	  smoc2	  and	  in	  the	  study	  of	  Melvin	  et	  al.	  against	  the	  splice	  donor	  site	  of	  exon	  11	  (3’	  of	   the	  dominant	  donor	  splice	  site)	  or	  the	  5’	  UTR	  (Bloch-­‐Zupan	  et	  al.,	  2011;	  Melvin	  et	  al.,	  2013).	  Except	   for	   the	   latter,	   these	  strategies	  might	  produce	  a	  truncated,	  partially	  functional	  protein.	  Such	  a	  protein	  might	   have	   various	   changes	   in	   its	   activity/specificity	   resulting	   in	   aberrant	  phenotypes.	  In	  our	  analysis,	  we	  limited	  this	  possibility	  by	  designing	  the	  ATG-­‐MO	  against	   the	   ATG	   translation	   start	   site	   of	   full-­‐length	   smoc2	   and	   the	   SPLICE-­‐MO	  against	  the	  first	  intron-­‐exon	  boundary	  of	  the	  full-­‐length	  smoc2.	  In	  addition,	  when	  assuming	  all	  studies	  were	  performed	  with	  an	  injection	  volume	  of	  1	  nl,	  the	  used	  amount	  of	  MO	  differs	   in	  all	  studies.	   Interestingly,	   the	  amount	  of	   injected	  MO	  in	  the	   paper	   of	   Bloch-­‐Zupan	   et	   al	   is	   almost	   45%	  higher	   for	   the	  MO	   targeting	   the	  splicing	  of	  exon	  11	  as	  compared	  to	  our	  study	  (5	  ng	  vs.	  3.5-­‐3.6	  ng).	  For	  Melvin	  et	  al,	   the	   differences	   were	   even	   bigger	   with	   an	   amount	   that	   was	   almost	   3	   times	  higher	  compared	  to	  our	  study	  (10	  ng	  vs.	  3.5-­‐3.6	  ng).	  Taking	  under	  consideration	  the	  typical	  non-­‐specific	  effects	  of	  a	  MO	  and	  the	  fact	  that	  we	  needed	  to	  co-­‐inject	  
p53	  MO	  to	  prevent	  head	  necrosis,	   it	   is	   interesting	   to	  notice	   that	   in	  both	  papers	  none	  of	  those	  were	  reported.	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Recently	   and	   in	   accordance	   with	   mouse	   models,	   a	   better	   alternative	   to	  morpholinos	   was	   developed:	   the	   targeted	   inactivation	   of	   genes	   of	   interest	   in	  zebrafish.	   Although	   the	   zebrafish	   genome	   is	   partially	   duplicated,	   making	  genomic	  modifications	  more	  complicated	  than	  in	  rodents,	  the	  recent	  technology	  can	   circumvent	   this	   problem.	   There	   are	   several	   strategies	   available	   at	   this	  moment	  with	   the	  most	   promising	   using	   endonucleases	   to	   induce	  DNA	  double-­‐strand	  breaks	  and	  activate	  the	  error-­‐prone	  non-­‐homologous	  end	  joining	  (NHEJ)	  or	  homology-­‐directed	  repair	  at	  specific	  genomic	  locations.	  Zinc-­‐finger	  nucleases	  (ZFNs)	   and	   transcription	   activator-­‐like	   effector	   nucleases	   (TALENs)	   have	   the	  Fok1	   enzyme	   bound	   to	   the	   target	   sequence,	   while	   the	   CRISPR/CAS9	   system	  requires	   the	   co-­‐injection	   of	   the	   mRNA	   of	   the	   target	   sequence	   and	   the	   mRNA	  encoding	   the	  Cas9	  enzyme	  (Doyon	  et	  al.,	  2008;	  Clark	  et	  al.,	  2011;	  Hwang	  et	  al.,	  2013).	  The	   latter	  system	  was	  suggested	  to	  be	  superior	  as	  the	  generation	  of	   the	  target	  mRNA	   sequence	   is	  much	   simpler	   and	   cheaper	   than	   the	   engineering	   and	  production	  of	   the	  ZFNs	  or	  TALENs,	  which	   require	   the	   enzyme	   to	  be	  physically	  bound	  to	  the	  target	  sequence.	  Yet	   the	  main	  advantage	  of	   the	  morpholino	   is	   the	  phenotypic	   analysis	   a	   few	   hours	   after	   injection.	   This	   advantage	   is	   lost	   as	   the	  screening	   for	   a	   germ-­‐line	   transmitting	   chimaera	   and	   the	   breeding	   of	   a	   stable	  mutant	   takes	   at	   least	   six	   months,	   similar	   to	   mouse	   models.	   However,	   once	   a	  viable	   stable	   mutant	   line	   is	   generated,	   no	   more	   injections	   are	   required.	   In	  addition,	  the	  small	  housing	  costs	  of	  the	  zebrafish	  and	  the	  high	  yield	  of	  embryos	  from	  a	  single	  mating	  provides	  an	  additional	  benefit	  as	  compared	  to	   the	  mouse.	  While	  we	  have	   the	  TALEN	  constructs	  ready	   to	   introduce	   into	   the	   fish,	   the	   time	  and	  funding	  limitations	  did	  not	  allow	  us	  to	  embark	  on	  this	  strategy.	  	  	  7.1.1.1	   smoc2	   morphants	   present	   a	   mild	   ventralization	   and	   defects	   in	  myelopoiesis	  Our	  analysis	  revealed	  that	  morphant	  embryos	  displayed	  a	  reduced	  axial	   length,	  somite	  defects,	  and	  a	  mild	  ventralization	  of	  the	  posterior	  tissues,	  among	  others.	  Molecular	   analysis	   indicated	   that	   there	   was	   an	   anterior	   defect	   in	   the	  development	  of	  the	  hemangioblast	  (scl,	  gata2,	  lmo2)	  and	  the	  myeloid	  progenitor	  cells	   (spi1b).	   As	   a	   result,	   the	   expression	   of	   both	  macrophage-­‐	   and	   neutrophil-­‐specific	  marker	  genes	  was	  affected	  at	   later	  stages	  of	  development.	  Concomitant	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with	  the	  loss	  of	  the	  myeloid	  progenitor	  marker	  spi1b,	  we	  showed	  a	  decrease	  in	  the	  expression	  level	  of	  Bmp	  target	  genes.	  It	  has	  been	  reported	  that	  the	  reduction	  of	  hemangioblast	  markers,	  tal1	  and	  lmo2,	  resulted	   in	   cardiovascular	   and	   hematopoietic	   defects	   (Dooley	   et	   al.,	   2005;	  Patterson	  et	  al.,	  2005).	  In	  contrast,	  spi1b	  morphants	  presented	  only	  myelopoiesis	  defects,	  without	  cardiovascular	  abnormalities	  (Rhodes	  et	  al.,	  2005;	  Patterson	  et	  al.,	   2007).	   We	   showed	   that	   smoc2	   morphants	   did	   not	   present	   cardiovascular	  defects,	   despite	   the	   loss	   of	   early	   tal1	   and	   lmo2	   expression	   in	   the	   ALPM.	  Potentially,	  the	  restoration	  of	  the	  tal1	  levels	  at	  20	  ss	  in	  smoc2	  morphants	  could	  compensate	   for	   the	   early	   loss	   of	   tal1	  expression	   and	   therefore	   ensure	   proper	  cardiovascular	   differentiation	   at	   later	   stages	   of	   development.	   In	   case	   this	   is	  indeed	   some	   sort	   of	   compensatory	   mechanism	   that	   ensures	   the	   proper	  cardiovascular	  development	  of	  the	  smoc2	  morphants,	  it	  appears	  to	  be	  unable	  to	  rescue	   the	   spi1b	  expression	   and	   the	  myeloid	   defects	   in	   the	   smoc2	   morphants.	  This	  hypothesis	  could	  be	  tested	  by	  co-­‐injecting	  the	  smoc2	  morphants	  with	  sub-­‐phenotypic	  doses	  of	  tal1	  or	  lmo2	  MO.	  	  As	  spi1b	  expression	  was	  downregulated	  in	  the	  smoc2	  morphants	  and	  spi1b	  and	  
smoc2	  morphants	  present	  comparable	  myeloid	  phenotypes,	  we	  hypothesize	  that	  the	   smoc2-­‐associated	   myelopoietic	   defects	   could	   be	   attributed	   to	   the	   reduced	  
spi1b	  mRNA	  levels.	  	  	  7.1.1.2.	  smoc2	  affects	  Bmp	  signaling	  in	  the	  anterior	  lateral	  plate	  mesoderm	  Previous	  studies	  have	  shown	   that	   the	   induction	  of	  spi1b	   in	   the	  hemangioblasts	  was	  dependent	  on	  alk8-­‐mediated	  Bmp	  signaling	  (Hogan	  et	  al.,	  2006;	  Sumanas	  et	  al.,	   2008).	   The	   maternal	   zygotic	   mutant	   for	   alk8,	   lost-­‐a-­‐fin,	   displays	   a	   strong	  dorsalized	   phenotype	   (Mintzer	   et	   al.,	   2001).	   However,	   despite	   the	   caudal	  embryonic	  tissues	  being	  the	  primary	  affected	  tissue	  in	  the	  lost-­‐a-­‐fin	  mutants	  and	  the	   smoc2	   morphants,	   the	   expression	   of	   hematopoietic	   marker	   genes	   in	   the	  PLPM	   appeared	   unaltered	   during	   early	   developmental	   stages.	   Similar	   to	   the	  
smoc2	  morphant,	  the	  lost-­‐a-­‐fin	  mutant	  had	  a	  reduced	  expression	  of	  spi1b,	  runx1	  and	  c-­‐myb	  in	  the	  ALPM	  during	  somitogenesis.	  As	  development	  progressed,	  both	  the	  loss	  of	  smoc2	  and	  the	  loss	  of	  Alk8	  resulted	  in	  a	  reduction	  of	  macrophage-­‐	  and	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neutrophil-­‐specific	   markers,	   suggesting	   that	   Smoc2	   might	   influence	   the	   Alk8-­‐mediated	  induction	  of	  myeloid	  specific	  genes	  (Hogan	  et	  al.,	  2006).	  Furthermore,	   studies	   of	   Smad	   proteins	   in	   zebrafish	   indicated	   that	   the	  hemangioblast	  markers,	  tal1	  and	   lmo2,	  were	  transcriptional	   targets	  of	   the	  Bmp	  signaling	   pathway	   and	   were	   redundantly	   regulated	   by	   smad1	   and	   smad5	  (McReynolds	  et	  al.,	  2007).	  The	  reduction	  of	  the	  expression	  level	  of	  tal1	  and	  lmo2	  in	  the	  smoc2	  morphants	  might	  therefore	  be	  a	  result	  of	  the	  reduced	  expression	  of	  Bmp	   target	   genes.	   Yet,	   the	   lost-­‐a-­‐fin	  mutant	  did	  not	   present	   a	   reduction	   in	   the	  expression	   level	   of	   tal1,	   indicating	   that	   the	   induction	   of	   tal1	   happens	  independently	   of	   Alk8-­‐mediated	  Bmp	   signaling,	   in	   contrast	   to	   the	   induction	   of	  
spi1b	  (Hogan	  et	  al.,	  2006).	  Together,	   this	   suggests	   that	   Smoc2	   might	   function,	   during	   early	   zebrafish	  development,	  as	  a	  specific	  modulator	  of	  the	  development	  of	  the	  hemangioblast	  in	  the	   ALPM	   (potentially	   by	   modulating	   Alk8-­‐independent	   Bmp	   signaling)	   and	  initiation	  of	   the	  myelopoietic	  program	   in	   the	  ALPM	   (potentially	  by	  modulating	  Alk8-­‐dependent	  Bmp	  signaling).	  Co-­‐injection	  of	  sub-­‐phenotypic	  doses	  of	  alk8	  MO	  and	  smoc2	  MO	  or	  co-­‐injection	  of	  the	  smoc2	  MO	  with	  caAlk8	  mRNA	  could	  test	  for	  the	   dependency	   of	   the	   smoc2	   morphant	   phenotype	   on	   Alk8-­‐mediated	   Bmp	  signaling.	  Investigation	   of	   the	   Bmp	   signaling	   pathway	   during	   pregastrula	   stages	   did	   not	  indicate	   apparent	   defects	   in	   the	   expression	   level	   or	   the	   expression	   domain	   of	  Bmp	   target	   genes	   vox	   and	   vent	   or	   the	   Bmp	   antagonist	   chd.	  While	   at	   12	   ss,	  we	  could	  show	  a	  downregulation	  of	  the	  Bmp	  target	  genes	  vox	  and	  ved	  in	  the	  ALPM	  of	  the	   smoc2	   morphants.	   Our	   qPCR	   analysis	   indicated	   that	   this	   reduction	   in	  expression	  could	  not	  be	  attributed	  to	  changes	  in	  the	  expression	  levels	  of	  the	  Bmp	  ligands,	   bmp2b	   and	   bmp4,	   although	   it	   was	   reported	   previously	   that	   the	  expression	   of	   bmp2b	   in	   the	   pharyngeal	   teeth	   was	   reduced	   in	   the	   smoc2	  morphants	   at	   56	   hpf	   (Bloch-­‐Zupan	   et	   al.,	   2011).	   Furthermore,	   no	   change	   in	  expression	  was	  detected	  for	  the	  extracellular	  inhibitor	  chd	  and	  the	  receptor	  alk8.	  Similar	  to	  the	  qPCR	  data,	  our	  WISH	  analysis	  indicated	  a	  reduction	  of	  anterior	  vox	  expression	  at	  12	  ss.	  Consequently,	  the	  reduction	  in	  Bmp	  signaling	  in	  the	  ALPM	  of	  
smoc2	  morphants	  and	  the	  associated	  anterior	  myeloid	  defect	   is	   in	   line	  with	  the	  reported	  role	  for	  Bmp	  signaling	  in	  mediating	  myeloid	  development	  in	  the	  ALPM.	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As	   modulation	   of	   the	   Bmp	   signaling	   pathway	   was	   shown	   to	   result	   in	   severe	  dorso-­‐ventral	  patterning	  defects	  prior	  to	  somitogenesis	  stages,	   the	  effect	  of	   the	  silencing	  of	  smoc2	  is	  surprisingly	  late	  and	  discrete.	  A	  possible	  explanation	  is	  that	  the	  morpholino	  approach	  is	  not	  100%	  efficient.	  This	  implies	  that	  some	  maternal	  
smoc2	  mRNA	  will	  be	  able	  to	  be	  translated	  into	  Smoc2	  proteins	  during	  the	  initial	  critical	  stages.	  Studies	  on	  murine	  SPARC,	  a	  SMOC2	  family	  member,	  have	  shown	  that	  Sparc	  mRNA	  has	  a	  half-­‐life	  of	  over	  24	  hours	  (Delany	  and	  Canalis,	  1998).	  The	  half-­‐life	   of	   Smoc2	   is	   unknown,	   but	   it	   is	   possible	   that,	   although	   smoc2	  morpholinos	  are	  able	  to	  silence	  most	  of	  the	  smoc2	  mRNA,	  the	  fraction	  of	  proteins	  that	  is	  translated	  in	  the	  morphants	  could	  persist	  for	  much	  longer	  and	  ensures	  the	  proper	  initial	  development.	  This	  potentially	  also	  explains	  the	  lack	  of	  phenotypes	  as	  seen	  in	  embryos	  with	  altered	  levels	  of	  Bmp	  signaling	  (Lieschke	  et	  al.,	  2002).	  As	   we	   have	   shown	   that	   the	   dorso-­‐ventral	   patterning	   in	   pregastrulation	  morphants	   is	   unchanged,	   it	   is	   unlikely	   that	   the	   pregastrulation	   fate	   map,	   as	  suggested	  by	  Lieschke	  is	  altered	  (Lieschke	  et	  al.,	  2002).	  We	  are	  however	  aware	  of	  the	  fact	  that	  the	  techniques	  used	  in	  this	  study	  have	  their	  limits	  and	  might	  not	  be	  sensitive	  enough	  to	  detect	  subtle	  differences	  that	  can	  alter	  cell	  fates.	  Another	  possibility	  is	  the	  compensation	  of	  the	  loss	  of	  Smoc2	  by	  its	  closet	  family	  member,	  Smoc1.	  However,	  this	  is	  unlikely	  as	  during	  initial	  dorsoventral	  patterning	  stages	  
smoc1	  could	  not	  be	  detected	  (our	  unpublished	  data	  and	  (Maier,	  2006).	  	  Through	  what	  mechanism	  the	  expression	  of	  the	  Bmp	  target	  genes	  is	  affected	  by	  Smoc2	  remains	  to	  be	  determined.	  However,	  Pentagone	  (Pent),	  a	  protein	  found	  in	  D.	  melanogaster	  and	  a	  member	  of	  the	  SPARC	  family,	  has	  a	  highly	  similar	  domain	  organization	   to	   Smoc1	   and	   Smoc2	   (Vuilleumier	   et	   al.,	   2010;	   Vuilleumier	   et	   al.,	  2011).	   Despite	   the	   reversed	   order	   of	   the	   second	   TY	   domain	   and	   the	   first	   EF-­‐hand,	   Pentagone	   was	   shown	   to	   be	   the	   closest	   Smoc2	   homologue	   in	   D.	  melanogaster	  (Vuilleumier	  et	  al.,	  2010;	  Vuilleumier	  et	  al.,	  2011).	  Overexpression	  of	  pent	  mRNA	  in	  zebrafish	  embryos	  resulted	  in	  similar	  dorsalizations	  as	  in	  smoc2	  mRNA	  injected	  embryos.	  Studies	  have	  shown	  that	  pent	  regulates	  the	  gradient	  of	  Bmp	   signaling	   by	   competing	  with	   the	   Bmp	   ligand	   Dpp,	   for	   binding	   to	   Dally,	   a	  heparan	   sulphate	   proteoglycan	   (HSPG).	   By	   doing	   so,	   Pent	   was	   suggested	   to	  promote	   ligand	   distribution,	   antagonize	   the	   co-­‐receptor	   function	   of	   Dally,	   or	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regulate	  the	  interaction	  of	  Dpp	  and	  Dally	  (Vuilleumier	  et	  al.,	  2010;	  Vuilleumier	  et	  al.,	  2011).	  Bearing	   this	   in	  mind,	  one	  could	   interpret	   the	  smoc2	  morphant	  WISH	  analysis	  for	  the	  players	  of	  the	  Bmp	  signaling	  pathway	  in	  a	  similar	  way.	  As	  there	  is	  no	  difference	  in	  the	  expression	  of	  the	  Bmp	  ligands,	  or	  the	  Bmp	  antagonist	  chd	  and	   yet	   a	   decrease	   in	   the	   Bmp	   target	   gene	   expression	   is	   apparent,	   one	   could	  hypothesize	  that	  the	  distribution	  of	  the	  ligand	  might	  be	  altered.	  With	  bmp2b	  and	  
bmp4	   being	   expressed	   in	   both	   the	   anterior	   and	   the	   posterior	   lateral	   plate	  mesoderm	   during	   somitogenesis	   stages,	   a	   gradient	   of	   Bmp	   signaling	   is	  established	  towards	  the	  middle	  of	  the	  embryo.	  Our	  WISH	  analysis	  indicated	  that	  the	   extent	   of	   the	   anterior	   and	   especially	   the	   posterior	   signal	   was	   reduced.	  Knowing	   that	   the	   expression	   of	   the	   Bmp	   ligands,	   bmp2b	   and	   bmp4,	   did	   not	  change	   and	   if	   there	   was	   indeed	   a	   reduction	   of	   the	   Bmp	   ligand	   diffusion,	   this	  could	  mean	  that	  an	  increased	  Bmp	  signaling	  is	  possible	   in	  the	  posterior	  part	  of	  the	   embryo,	   explaining	   the	   ventralized	   phenotype	   we	   see	   in	   the	   smoc2	  morphants	  at	  24	  hpf.	  	  	  
	  
Figure	  7.1:	  smoc2	  morphants	  display	  a	  reduced	  extent	  of	  vox	  expression	  A-­‐D.	  Lateral	  views,	  anterior	  to	  the	  top;	  12	  ss	  embryos.	  A-­‐B.	  WISH	  analysis	  for	  the	  Bmp	  target	  gene	  vox.	  C-­‐D.	  Schematic	  representation	  of	  embryos	  in	  A	  and	  B	  with	  posterior	  vox	  expression	  indicated	  in	  red.	  	  In	   addition,	   SMOC1	   was	   previously	   shown	   to	   interact	   with	   heparan	   sulphate	  proteoglycans	  (HSPG)	  in	  mice,	  thereby	  regulating	  cell	  adhesion	  (Klemencic	  et	  al.,	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2013).	   Similar	   HSPG	   binding	   sites	   have	   been	   found	   in	   mouse	   and	   zebrafish	  Smoc2.	   This	   suggests	   that	   interaction	   of	   HSPG	   and	   Smoc2	   in	   zebrafish	   and	  competition	   with	   Bmp	   ligands	   for	   HSPG	   could	   be	   possible	   (Klemencic	   et	   al.,	  2013;	  (Vuilleumier	  et	  al.,	  2010;	  Vuilleumier	  et	  al.,	  2011).	  	  This	   hypothesis	   is	   further	   supported	   by	   the	   fact	   that	   Pent	   was	   suggested	   to	  function	   upstream	   of	   the	   Alk8	   receptor	   as	   the	   overexpression	   of	   pent	   could	  rescue	   the	   bmp2b-­‐	   but	   not	   the	   alk8-­‐mediated	   ventralization.	   Interestingly,	  zebrafish	   smoc2	   gain	   of	   function	   resulted	   in	   similar	   dorsalized	   phenotypes,	  suggesting	  a	  functional	  conservation	  between	  pent	  and	  smoc2	  (Vuilleumier	  et	  al.,	  2010).	  	  Furthermore,	   the	   X.	   laevis	   orthologue,	   xsmoc1,	   was	   shown	   to	   act	   as	   a	   Bmp	  antagonist	   possibly	   through	   Mapk-­‐mediated	   phosphorylation	   of	   the	   R-­‐Smads.	  The	   phenotype	   in	   the	   xsmoc1	   morphants	   was	   shown	   to	   be	   rescued	   after	   co-­‐injecting	   zebrafish	   smoc2	  mRNA	   (Thomas	   et	   al.,	   2009)	   suggesting	   a	   functional	  conservation	  of	  the	  gene.	  Since	  there	  is	  only	  one	  smoc	  gene	  in	  X.	  laevis,	  and	  two	  paralogues	   in	   zebrafish,	   chickens,	   mice	   and	   humans,	   it	   is	   difficult	   to	   make	  statements	   on	   conservation	   of	   function.	   It	   must	   however	   be	   noted	   that	   the	  phenotype	   of	   smoc1	   morphant	   zebrafish	   is	   very	   different	   than	   that	   of	   smoc2	  morphants,	  which	  are	  more	  similar	  to	  the	  ventralized	  xsmoc1	  morphant	  defects	  (Thomas	  et	  al.,	  2009;	  Abouzeid	  et	  al.,	  2011;	  Rainger	  et	  al.,	  2011).	  In	  addition,	  gain	  of	  function	  of	  xsmoc1	  and	  smoc2	  result	  in	  similar	  dorsalized	  phenotypes	  as	  well	  (Vuilleumier	  et	  al.,	  2010).	  	  	  In	  summary,	  our	  analysis	  shows	  that	  smoc2	  affects	  myelopoiesis	  in	  the	  anterior	  lateral	  plate	  mesoderm	  of	  developing	  zebrafish	  embryos,	  potentially	  through	  the	  modulation	   of	   Bmp	   signaling.	   It	   is	   tempting	   to	   speculate	   on	   how	   Smoc2	  	  regulates	  embryonic	  myelopoiesis	  in	  the	  anterior	  lateral	  plate	  mesoderm	  during	  zebrafish	  development.	  One	  possibility	  is	  that	  by	  binding	  to	  the	  same	  sidechains	  of	   the	  HSPG	  present	  on	   the	  cell	  membrane,	  Smoc2	  competes	  with	  Bmp	   ligands	  for	   these	   interactions	   and	   therefore	   promotes	   the	   diffusion	   of	   Bmp	  molecules	  further	  away	  from	  the	  source.	  Thereby	  Smoc2	  ensures	  a	  widened	  Bmp	  gradient,	  with	  a	  shallower	  slope	  as	  compared	  to	  the	  natural	  Bmp	  gradient.	  In	  the	  absence	  of	  Smoc2,	   the	  gradient	  of	   the	  Bmp	  signaling	   is	   limited	   to	   the	   intrinsic	  diffusion	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properties	   of	   the	  Bmp	   ligands	   itself.	   Therefore	   a	   steeper	   gradient	   can	  be	   seen,	  with	   cells	  more	   distant	   from	   the	   source	   of	   Bmp	   ligands	   not	   responding	   to	   the	  signal.	  The	  cells	  closest	  to	  the	  source,	  however,	  will	  have	  more	  ligands	  available	  as	   these	  cannot	  diffuse	  away	   further.	  When	  Smoc2	   is	  abundantly	  available,	   the	  Smoc2	   proteins	   outcompete	   the	   Bmp	   ligands	   for	   the	   HSPG	   binding	   sites.	   This	  results	   in	  an	  even	   further	  spreading	  of	   the	  Bmp	   ligands	  and	  a	   reduction	  of	   the	  overall	  Bmp	  signaling.	   	  
	  
Figure	  7.2:	  Hypothetical	  mechanism	  of	  action	  of	  Smoc2	  based	  on	  the	  data	  of	  the	  zebrafish	  morphants	  
	  	   101	  
A.	  Binding	  of	  Bmp	  ligands	  to	  the	  receptor	  is	  mediated	  by	  the	  recruiting	  action	  of	  HSPGs.	  Bmp	  ligands	  bind	  the	  sidechains	  of	  these	  HSPG	  and	  thereby	  get	  recruited	  towards	  the	  cell	  membrane	  and	  the	  Bmp	  receptors.	  B.	  Bmp	  proteins	  diffuse	  away	  from	  their	  source.	  Smoc2	  affects	  the	  diffusion	  of	  the	  Bmp	  ligands	  and	  shapes	  the	  extent	  of	  Bmp	  signaling.	  	  	  Therefore	   Smoc2	   affects	   the	   diffusion	   of	   the	   Bmp	   ligands	   and,	   just	   like	   in	   D.	  melanogaster,	   shapes	   the	  gradient	  of	  Bmp	  signaling	   that	   is	  required	   for	  proper	  specification	  of	  the	  hemangioblasts	  during	  early	  stages	  and	  the	  activation	  of	  the	  myeloid	  progenitor	  specific	  program	  at	  later	  stages	  of	  zebrafish	  development.	  	  More	  research	  is	  however	  needed	  to	  investigate	  the	  relation	  between	  Smoc2	  and	  Bmp,	  and	  to	  assess	  if	  there	  is	  a	  direct	  interaction,	  or	  if	  a	  secondary	  partner,	  like	  proteoglycans	  is	  involved.	  	  
7.1.2.	  smoc2	  gain	  of	  function	  	  7.1.2.1	  Smoc2	  modulates	  Wnt5b	  mediated	  non-­‐canonical	  Wnt	  signaling	  The	  overexpression	  of	  smoc2	  mRNA	  in	  the	  zebrafish	  embryo	  resulted	  in	  a	  range	  of	  phenotypes	  at	  the	  initial	  stages	  of	  somitogenesis.	  Together	  with	  dorso-­‐ventral	  patterning	   defects	   (DV),	   the	   injected	   embryos	   presented	   convergence	   and	  extension	  defects	  (CE).	  These	  DV	  and	  CE	  defects	  are	  traditionally	  the	  result	  of	  a	  defective	  Bmp	  and	  non-­‐canonical	  Wnt	  signaling,	  respectively.	  	  At	  the	  shield	  stage,	  a	  subtle	  increase	  in	  chd	  expression	  and	  a	  subtle	  decrease	  in	  
gata2	   expression	  were	  detected.	  Although	   this	  could	  explain	   the	  DV	  patterning	  defect,	   the	   difference	   in	   chd	   expression	   at	   70%	   epiboly	   was	   even	   smaller.	   In	  embryos	   with	   similar	   DV	   patterning	   defects	   at	   late	   stages,	   the	   changes	   in	   the	  expression	   of	   chd	   were	   reported	   to	   be	   more	   severe	   than	   upon	   injection	   with	  
smoc2	  mRNA	   (Ghiselli	   and	   Farber,	   2005;	   Seebald	   and	   Szeto,	   2011;	   Wu	   et	   al.,	  2012).	  We	  therefore	  conclude	  that	  additional	  factors	  must	  be	  contributing	  to	  the	  DV	  pattering	  defects	  of	  the	  smoc2	  mRNA	  injected	  embryos	  or	  that	  at	  later	  stages	  the	   Bmp	   signaling	   is	   disturbed	   more	   severely.	   In	   addition,	   the	   smoc2	   mRNA	  injected	   embryos	   also	   presented	   CE	   movement	   defects,	   which	   are	   typically	  regulated	   by	   the	   non-­‐canonical	   Wnt	   signaling	   pathway.	   Analysis	   of	   the	   latter	  indicated	  that	  a	   full	  and	  specific	  rescue	  of	  the	  smoc2	  mRNA	  induced	  phenotype	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could	   be	   obtained	   upon	   co-­‐injection	   with	   wnt5b	   mRNA.	   This	   indicates	   that	  Smoc2	   modulates	   Wnt5b	   mediated	   signaling,	   but	   whether	   this	   is	   a	   through	   a	  direct	   interaction,	   or	   indirectly	   through	   other	   binding	   partners,	   receptors	   or	  cofactors	  or	  through	  other	  signaling	  pathways	  remains	  to	  be	  investigated.	  The	  full	  rescue	  upon	  co-­‐injection	  with	  wnt5b	  mRNA	  only	  suggests	  that	  Wnt5b	  is	  involved.	  It	  is	  important	  to	  mention	  that	  manipulation	  of	  Wnt5b-­‐mediated	  non-­‐canonical	   Wnt	   signaling	   was	   not	   reported	   to	   result	   in	   similar	   dorso-­‐ventral	  defects	   as	  were	   seen	   after	   injection	  with	   smoc2	  mRNA	   (Hammerschmidt	   et	   al.,	  1996;	   Kilian	   et	   al.,	   2003;	   Marlow	   et	   al.,	   2004).	   In	   contrast,	   Bmp	   mutants	   like	  
snailhouse	   (snh;	   bmp7),	   swirl	   (swr;	   bmp2b)	   and	   somitabun	   (sbn;	   smad5)	  displayed,	   next	   to	   dorso-­‐ventral	   patterning	   defects,	   typical	   CE	   defects	   such	   as	  wider	  axial	  structures	  and	  somites	  all	  around	  the	  embryo	  (Mullins	  et	  al.,	  1996).	  Since	  non-­‐canonical	  Wnt	  mutants	  do	  not	  display	  DV	  defects,	  and	  as	  Bmp	  mutants	  do	   display	   CE	   defects,	   one	  might	   suggest	   that	   the	   Bmp	   signaling	   pathway	   lies	  upstream	   of	   the	   Wnt	   signaling	   pathway	   (Hammerschmidt	   et	   al.,	   1996;	  Heisenberg	  et	   al.,	   2000;	  Kilian	   et	   al.,	   2003).	  This	  was	   further	   supported	  by	   the	  data	   on	   the	   reduced	   expression	   levels	   of	   non-­‐canonical	   Wnts	   in	   bmp	   mutant	  zebrafish	  (Myers	  et	  al.,	  2002).	  However,	  which	  pathway	  regulates	  which	   is	  still	  an	   issue	   in	   both	   the	   zebrafish	   and	   the	   cartilage	   and	  bone	   research	   community	  and	  further	  research	  is	  needed	  to	  investigate	  this	  relation.	  	  Yet	   if	   the	   primary	   target	   of	   Smoc2	   is	   to	   be	   the	   non-­‐canonical	   Wnt	   signaling	  pathway,	  one	  could	  hypothesize	  about	   the	   function	   that	  Smoc2	  has	  within	   that	  pathway.	  As	   Smoc2	  was	   shown	   to	  mediate	   the	  progression	  of	   the	   cell	   cycle	  by	  associating	  with	  Integrin-­‐like	  kinase	  (ILK)	  through	  an	  unknown	  factor	  and	  as	  ILK	  has	  been	  associated	  with	  Wnt	   signaling	   (Mulholland	  et	   al.,	   2006;	  Oloumi	  et	   al.,	  2006;	   Yamabi	   et	   al.,	   2006),	   one	   could	   speculate	   that	   a	   Wnt	   ligand	   or	   (co-­‐)receptor	   might	   be	   that	   unknown	   factor.	   In	   addition,	   changes	   in	   the	   DV	  patterning	   were	   shown	   to	   affect	   the	   expression	   of	   wnt5b	   and	   wnt11	   and	  therefore	   co-­‐injection	   of	   wnt5b	   mRNA	   might	   restore	   the	   non-­‐canonical	   Wnt	  balance	  resulting	  in	  a	  rescue	  of	  the	  smoc2	  mRNA	  induced	  phenotypes	  (Myers	  et	  al.,	  2002).	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However,	  to	  test	  if	  any	  of	  these	  hypotheses	  stand,	  further	  research	  is	  needed	  to	  clarify	   the	   role	   of	   all	   these	   players	   and	   their	   interactions	   during	   the	   different	  stages	  of	  zebrafish	  development.	  	  	  7.1.2.2.	  The	  FS-­‐domain	  is	  essential	  for	  the	  function	  of	  Smoc2	  Besides	   the	   full	   size	   Smoc2,	  we	   began	   testing	   the	   biological	   importance	   of	   the	  different	  Smoc2	  domains.	  Our	  data	   indicated	  that	  none	  of	   the	  domains,	  besides	  the	   FS	   domain,	   contributed	   to	   the	   smoc2	   mRNA	   induced	   phenotype.	   The	   FS	  domain	   appeared	   to	   influence	   the	   severity	   of	   the	   phenotype.	   The	   name	  follistatin-­‐like	  domain,	  is	  somewhat	  misleading	  as	  this	  immediately	  suggests	  that	  this	  domain	  has	  a	  similar	  function	  as	  Follistatin,	  an	  extracellular	  Tgfβ/Bmp/Gdf	  antagonist	  (Esch	  et	  al.,	  1987;	  Balemans	  and	  Van	  Hul,	  2002).	  However,	  no	  proof	  has	  been	  provided,	  in	  this	  study	  or	  in	  any	  other	  that	  the	  FS	  domain	  can	  bind	  any	  of	  these	  ligands.	  	  More	  likely,	  the	  loss	  of	  the	  FS	  domain	  interferes	  with	  the	  structure	  of	  the	  protein.	  In	  SPARC,	  the	  adjacent	  FS	  and	  EC	  domains	  were	  shown	  to	  interact	  and	  regulate	  the	  conformation	  of	  the	  protein	  (Hohenester	  et	  al.,	  1997;	  Busch	  et	  al.,	  2000).	  In	  Smoc2,	  however,	  the	  FS	  and	  EC	  domains	  are	  separated	  by	  two	  TY	  domains	  that	  flank	  a	  putative	  SMOC	  domain,	  which	  could	  alter	  the	  interaction	  between	  the	  FS	  and	   the	   EC	   domain.	   Surprisingly,	   the	   loss	   of	   the	   EC	   domain	   does	   not	   interfere	  with	  the	  severity	  of	  the	  phenotype,	  which	  indicates	  that	  the	  difference	  caused	  by	  removing	   the	   FS	   domain	   is	   unlikely	   to	   originate	   from	   changes	   in	   the	  conformation	  of	  Smoc2.	  Given	  the	  reported	  interaction	  of	  the	  EC	  domain	  with	  i	  Integrin	  and	  the	  suggested	  interaction	  of	  the	  EC	  doman	  with	  HSPGs,	  the	  absence	  of	  a	  phenotypic	  difference	  upon	  injection	  with	  the	  smoc2^EC	  indicated	  that	  these	  interaction	  partners	  do	  not	  contribute	  to	  the	  development	  of	  the	  gain	  of	  function	  phenotype	  (Maier	  et	  al.,	  2008;	  Klemencic	  et	  al.,	  2013).	  	  More	  importantly,	   the	  FS	  domain	  harbors	  a	  Kazal	  domain,	  which	  functions	  as	  a	  serine	   protease	   inhibitor	   (Hohenester	   et	   al.,	   1997).	   The	   loss	   of	   the	   FS	   domain,	  but	   not	   the	   loss	   of	   the	   EC	   or	   SMOC	  domain,	   could	   therefore	   result	   in	   a	   Smoc2	  protein	  that	   is	  more	  prone	  to	  proteases.	  One	  could	   imagine	  that	  the	  window	  of	  activity	  of	  a	  protein,	  with	  a	  changed	  half-­‐life,	  is	  smaller	  and	  that	  overexpression	  of	   such	   a	   less	   stable	   protein	   might	   result	   in	   milder	   phenotypes.	   Remarkably,	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zebrafish	   injected	  with	  the	  FS	  mutant	  still	  present	  defects,	  which	   indicates	  that	  the	   FS	   domain	   alone	   is	   not	   responsible	   for	   the	   defect.	   We	   suggest	   that	   other	  domains	   like	   the	   TY1	   or	   TY2	   domain,	   although	   being	   reported	   to	   prevent	  proteolytic	  degradation	  (Molina	  et	  al.,	  1996;	  Lenarcic	  and	  Bevec,	  1998),	  or	  other	  stretches	  of	  amino	  acids	  are	  more	  important	  for	  the	  induction	  of	  the	  phenotype.	  Additional	   mutant	   studies	   are	   therefore	   required	   to	   determine	   which	   part	   of	  Smoc2	  causes	  the	  phenotype.	  	  	  
7.2	  SMOC2	  in	  the	  chicken	  limb	  model	  	  
7.2.1.	  SMOC2	  overexpression	  results	  in	  a	  suppression	  of	  FGF8	  expression	  Processing	  of	  successfully	  injected	  limbs	  by	  means	  of	  WISH	  analysis	  indicated	  an	  apparent	   change	   in	   the	   expression	   of	   FGF8,	   essential	   for	   the	   proximodistal	  outgrowth	   of	   the	   limb	   (Niswander	   et	   al.,	   1993;	   Ohuchi	   et	   al.,	   1997;	   Saunders,	  1998).	   FGF8	   is	   expressed	   in	   the	   apical	   ectodermal	   ridge	   that	   regulates	   the	  proximo-­‐distal	   outgrowth	   of	   the	   limb.	   Previously	   it	   was	   shown	   that	   Bmp	  signaling	   controls	   the	  dorso-­‐ventral	   patterning	  by	   regulating	   the	   expression	   of	  EN-­‐1	  but	  also	  the	  proximo-­‐distal	  outgrowth	  of	  the	  limb	  bud	  by	  inducing	  the	  AER	  and	  the	  associated	  FGF	  signal.	  Once	  the	  AER	  is	  induced	  in	  the	  limb	  bud,	  the	  Bmp	  signaling	   exerts	   the	   opposite	   effect:	   it	   negatively	   regulates	   the	  maintenance	   of	  the	   AER	   (Pizette	   and	   Niswander,	   1999;	   Pizette	   et	   al.,	   2001).	   Therefore,	   it	   is	  tempting	   to	   hypothesize	   that	   SMOC2	   interferes	   with	   the	   expression	   of	   FGF8	  through	   modulation	   of	   BMP	   signaling,	   similar	   to	   its	   role	   in	   D.	   rerio	   and	   D.	  melanogaster.	  	  	  
7.3	  SMOC2	  in	  mice	  	  Crossing	  Smoc2+/-­‐	  mice	   resulted	   in	  mendelian	  distributed	  Smoc2-­‐/-­‐	  mice,	  which	  presented	   an	   embryonic	   lethal	   phenotype.	   Our	   preliminary	   analysis	   indicated	  that	  the	  embryos	  die	  around	  8	  dpc,	  suggesting	  that	  SMOC2	  has	  a	  crucial	  function	  during	   the	   process	   of	   embryonic	   development.	   The	   strong	   conservation	   of	   the	  regulatory	  components	  of	  the	  hematopoietic	  molecular	  machinery	  across	  species	  would	  suggest	  that	  SMOC2,	  just	  as	  in	  zebrafish,	  regulates	  hematopoiesis	  in	  mice.	  
	  	   105	  
Indeed,	   TGFβ/BMP	   signaling	   was	   reported	   to	   influence	   the	   formation	   of	   the	  mesoderm	   and	   subsequently	   induction	   of	   hemangioblasts	   (Dzierzak	   and	  Medvinsky,	  1995;	  Baron,	  2001).	  However,	  the	  developmental	  delay	  of	  the	  Smoc2-­‐/-­‐	   embryos	   does	   not	   allow	   us	   to	   make	   any	   statement	   on	   the	   relation	   of	   the	  apparent	  reduction	  in	  blood	  formation	  in	  the	  Smoc2-­‐/-­‐	  embryos	  and	  the	  zebrafish	  loss	   of	   function	   data.	   Interestingly,	   the	   expression	   pattern	   of	   SMOC2	   in	  mouse	  embryos	  appears	  from	  embryonic	  day	  7.5	  onwards	  in	  the	  Reichert’s	  membrane,	  a	  tissue	  found	  only	  in	  rodents,	  that	  separates	  the	  embryonic	  endoderm	  from	  the	  throphoblast	   cells	   (Maier	   et	   al.,	   2008).	   No	   additional	   expression	  was	   detected	  until	   10.5	   days	   post	   coitus,	   a	   stage	   at	   which	   the	   Smoc2-­‐/-­‐	   embryo	   has	   died	  already.	   This	   could	   indicate	   that	   the	   expression	   of	   SMOC2	   in	   the	   Reichert’s	  membrane	   is	   crucial	   for	   the	   development	   of	   the	   mouse	   embryo	   either	   by	  influencing	  the	  development	  of	  the	  embryo	  itself	  or	  by	  affecting	  the	  integrity	  of	  the	  Reichert’s	  membrane.	  The	  Reichert’s	  membrane	  was	  purported	  to	  influence	  the	  materno-­‐embryonic	   exchange	   (Jollie,	   1968;	   Jensen	   et	   al.,	   1975)	   and	   it	  was	  suggested	   that	   a	   defective	   Reichert’s	   membrane	   could	   result	   in	   wasting	   and	  death	  of	  the	  embryos	  (Williamson	  et	  al.,	  1997).	  	  Our	   Smoc2-­‐/-­‐	   phenotype	   differs	   greatly	   from	   the	   homozygous	   Smoc2	   knock-­‐in	  mice	  of	  the	  group	  of	  Hans	  Clevers	  (Munoz	  et	  al.,	  2012).	  They	  inserted	  an	  EGFP-­‐ires-­‐CreERT2	  cassette	  at	   the	  translational	  start	  site	  of	  Smoc2	  and	  reported	  that	  these	   mice	   do	   not	   present	   an	   embryonic	   lethal	   phenotype.	   Homozygous	   mice	  were	  apparently	  viable	  and	  did	  not	  show	  any	  defects.	  We	  can	  only	  speculate	  on	  the	  underlying	  reason	  for	  this	  major	  difference	  in	  phenotypes.	  This	  could	  be	  due	  to	  the	  difference	  in	  strategy,	  or	  strain	  of	  mice	  used	  to	  generate	  the	  knockout.	  It	  is	  not	   uncommon	   to	   see	   a	   difference	   in	   phenotypes	   when	   a	   gene	   is	   targeted	   in	  different	  strains	  or	  using	  different	  approaches.	  For	  example,	  Noggin-­‐/-­‐	  mice	  were	  shown	   to	   display	   different	   defects	   depending	   on	   the	   strain	   that	   was	   used	  (Tylzanowski	  et	  al.,	  2006).	  Furthermore,	  it	  was	  reported	  that	  the	  approach	  used	  to	  knock	  out	  Smoc1	  resulted	  in	  a	  different	  phenotype	  (Okada	  et	  al.,	  2011;	  Rainger	  et	  al.,	  2011).	   In	  our	  analysis,	  we	  replaced	  the	   first	   intron	  with	  the	  LacZ	  casette,	  while	  in	  the	  study	  of	  Munoz,	  they	  targeted	  their	  cassette	  at	  the	  translation	  start	  site	  of	  Smoc2.	  No	  further	  evidence	  was	  provided	   in	  their	  paper	  on	  whether	  the	  translation	   start	   site	   is	   therefore	   still	   active	   and	   a	  modified,	   potentially	   active	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protein	   is	  still	  present	  (Munoz	  et	  al.,	  2012).	   It	   is	   therefore	  unclear	  whether	   the	  published	  Smoc2	  knock-­‐in	  mouse	  is	  a	  full	  Smoc2	  null	  mouse.	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To	   investigate	   the	  complexity	  of	  human	  biology	  and	   its	  associated	  pathological	  conditions	   we	   use	   animal	   models	   with	   comparable	   genetics,	   anatomy	   and/or	  physiology.	   In	   this	   project	   we	   used	   multiple	   animal	   models,	   each	   with	   their	  strengths	  and	  limitations,	  and	  best	  suited	  for	  the	  specific	  question	  we	  wanted	  to	  answer.	   Nevertheless,	   the	   findings	   presented	   in	   this	   thesis	   emphasize	   the	   fact	  that	   the	   intricate	   nature	   of	   the	   extracellular	   matrix	   puts	   forward	   a	   major	  challenge,	   animal	  models	  notwithstanding.	  The	  data	   indicate	   that	   changing	   the	  expression	   of	   just	   one	   single	   component	   results	   in	   a	   complex	   combination	   of	  tissue	   specific	   phenotypes.	   Using	   the	   zebrafish	   model,	   we	   have	   shown	   that	  Smoc2	   is	   associated	   with	   Bmp	   and	   Wnt5b	   signaling.	   In	   addition,	   using	   the	  chicken	   limb	  bud	  model,	  we	   associated	   SMOC2	  with	  FGF8	   expression	  which	   is	  regulated	  by	  BMP	  signaling.	  Furthermore,	  our	  preliminary	  analysis	  of	  the	  Smoc2-­‐/-­‐	  mouse	  indicated	  that	  SMOC2	  is	  a	  crucial	  matricellular	  protein	  during	  the	  early	  stages	  of	  embryonic	  development.	  	  	  In	  zebrafish,	  further	  research	  is	  required	  to	  identify	  the	  interaction	  partner(s)	  of	  Smoc2,	  which	  could	  be	  a	   signaling	   ligand,	   a	   cofactor	  or	   coreceptor.	  As	  we	  only	  report	  on	  the	  downstream	  changes	  induced	  by	  the	  manipulation	  of	  Smoc2	  levels,	  we	  can	  only	  hypothesize	  on	  the	  function	  of	  Smoc2	  and	  the	  level	  at	  which	  Smoc2	  is	  interfering	  with	  a	  particular	  signaling	  cascade.	  Our	  analysis	  indicated	  that	  Bmp	  and/or	  Wnt	   ligands,	   cofactors	  or	   receptors	  are	   the	  primary	  candidates	   to	  have	  such	  a	  role.	  One	  could	  therefore	  start	  speculating	  that	  Smoc2	  affects	   the	   ligand	  distribution,	   ligand-­‐receptor	   interaction	   or	   co-­‐factor	   availability	   to	   mention	   a	  few.	  As	  this	  are	   just	  speculations,	   the	   identification	  of	  the	  binding	  partner(s)	  of	  Smoc2	  will	  assist	  to	  determine	  the	  primary	  target	  of	  Smoc2,	  distinguish	  primary	  from	   secondary	   defects	   and	   eventually	   clarify	   the	   function	   of	   Smoc2.	   This	  becomes	   relevant	   as	   our	   gain	   and	   loss	   of	   function	   analysis	   indicate	   different	  targets	   for	   Smoc2.	   With	  wnt5b	   also	   expressed	   in	   the	   ALPM	   and	   loss	   of	   Bmp	  signaling	   also	   resulting	   in	   CE	   defects,	   both	   mechanisms	   are	   amongst	   the	  possibilities.	  	  Furthermore,	   a	   thorough	   dorso-­‐ventral	   patterning	   analysis	   of	   the	  overexpression	   phenotype	   during	   pregastrula	   and	   segmentation	   stages	   and	   is	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required,	  especially	  in	  light	  of	  the	  reduced	  expression	  of	  the	  Bmp	  target	  genes	  in	  the	  smoc2	  morphants.	  	  Additionally,	   the	   domain	   analysis	   will	   have	   to	   be	   extended	   to	   other	   different	  domains.	  The	  identification	  of	  binding	  partners	  will	  help	  narrowing	  down	  what	  SMOC2	  domain	  and	  what	  peptide	  sequence	  is	  involved	  in	  the	  interaction.	  	  	  In	   the	   chicken	   limb	   bud,	   all	   tools	   were	   generated	   for	   the	   investigation	   of	   the	  outgrowth	   defect	   seen	   in	   the	   RCASBPA-­‐SMOC2	   injected	   limbs.	   Analysis	   of	   the	  expression	  of	  additional	  molecular	  markers	  (Bmp	  target	  genes	  like	  EN-­‐1	  or	  VOX	  and	  VENT,	  and	  other	  FGF	  and	  WNT	  related	  genes)	  will	  add	  valuable	  information	  for	  the	  interpretation	  of	  the	  induced	  defect.	  In	  addition,	  injection	  at	  later	  stages	  of	  development,	   could	  also	  be	   interesting,	  especially	  as	   it	  was	  shown	  that	  Bmp	  blocks	   the	   expression	   of	   FGF	   ligands	   once	   the	   AER	   is	   induced.	   (Pizette	   and	  Niswander,	  1999;	  Pizette	  et	  al.,	  2001).	  For	  the	  Smoc2-­‐/-­‐	  mouse,	  earlier	  stages	  of	  development	  (5.5-­‐7.5	  dpc)	  will	  have	  to	  be	  analyzed	  morphologically	  and	  molecularly	  (WISH,	  IHC)	  in	  order	  to	  investigate	  the	   dramatic	   effect	   of	   the	   loss	   of	   Smoc2	   on	   the	   development	   of	   the	   embryo.	  Experts	   in	   field	   of	   mouse	   embryonic	   development	   advised	   us	   to	   use	  mesenodermal	   probes	   as	   defects	   in	   the	   mesendoderm	   could	   explain	   the	  phenotype.	  Furthermore,	  the	  results	  of	  the	  zebrafish	  and	  chicken	  studies	  should	  be	  taken	  under	  consideration	  when	  choosing	  the	  probes	  of	  interest.	  In	  addition,	  valuable	   information	   could	   be	   added	   when	   investigating	   a	   tissue	   specific	  knockout.	  As	  our	  lab	  is	  interested	  in	  the	  development	  of	  the	  joint	  and	  as	  Smoc2	  was	  isolated	  from	  the	  articular	  cartilage	  and	  shown	  to	  be	  expressed	  in	  the	  joint	  interzone,	  crossing	  a	  Smoc2fl/fl	  mouse	  with	  a	  mouse	  with	  joint	  interzone	  specific	  (Gdf5;	  (Buxton	  et	  al.,	  2001))	  or	  cartilage	  specific	  (Col2;	  (Seyer	  and	  Vinson,	  1974))	  Cre	  expression	  should	  prevent	  early	  lethal	  phenotypes	  and	  might	  shed	  new	  light	  on	  the	  role	  of	  SMOC2	  in	  the	  context	  of	  the	  joint.	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Musculoskeletal	   conditions	   are	   the	   leading	   cause	   of	   morbidity	   and	   disability,	  resulting	   in	   enormous	   healthcare	   costs	   and	   working	   disability.	   About	   150	  diseases,	   syndromes	   and	   disorders	   are	   grouped	   in	   the	   musculoskeletal	  conditions,	   each	   being	   progressive	   and	   associated	   with	   pain	  (http://www.who.int).	   One	   of	   them	   is	   OA,	   a	   chronic	   and	   progressive	   joint	  disorder	   that	   is	   caused	  by	  degradation	  of	   the	  articular	  cartilage	  and	  associated	  defects	   of	   the	   subchondral	   bone.	   Although	   many	   research	   groups	   have	  investigated	  the	  onset	  and	  progression	  of	  this	  disabling	  condition,	  the	  underlying	  cause	  or	  mechanism	  is	  far	  from	  completely	  understood.	  	  Therefore	  our	  lab	  analyzed	  a	  protein	  extract	  from	  bovine	  articular	  cartilage	  with	  in	  vivo	  chondrogenic	  activity	  and	  isolated	  the	  SMOC2	  protein.	  In	  addition,	  Smoc2	  was	   shown	   to	   be	   expressed	   in	   the	   joint	   interzone	   of	   mouse	   embryonic	   digits.	  Recent	  evidence	  indicated	  that	  signaling	  pathways,	  which	  are	  known	  to	  regulate	  the	   embryonic	   stages	   of	   development,	   are	   reactivated	   during	   the	   onset	   and	  progression	   of	   multiple	   conditions,	   including	   musculoskeletal	   diseases.	  Therefore,	  we	  used	  developmental	  models	  to	  analyze	  the	  function	  of	  SMOC2.	  	  To	  investigate	  the	  SMOC2	  associated	  signaling	  pathway(s),	  we	  used	  the	  zebrafish	  model	  system	  and	  performed	  loss	  and	  gain	  of	  function	  experiments.	  	  Our	  loss	  of	  function	  analysis	  indicated	  that	  Smoc2	  affected	  myeloid	  development	  by	   reducing	   the	   number	   of	  macrophages	   and	   neutrophils	   during	   the	   primitive	  wave	  of	  zebrafish	  hematopoiesis.	  This	  defect	  could	  be	  traced	  back	  to	  the	  reduced	  expression	   of	   the	   myeloid	   progenitor	   specific	   gene	   spi1b	   at	   earlier	   stages	   of	  development.	  In	  addition,	  we	  detected	  a	  reduction	  in	  Bmp	  signaling,	  which	  was	  previously	  shown	  to	  regulate	  spi1b	  expression.	  This	  suggests	  that	  Smoc2	  affects	  Bmp	  signaling	  in	  the	  ALPM,	  potentially	  by	  manipulation	  of	  the	  Bmp	  gradient.	  Our	  gain	  of	  function	  analysis	  indicated	  that	  Smoc2	  affects	  the	  DV	  patterning	  and	  CE	  movements	   during	   the	   gastrulation	   and	   subsequent	   segmentation	   stages	   of	  zebrafish	   development.	   In	   addition,	   Smoc2	   appeared	   to	   mediate	   the	   Wnt5b	  mediated	  non-­‐canonical	  Wnt	  signaling	  pathway.	  Although	  Smoc2	  could	  affect	  both	  the	  Bmp	  and	  the	  Wnt	  pathway	  directly,	  it	  is	  as	  likely	  that	  Smoc2	  affects	  just	  one	  of	  them,	  which	  subsequently	  affects	  the	  other	  one.	  Obviously,	   the	   interaction	   and	  modulation	   of	   these	   signaling	   pathways	   all	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depend	  on	  the	  specific	  microenvironment	  and	  the	  spatio-­‐temporal	  context	  of	  the	  
smoc2	  expressing	  cells.	  	  In	   order	   to	   relate	   the	   function	   of	   SMOC2	   to	   the	   homeostasis	   of	   the	   joint,	   the	  zebrafish	  model	  is	  less	  suited.	  Therefore,	  we	  opted	  for	  the	  chicken	  limb	  model,	  as	  the	  joints	  in	  these	  limbs	  are	  more	  equal	  to	  human	  joints.	  To	  overexpress	  SMOC2	  in	  the	  chicken	  limb	  bud,	  we	  cloned	  SMOC2	  into	  the	  RCAS	  viral	  vector	  that	  allows	  for	   infection	   of	   the	   chicken	   cells.	   Localized	   injection	   of	   this	   RCASBPA-­‐SMOC2	  virus	   resulted	   in	   an	   outgrowth	   defect	   along	   the	   proximo-­‐distal	   axis.	   Our	  preliminary	  analysis	  of	  the	  injected	  limbs	  indicated	  a	  reduced	  FGF8	  expression	  in	  the	   AER,	   which	   is	   known	   to	   regulate	   the	   outgrowth	   of	   the	   limb.	   However,	   it	  remains	  unclear	  whether	  SMOC2	  directly	  affects	  FGF	  transcription	  or	  affects	  the	  expression	  through	  a	  secondary	  partner,	  like	  BMP.	  	  As	   a	   third	   animal	   model,	   we	   have	   used	   the	   mouse	   model	   to	   analyze	   the	  phenotype	   upon	   loss	   of	   SMOC2.	   Smoc2-­‐/-­‐	   mouse	   embryos	   presented	   a	   lethal	  phenotype	  during	  early	  stages	  of	  development.	  As	  Smoc2	   is	  only	  reported	  to	  be	  expressed	  in	  the	  Reichert’s	  membrane	  at	  those	  stages,	  potentially	  a	  defect	  in	  the	  Reichert’s	  membrane	  underlies	  the	  lethal	  phenotype.	  	  In	  conclusion,	  our	  work	  revealed	  new	  insights	  in	  the	  essential	  function	  of	  SMOC2	  during	   zebrafish,	   chicken	   and	   mouse	   embryonic	   development,	   which	   allows	  further	  research	  to	  determine	  the	  role	  of	  SMOC2	  within	  the	  intricate	  network	  of	  signaling	  cascades.	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Musculoskeletale	  aandoeningen	  zijn	  de	  primaire	  oorzaak	  van	  ziekte	  en	  ongemak	  die	   resulteren	   in	   enorme	   medische	   kosten	   en	   werkverlet.	   Ongeveer	   150	  progressieve	   en	   met	   pijn	   geassocieerde	   ziekten,	   syndromen	   en	   aandoeningen	  worden	   gegroepeerd	   onder	   de	   musculoskeletale	   aandoeningen	  (http://www.who.int).	   Eén	   daarvan	   is	   osteoarthritis,	   een	   chronische	   en	  progressieve	   aandoening	   van	   de	   gewrichten	   die	   veroorzaakt	   wordt	   door	   de	  afbraak	   van	   het	   gewrichtskraakbeen	   en	   defecten	   van	   het	   onderliggende	  subchondrale	   bot.	   Ondanks	   het	   intense	   onderzoek	   van	   verschillende	   groepen	  naar	   de	   initiatie	   en	   de	   progressie	   van	   deze	   invaliderende	   aandoening	   is	   de	  onderliggende	  oorzaak	  en	  het	  mechanisme	  van	  de	  aandoening	  nog	  niet	  duidelijk.	  Om	   die	   reden	   heeft	   ons	   labo	   een	   proteine	   extract	   met	   kraakbeeninducerende	  activiteit	   in	   vivo,	   afkomstig	   van	   het	   gewrichtskraakbeen	   van	   een	   rund,	  onderzocht	   en	   het	   SMOC2	   proteïne	   geïsoleerd.	   Daarenboven	  werd	   aangetoond	  dat	  Smoc2	  tot	  expressie	  komt	  in	  de	  gewrichtsinterzone	  van	  de	  embryonale	  muis	  digit.	   Recent	   onderzoek	   heeft	   uitgewezen	   dat	   de	   signaalcascades,	   die	   de	  embryonale	   ontwikkeling	   regelen,	   gereactiveerd	   kunnen	   worden	   tijdens	   de	  beginfasen	   en	  de	   verdere	   onwikkeling	   van	   verschillende	   aandoeningen.	  Om	  de	  functie	   van	   SMOC2	   te	   verklaren	   hebben	   we	   daarom	   gekozen	   om	   model	  organismen	  in	  hun	  embryonaal	  stadium	  te	  analyseren.	  	  We	   hebben	   het	   zebravis	   model	   aangewend	   om	   uit	   te	   zoeken	   met	   welke	  signaalcascade	  Smoc2	  geassocieerd	   is.	  Daartoe	  werden	   loss	  en	  gain	  of	   function	  analyses	  uitgevoerd.	  	  Volgens	  de	  data	  uit	  onze	  loss	  of	  function	  studie	  beïnvloedde	  Smoc2	  de	  myeloïde	  ontwikkeling	  door	  het	  aantal	  macrofagen	  en	  neutrofielen	  te	  reduceren	  tijdens	  de	  primaire	   ontwikkeling	   van	   het	   hematopoïetisch	   systeem	   in	   de	   zebravis.	   Dit	  defect	   bleek	   veroorzaakt	   te	   worden	   door	   een	   verlaagde	   expressie	   van	   spi1b	  tijdens	   voorafgaande	   stadia.	   Bovendien	   konden	   we	   een	   reductie	   van	   de	   Bmp	  signalisatie	  aantonen,	  waarvan	  voorheen	  aangetoond	  was	  dat	  die	  de	  inductie	  van	  
spi1b	  medieert.	  Hieruit	  kunnen	  wij	  suggereren	  dat	  Smoc2	  een	  effect	  heeft	  op	  de	  Bmp	   signaal	   cascade	   in	   het	   ALPM,	   mogelijks	   door	   de	   gradiënt	   van	   Bmp	  signalisatie	  te	  beïnvloeden.	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Uit	   de	   gain	   of	   function	   experimenten	   bleek	   dat	   Smoc2	   een	   effect	   heeft	   op	   de	  ontwikkeling	   van	   de	   dorsale	   en	   ventrale	   weefsels	   en	   de	   regulatie	   van	   de	  gecoördineerde	  celmigratie	   tijdens	  gastrulatie	  en	  segmentatie	   fasen	  beïnvloedt.	  Daarenboven	   bleek	   dat	   Smoc2	   de	   Wnt5b	   gemedieerde	   non-­‐canonical	   Wnt	  signaalcascade	   reguleert.	   Hoewel	   Smoc2	   zowel	   de	   Bmp	   als	   de	   Wnt	  signaalcascade	   zou	   kunnen	   reguleren,	   is	   het	   evengoed	   mogelijk	   dat	   Smoc2	  slechts	  één	  van	  de	   twee	  beïnvloedt	  en	  dat	  die	  op	  zijn	  beurt	  de	  andere	   cascade	  treft.	   Uiteraard	   is	   de	   interactie	   and	   de	   beïnvloeding	   van	   deze	   signallcascades	  afhankelijk	   van	   de	   specifieke	   micro-­‐omgeving	   en	   de	   ruimtelijke	   en	   tijdelijke	  context	  van	  de	  cellen	  die	  smoc2	  tot	  expressie	  brengen.	  	  	  Om	  binnen	  de	  context	  van	  een	  gewricht	  de	  functie	  van	  Smoc2	  te	  bepalen,	  is	  het	  zebravis	   model	   minder	   geschikt.	   Aangezien	   de	   gewrichten	   van	   de	   kip	   meer	  gelijkenissen	  vertonen	  met	  die	  van	  de	  mens	   is	  het	  kippen	   ledemaat	  model	  een	  betere	  optie.	  Opdat	  we	  Smoc2	  tot	  overexpressie	  zouden	  kunnen	  brengen	  in	  het	  lidmaat	   van	   het	   kippenembryo,	   hebben	   we	   Smoc2	   in	   de	   virale	   RCAS	   vector	  gekloneerd.	   De	   gelokaliseerde	   injectie	   van	   het	   RCASBPA-­‐SMOC2	   virus	  resulteerde	   in	   een	   verstoorde	   uitgroei	   van	   het	   lidmaat.	   Onze	   preliminaire	  analyse	  wees	  op	  een	  gereduceerde	  FGF8	  expressie	  in	  de	  AER,	  waarvan	  geweten	  is	  dat	  het	  de	  uitgroei	  van	  het	  ledemaat	  controleert.	  Onze	  analyse	  laat	  niet	  toe	  om	  uit	  te	  maken	  of	  SMOC2	  de	  transcriptie	  van	  FGF8	  rechtstreeks,	  al	  dan	  niet	  via	  een	  secundaire	  interactie	  partner	  beïnvloed.	  	  In	   een	   derde	   proefdiermodel,	   hebben	  we	   het	   phenotype	   van	   de	   Smoc2-­‐/-­‐	  muis	  bestudeerd.	  De	  afwezigheid	  van	  het	  SMOC2	  proteïne	   resulteerde	   in	  een	   lethaal	  defect	  tijdens	  de	  vroege	  fasen	  van	  embryonale	  ontwikkeling.	  Mogelijks	  is	  dit	  het	  resultaat	  van	  een	  defect	  in	  het	  membraan	  van	  Reichert,	  waar	  Smoc2	  tijdens	  deze	  stadia	  tot	  expressie	  komt.	  	  Samengevat	   heeft	   ons	   werk	   bijgedragen	   tot	   nieuwe	   inzichten	   in	   de	   essentiële	  functie	   van	   SMOC2	   tijdens	   de	   embryonale	   ontwikkeling	   van	   zebravis,	   kip	   en	  muis.	  Deze	  data	  laat	  verdere	  onderzoeksprojectentoe	  om	  een	  rol	  te	  bepalen	  voor	  SMOC2	  binnen	  het	  ingewikkelde	  netwerk	  van	  signaal	  cascades.	  








	  	  	  	  	  	  
Addendum:	  
Molecular	  analysis	  of	  the	  muscle	  
phenotype	  of	  Noggin	  null	  mice	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Our	   laboratory	  has	  a	   longstanding	   interest	   in	   the	  molecular	  and	  genetic	  events	  regulating	   BMP	   signaling	   in	   the	   developing	   limb.	   One	   of	   such	   novel	   candidate	  regulators	   could	   be	   SMOC2.	   Another	   one,	   NOGGIN,	   has	   also	   been	   a	   subject	   of	  research	  interest	  of	  the	  host	  lab	  and	  was	  also	  investigated	  during	  this	  PhD	  thesis.	  Specifically,	   we	   pursued	   hitherto	   undescribed	   embryonic	   muscle	   phenotype	  present	  in	  Noggin	  null	  mice.	  	  
A.1	  Introduction	  	  
	  
A.1.1	  NOGGIN	  NOGGIN	   is	   a	   glycosylated,	   secreted	  64kDa	  protein	  homeodimer	   and	  one	  of	   the	  many	  extracellular	  antagonists	  of	  the	  BMP	  signaling	  pathway.	  Similar	  to	  Chordin,	  
Chordin-­‐like,	  Follistatin,	  Fsrp	  and	  Cerberus,	  Noggin	  encodes	  a	  protein	  that	  directly	  binds	   to	   the	  BMP	   (BMP2,	  BMP4,	  BMP5,	  BMP7)	   and	  GDF	   (GDF5,	  GDF6)	   ligands	  with	   various	   affinities,	   but	   in	   a	   picomolar	   range	   for	   BMP2	   and	   BMP4	  (Zimmerman	   et	   al.,	   1996;	  Merino	   et	   al.,	   1999;	  Gazzerro	   and	  Canalis,	   2006).	   By	  preventing	  interaction	  of	  the	  ligands	  with	  their	  receptor,	  NOGGIN	  interferes	  with	  the	  downstream	  activation	  of	  the	  signaling	  cascade.	  	  	  
Noggin	  was	   first	   identified	   in	  X.	   laevis	   based	  on	   its	   ability	   to	   induce	   secondary	  axis	   formation	   (Smith	   et	   al.,	   1993;	   Brunet	   et	   al.,	   1998;	  McMahon	   et	   al.,	   1998).	  During	   later	   developmental	   stages,	   Noggin	   is	   expressed	   in	   the	   Spemann	  organizer	   where	   it	   regulates	   the	   development	   of	   dorsal	   tissues	   (Smith	   et	   al.,	  1993;	   McMahon	   et	   al.,	   1998).	   In	   the	   mouse	   model,	   Noggin	   was	   shown	   to	   be	  initially	  expressed	  in	  the	  node	  and	  later	  restricted	  to	  the	  notochord,	  the	  floor	  and	  roof	  plates	  of	  the	  neural	  tube	  and	  the	  dermomyotome.	  The	  presence	  of	  NOGGIN	  is	   required	   for	   the	   development	   of	   the	   ectodermal	   derived	   neural	   tube,	   hair	  follicles,	  teeth,	  lens	  and	  retina	  and	  the	  mesodermal	  derived	  tissues	  like	  the	  bone,	  cartilage,	  joints	  and	  somites	  (reviewed	  in	  (Balemans	  and	  Van	  Hul,	  2002).	  	  Loss	   of	   NOGGIN	   in	   mice	   resulted	   in	   an	   embryonic	   lethal	   phenotype	   that	   is	  characterized	   by	   different	   developmental	   defects	   such	   as	   exencephaly,	   axial	  outgrowth	   defects	   with	   a	   loss	   of	   the	   caudal	   vertebrae,	   failure	   of	   neural	   tube	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closure,	  excessive	  cartilage	  formation	  and	  fused	  joints	  to	  mention	  a	  few	  (Fig	  A1)	  (Brunet	   et	   al.,	   1998).	   In	   addition,	   our	   lab	   has	   discovered	   a	   late	   onset	   muscle	  defect.	  	  	  
	  
Fig	  A1:	  Noggin	  null	  mice	  present	  multiple	  developmental	  defect	  A-­‐B.	  Newborn	   littermates	  of	  a	  Noggin+/-­‐	  mating.	  The	  Noggin-­‐/-­‐	  embryo	  presents	  hemorrhages,	  shorter	  and	  thicker	   limbs,	   exencephaly,	   and	   loss	   of	   caudal	   vertebrae.	   C-­‐D:	   Skeletal	   staining	   of	   the	   forelimb	   of	   18	   dpc	  embryos	  displayed	  joint	  fusions	  and	  excessive	  cartilage	  and	  bone	  formation	  	  	  
A.1.2	  Mouse	  embryonic	  muscle	  development	  During	   embryonic	   development,	   the	   lateral	   plate	   mesoderm	   segments	   into	  bilaterally	  organized	  somites.	  This	  temporary	  tissue	  further	  differentiates	  into	  a	  ventral-­‐medial	   part,	   called	   the	   sclerotome,	   and	   a	   dorsal-­‐lateral	   part,	   called	   the	  dermomyotome.	  The	  sclerotome	  gives	   rise	   to	   the	  cartilage	  and	   the	  bone	  of	   the	  vertebral	   column,	   while	   the	   dermomyotome	   develops	   into	  muscle,	   endothelia,	  cartilage,	  connective	  tissue	  and	  dermis	  (Fig	  A3).	  	  At	   9.5	   dpc,	   PAX3	   positive	   cells	   at	   the	   epaxial	   and	   the	   hypaxial	   lip	   of	   the	  dermomyotome	   delaminate	   and	   migrate	   inwards	   to	   form	   an	   underlying	   cell	  population,	  the	  myotome	  (Fig	  A3).	  This	  cell	  population	  will	  eventually	  give	  rise	  to	   the	  muscles	   of	   the	   back	   and	   the	   trunk.	   At	   the	   limb	   level	   however,	   the	   cells	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from	   the	  hypaxial	  dermomyotome	  delaminate	   and	  migrate	   into	   the	  developing	  limb	  bud,	  where	  they	  will	  start	  differentiating	  into	  the	  muscles	  of	  the	  limb.	  At	   10.5-­‐12.5	   dpc,	   the	   first	   wave	   of	  myogenesis	   (embryonic	  myogenesis)	   takes	  place	  (Fig	  A2).	  Embryonic	  myoblasts	  fuse	  with	  each	  other	  and	  differentiate	  into	  a	  large	  primary	  myofibers.	  As	  most	  of	   the	  myoblasts	   remain	   in	  a	   committed	  and	  undifferentiated	   state,	   the	   number	   of	  myofibers	   produced	   in	   this	   first	  wave	   is	  limited.	  These	  primary	  myofibers	  serve	  to	  form	  the	  basic	  muscle	  pattern.	  These	  primary	   fibers	  will	   then	   trigger	   the	   proliferation	   of	   the	   fetal	  myoblasts,	  which	  will	  give	  rise	  to	  many	  smaller	  secondary	  myofibers	  during	  the	  secondary	  wave	  of	  myogenesis	  (14.5-­‐16.5	  dpc),	  or	  fetal	  myogenesis	  (Fig	  A2).	  Next	   to	   these	   types	  of	  myoblasts	   and	  myofibers,	   some	  cells	   stay	  PAX7	  positive	  and	  stay	  in	  an	  undifferentiated	  state	  (Fig	  A2).	  These	  cells	  are	  present	  from	  early	  stage	   onwards	   and	   give	   rise	   to	   fetal	  myoblasts.	   However,	  when	   PAX7	   positive	  cells	  can	  be	  morphologically	  identified	  as	  mononucleated	  cells	  residing	  between	  the	  myofiber	  plasma	  membrane	  and	  the	  basal	  lamina	  (17,5	  dpc),	  they	  are	  called	  satellite	   cells.	   These	   cells	   form	   the	   stem	   cell	   niche	   of	   the	   muscle	   and	   are	  responsible	  for	  the	  growth	  and	  restoration	  of	  the	  muscle	  following	  triggers	  like	  trauma	  or	  physical	  exercise	  during	  postnatal	  stages.	  	  	  
	  
Figure	  A2:	  Timing	  of	  differentiation	  of	  different	  muscle	  cell	  populations	  Embryonic	   myoblasts	   give	   rise	   to	   large	   primary	   fibers,	   while	   fetal	   myoblasts	   differentiate	   into	   small	  secondary	   fibers.	   Mitogens,	   secreted	   by	   the	   embryonic	   myoblasts,	   promote	   the	   proliferation	   of	   fetal	  myoblasts.	   Further	   differentiation	   of	   these	   fetal	   myoblasts	   is	   regulated	   by	   BMP	   signaling.	   A	   third	   cell	  population	  of	  Pax7	  positive	  cells	  is	  able	  to	  develop	  into	  both	  primary	  and	  secondary	  fibers	  or	  satellite	  cells.	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A.1.3	  Molecular	  regulation	  of	  myogenesis.	  One	  of	  the	  earliest	  indications	  of	  myogenic	  commitment	  is	  the	  expression	  of	  Pax3	  and	   Pax7	   in	   the	   dermomyotome	   (Fig	   A3).	   PAX3	   is	   required	   for	   somite	  segmentation,	   (dermo)myotome	  formation	  and	   limb	  musculature	  development,	  whereas	  PAX7	  is	  necessary	  for	  the	  maintenance	  of	  adult	  satellite	  cells	  (Bober	  et	  al.,	   1994;	   Goulding	   et	   al.,	   1994;	   Seale	   et	   al.,	   2000;	   Tajbakhsh	   and	  Buckingham,	  2000;	  Schubert	  et	  al.,	  2001;	  Oustanina	  et	  al.,	  2004;	  Relaix	  et	  al.,	  2004;	  Relaix	  et	  al.,	  2005;	  Relaix	  et	  al.,	  2006;	  Frantz	  et	  al.,	  2010).	  	  During	   the	   process	   of	   differentiation,	   the	   myogenic	   cells	   lose	   their	   Pax3/7	  expression	  and	  begin	  expressing	  myogenic	  regulatory	   factors	  (MRF)	   like	  MyoD,	  
Myf5,	   Myf6,	   and	   Myogenin	   (Fig	   A3).	   These	   are	   helix-­‐loop-­‐helix	   proteins	   that	  regulate	  the	  further	  development	  of	  the	  skeletal	  muscle	  (Sabourin	  and	  Rudnicki,	  2000;	  Bentzinger	  et	  al.,	  2012).	  Upon	  association	  with	  the	  ubiquitously	  expressed	  E-­‐proteins,	   the	  MRFs	   can	  bind	   to	   specific	  DNA	  motifs	   (E-­‐boxes)	   to	   activate	   the	  transcription	  of	  their	  target	  genes.	  Using	  knockout	  mouse	  models,	  it	  was	  shown	  that	   not	   all	  MRFs	   are	   required	   for	   normal	  muscle	   development	   and	   individual	  MRFs	   are	   unable	   to	   completely	   substitute	   for	   each	   other.	   Single	   knockouts	   for	  
MyoD,	  Myf5	  and	  Myf6	  were	  able	   to	  develop	  normal	  muscle	  although	  with	  some	  delays,	  while	   the	   loss	  of	  Myogenin	   resulted	   in	  perinatal	   lethal	  phenotypes	  with	  severe	   muscle	   defects.	   Double	   knockouts	   however,	   resulted	   in	   more	   dramatic	  defects	  (Braun	  et	  al.,	  1992;	  Rudnicki	  et	  al.,	  1992;	  Hasty	  et	  al.,	  1993;	  Nabeshima	  et	  al.,	  1993;	  Rudnicki	  et	  al.,	  1993;	  Braun	  and	  Arnold,	  1995;	  Arnold	  and	  Braun,	  1996;	  Rawls	  et	  al.,	  1998).	  Furthermore,	  MYOD	  and	  MYF5	  appeared	  to	  regulate	  the	  early	  stages	  of	  myoblast	  determination,	  while	  MYF6	  and	  MYOGENIN	  were	  required	  for	  the	  further	  differentiation.	  	  Once	   the	   progenitor	   population	   is	   determined	   and	   differentiation	   is	   initiated,	  post-­‐mitotic	   myoblasts	   will	   adhere,	   align	   and	   fuse	   in	   order	   to	   generate	  multinucleated	   myofibers.	   In	   addition,	   the	   expression	   of	   Myosin	   heavy	   chain	  (MHC),	  Actin	  and	  Desmin	  among	  others	  contributes	  to	  the	  development	  of	  a	  fully	  differentiated	  muscle	  with	  a	  functional	  contractile	  apparatus.	  	  	  The	   dermomyotomal	   and	   sclerotomal	   somitic	   populations	   are	   subject	   to	   the	  crosstalk	  of	  WNT,	  SHH,	  and	  BMP	  signaling	  cascades,	  which	  ensures	  an	  intricate	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balance	   that	   allows	   for	   a	   regulated	   differentiation	   of	   these	   lineages	   (Fig	   A3)	  (http://www.rndsystems.com/resources/images/5834.pdf).	   WNT	   signaling	  from	  the	  overlying	  epidermis	  and	   the	  roof	  plate	  of	   the	  neural	   tube	   induces	   the	  expression	   of	   dermomyotome	   specific	   genes,	   while	   SHH	   signaling	   from	   the	  notochord	   and	   the	   floor	   plate	   of	   the	   neural	   tube	   induces	   sclerotomal	   gene	  expression.	   In	   addition,	  Bmp	   expression	   in	   the	   epidermis,	   the	   roof	   plate	   of	   the	  neural	   tube	   and	   the	   lateral	   plate	   mesoderm	   prevents	   the	   differentiation	   of	  myogenic	   precursors	  while	  NOGGIN,	   present	   in	   the	   roof	   and	   floor	   plate	   of	   the	  neural	   tube,	   blocks	   this	   BMP	   action	   and	   therefore	   allows	   for	   the	   myogenic	  precursors	   to	   differentiate	   (Yusuf	   and	   Brand-­‐Saberi,	   2006).	   This	   balance	  between	   multiple	   signaling	   pathways	   results	   in	   the	   restricted	   expression	   of	  MRFs	  and	  Pax	  genes	  in	  the	  proper	  cell	  populations	  (Fig	  A2).	  	  
	  
Figure	  A3:	  Overview	  of	  the	  anatomy	  and	  signaling	  events	  in	  the	  somite	  Schematic	  representation	  of	  transversal	  section	  of	  embryonic	  myogenic	  induction	  at	  early	  (A)	  and	  late	  stage	  (B)	  of	  myogenic	  induction.	  
	  Besides	   its	   role	  during	   the	  patterning	  of	   the	   somite,	  BMP	  signaling	   also	   affects	  the	   differentiation	   of	   myofibers.	   The	   effect	   of	   BMP	   signaling	   was	   shown	   to	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depend	   on	   the	   developmental	   stage	   and	   the	   progression	   along	   the	   myogenic	  program.	   The	   differentiation	   of	   embryonic	   myoblasts	   was	   shown	   to	   be	  insensitive	   to	   BMP	   signals,	  whereas	   the	   fetal	  myoblasts	   and	   the	   PAX7	  positive	  precuresors	   require	   a	   decrease	   of	   the	   BMP	   signaling	   in	   order	   to	   allow	   further	  myogenic	  differentiation	  (Fig	  A2).	  One	  of	   the	   tissues	   severely	   affected	   in	  Noggin-­‐/-­‐	  mice	   is	   the	  developing	  muscle.	  This	  phenotype	  has	  not	  been	  reported	  to	  date	  and	  this	  part	  of	  my	  thesis	  focused	  on	  the	  molecular	  basis	  of	  this	  defect.	  	  
A.2	  Results	  	  
A.2.1	  Muscle	  phenotype	  in	  Noggin-­‐/-­‐	  embryos	  The	  Noggin-­‐/-­‐	  mice	  presented	  a	  muscle	  defect	  during	  the	  final	  stages	  of	   in	  utero	  development.	   As	   the	   embryos	   display	   an	   excessive	   chondrogenesis,	   the	   size	   of	  the	  muscles	   in	   the	  Noggin-­‐/-­‐	   embryos	   is	   reduced	   from	  early	  stages	  onwards.	  At	  18.5	   dpc,	   the	   Noggin-­‐/-­‐	   embryos	   displayed	   a	   dramatic	   muscle	   phenotype	  characterized	   by	   disorganized	   myofibers	   that	   failed	   to	   align.	   In	   addition,	   the	  number	   of	   multinucleated	   myofibers	   appeared	   reduced,	   more	   mononucleated	  myoblasts	  were	  found	  (arrowheads	  in	  Fig	  A3D)	  and	  the	  nuclei	  failed	  to	  migrate	  towards	   the	  plasma	  membrane	   in	   the	  Noggin	   null	  muscles.	  When	   tracing	  back	  the	   defect	   at	   earlier	   stages	   of	   development,	   we	   could	   not	   detect	   any	   of	   these	  defects	   at	   16.5	   dpc,	   indicating	   that	   between	   16.5	   dpc	   and	   18.5	   dpc	   (fetal	  myogenesis)	  the	  loss	  of	  Noggin	  had	  a	  dramatic	  effect.	  	  	  
	  
Figure	  A3:	  Noggin-­‐/-­‐	  embryos	  display	  a	  dramatic	  muscle	  defect	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A-­‐F.	  Newborn	   littermates	  of	  a	  Noggin+/-­‐	  mating.	  H&E	  staining	  on	  sagittal	  sections	  through	  the	   limb	  shows	  the	  excessive	  chondrogenesis	  and	  the	  disorganization	  of	   the	  muscle	   fibers	   in	   the	  Noggin-­‐/-­‐	  embryos	  (A-­‐D).	  Same	  section	  of	  C	  and	  D	  under	  polarized	  light	  (E-­‐F).	  Adapted	  from	  (Tylzanowski	  et	  al.,	  2006)	  	  
A.2.2	  Selection	  of	  a	  muscle	  To	   be	   able	   to	   correctly	   compare	   Noggin	   null	   muscles	   with	   their	   wild	   type	  littermates,	  we	  needed	  to	  select	  anatomically	  the	  same	  muscle	  in	  both	  genotypes.	  Therefore	  we	  performed	  H&E	  stainings	  and	  compared	  the	  anatomy	  of	  the	  limbs.	  As	   the	   limbs	   of	   the	  Noggin	   null	   mouse	   were	   shorter	   and	   thicker	   and	   had	   an	  excess	   of	   cartilage,	   the	   identification	   of	   the	   different	  muscles	  was	   not	   evident.	  Using	   the	   Jatlasviewer	   (www.emage.org),	   we	   could	   identify	   the	   same	   muscle	  (musculus	  flexor	  carpi	  ulnaris)	  identifiable	  in	  the	  control	  and	  the	  Noggin-­‐/-­‐	  limbs	  (Fig	  A4).	  We	  focused	  on	  three	  different	  stages	  of	  fetal	  myogenesis	  as	  the	  defect	  developed	   during	   this	   phase	   of	   muscle	   development.	   Specifically,	   we	   isolated	  limbs	  at	  the	  stage	  at	  which	  there	  was	  no	  apparent	  defect	  (16.5	  dpc),	  a	  dramatic	  defect	  (18.5	  dpc)	  and	  the	  stage	  in	  between	  (17.5	  dpc).	  	  	  
	  
Figure	  A4:	  Identification	  of	  the	  musculus	  flexor	  carpi	  ulnaris	  A-­‐F:	  H&E	  staining	  on	  sagittal	  sections	  of	  the	  limbs	  at	  the	  indicated	  stages	  and	  genotype.	  The	  musculus	  flexor	  carpi	   ulnaris	   is	   digitally	   indicated	   in	   green.	   H-­‐I.	   The	   limb	   at	   15-­‐16	   dpc	   using	   Jatlasviewer.	   The	  musculus	  flexor	  carpi	  ulnaris	  is	  colored	  in	  red.	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A.2.3	  Morphological	  analysis	  To	  further	  visualize	  the	  difference	  in	  the	  myofiber	  morphology,	  we	  performed	  an	  Actin	  staining	  using	  Phalloidin	  and	  measured	  the	  thickness	  of	  the	  myofibers.	  As	  indicated	  before,	  no	  difference	  in	  the	  overall	  morphology	  of	  the	  muscle	  could	  be	  detected	  at	  16.5	  dpc.	  During	  later	  stages	  however,	  a	  decrease	  in	  the	  thickness	  of	  the	  muscle	  fiber	  was	  apparent	  (Fig	  A5).	  	  	  
	  
	  
Figure	  A5:	  Analysis	  of	  the	  muscle	  fiber	  thickness	  A-­‐F:	  Actin	  immunofluorescence	  on	  cross-­‐sections	  of	  muscles	  at	  the	  indicated	  stages.	  G:	  Quantification	  using	  ImageJ	  of	   the	   thickness	  of	   the	   fiber.	  Values	  plotted	  as	  mean	  ±	  SEM;	  over	  100	   fibers	  of	  at	   least	  3	  different	  mice	  embryos	  were	  analyzed	  per	  condition;	  *p<0.05	  	  
A.2.4	  BMP	  signaling	  As	   NOGGIN	   is	   a	   BMP	   antagonist,	   we	   hypothesized	   that	   this	   phenotype	   could	  result	   in	  an	  overactivation	  of	   the	  BMP	  signaling.	  Therefore	  we	   investigated	   the	  activation	   of	   the	   SMAD	   1/5/8	   proteins	   and	   the	   expression	   level	   of	   different	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immediate	   BMP	   target	   genes	   in	   the	   developing	   limbs	   with	   the	   focus	   on	   the	  developing	  muscle.	  The	  immunohistochemical	  analysis	  for	  the	  phosphorylated	  SMAD	  1/5/8	  showed	  an	  apparent	   increase	  of	  SMAD	  activation	   from	  16.5	  dpc	  onwards.	   Interestingly,	  the	  morphological	  muscle	  defects	  could	  only	  be	  detected	  from	  17.5	  dpc	  onwards	  (Fig	   A6A).	   The	   expression	   of	   immediate	   BMP	   target	   genes	  was	   analyzed	   using	  qPCR	  at	  16.5	  dpc	  and	  indicated	  that	  two	  of	  them,	  Id3	  and	  Msx1,	  were	  significantly	  upregulated	  (Fig	  A6B).	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Figure	  A6:	  Analysis	  of	  the	  BMP	  signaling	  pathway	  A.	  Quantification	  of	  P-­‐SMAD	  1/5/8	  immunohistochemistry	  on	  sagittal	  sections.	  B-­‐E.	  Immunohistochemistry	  for	  P-­‐SMAD1/5/8	  in	  Noggin+/+	  and	  Noggin-­‐/-­‐	  16.5	  dpc	  limbs.	  Muscle	  is	  delineated	  in	  red,	  cartilage	  and	  bone	  in	  blue.	  D-­‐E.	  Blowout	  of	  muscle	  area	  delineated	  in	  black	  in	  B	  and	  C.	  Scale	  bar:	  100	  μm.	  F.	  qPCR	  analysis	  of	  BMP	  target	  genes	  at	  E16.5.	  Values	  plotted	  as	  mean	  ±	  SEM;	  n=5;	  *p<0.05	  
	  
A.2.5	  Proliferation	  Since	  a	  decrease	  in	  the	  size	  of	  the	  muscle	  could	  have	  been	  caused	  by	  a	  change	  in	  the	   rate	   of	   proliferation	   and	   it	   was	   shown	   previously	   that	   BMP	   signaling	   can	  change	  the	  rate	  of	  proliferation	  (Wang	  et	  al.,	  2010),	  we	  analyzed	  the	  cell	  mitotic	  activity	  using	  a	  KI67	  antibody.	  Despite	   the	  difference	   in	  size	  of	   the	  muscle	  and	  thickness	  of	  the	  fibers,	  no	  significant	  difference	  in	  the	  cell	  proliferation	  could	  be	  detected	  in	  the	  Noggin	  null	  muscle	  (Fig	  A7).	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Figure	  A7:	  Analysis	  of	  the	  mitotic	  activity	  A	  Quantification	  of	  KI67	   immunohistochemistry	  on	   sagittal	   sections.	  Values	  plotted	  as	  mean	  ±	   SEM;	  n=5;	  *p<0.05.	   B-­‐E:	   Immunohistochemistry	   for	   KI67	   in	   Noggin+/+	   and	   Noggin-­‐/-­‐	   16.5	   dpc	   limbs.	   Muscle	   is	  delineated	   in	   red,	   cartilage	  and	  bone	   in	  blue.	  D-­‐E.	  Blowout	  of	  muscle	  area	  delineated	   in	  black	   in	  B	  and	  C.	  Scale	  bar:	  100	  μm.	  	  
A.2.6	  PAX7	  positive	  progenitor	  cells	  Next	  to	  the	  contribution	  of	  the	  embryonic	  and	  the	  fetal	  myoblast,	  a	  third	  type	  of	  cells,	  the	  PAX7	  positive	  cells,	  contributes	  to	  the	  development	  of	  a	  muscle.	  During	  postnatal	  stages,	   they	  were	  shown	  to	  be	  responsible	   for	   further	  muscle	  growth	  and	  regeneration	  upon	  trauma,	  but	  also	  during	  embryonic	  stages	  they	  contribute	  significantly	  to	  the	  development	  of	  muscle	  (Kassar-­‐Duchossoy	  et	  al.,	  2005;	  Relaix	  et	   al.,	   2005).	   Therefore	   we	   decided	   to	   investigate	   this	   cell	   population.	  Interestingly,	   the	   number	   of	   PAX7	   positive	   cells	   was	   progressively	   reduced	   in	  
Noggin-­‐/-­‐	  muscles	  (Fig	  A8).	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Figure	  A8:	  Analysis	  of	  the	  satellite	  cells	  	  A.	  Quantification	  of	  PAX7	  immunohistochemistry	  on	  sagittal	  sections.	  Values	  plotted	  as	  mean	  ±	  SEM;	  n≤5;	  *p<0.05.	  B-­‐E.	  Immunohistochemistry	  for	  PAX7	  in	  Noggin+/+	  and	  Noggin-­‐/-­‐	  18	  dpc	  limbs.	  Muscle	  is	  delineated	  in	  red,	  cartilage	  and	  bone	  in	  blue.	  D-­‐E.	  Blowout	  of	  muscle	  area	  delineated	  in	  black	  in	  B	  and	  C.	  Scale	  bar:	  100	  μm.	  
A.3	  Discussion	  	  While	  analyzing	  the	  Noggin	  null	  phenotype,	  we	  discovered	  a	  hitherto	  unreported	  muscle	  defect.	  Interestingly,	  the	  defect	  reported	  here	  has	  a	  late	  onset,	  indicating	  that	   the	   initial	   muscle	   induction	   and	   formation	   occurs	   normally.	   At	   the	   later	  stages	  however,	  when	  the	  muscle	  acquire	  more	  mass,	  it	  becomes	  sensitive	  to	  the	  absence	  of	  NOGGIN.	  Our	  analysis	  indicated	  that	  the	  loss	  of	  NOGGIN	  in	  the	  mouse	  embryonic	   muscle	   resulted	   in	   an	   increased	   BMP	   signaling	   together	   with	   a	  decrease	  in	  the	  relative	  number	  of	  PAX7	  positive	  cells.	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A.3.1	  The	  effect	  of	  BMP	  signaling	  Our	  analysis	  indicated	  that	  the	  loss	  of	  NOGGIN	  during	  embryonic	  stages	  resulted	  in	  an	  increased	  Bmp	  signaling.	  Molecularly,	  the	  inhibitory	  effect	  of	  BMP	  signaling	  on	  the	  myogenic	  program	  was	  suggested	  to	  be	  a	  result	  of	  the	  sequestering	  of	  the	  E-­‐proteins	   by	   the	   immediate	  BMP	   target	   genes	   (Id1,	  2,	  3)	   (Clever	   et	   al.,	   2010).	  Thereby	   the	   ID	   proteins	   block	   the	   MRF-­‐mediated	   activation	   of	   the	   myogenic	  program,	  which	   is	   dependent	   on	   the	   binding	   of	   the	  MRFs	   to	   these	   E-­‐proteins.	  Furthermore,	   MSX1	  was	   shown	   to	   block	   celullar	   differentiation	   by	   preventing	  cell	  cycle	  exit	  and	  to	  antagonize	  the	  myogenic	  activity	  of	  PAX3	  in	  migrating	  limb	  muscle	  precursors	  (Bendall	  et	  al.,	  1999;	  Hu	  et	  al.,	  2001;	  Hughes,	  2001;	  Perk	  et	  al.,	  2005).	  Since	  the	  BMP	  target	  genes	  are	  upregulated	  in	  the	  Noggin	  null	  mice,	  the	  sequestering	  of	  the	  E-­‐proteins,	  the	  inhibition	  of	  cell	  cycle	  exit	  and/or	  the	  loss	  of	  differentiation	   of	   the	   migrating	   limb	   precursors	   are	   all	   potential	   mechanisms	  underlying	  the	  Noggin	  null	  muscle	  phenotype.	  The	  BMP	  signaling	  was	  shown	  to	  regulate	   the	  patterning	  of	   the	  somite	  and	  the	  myogenic	  program,	  thus	  a	  muscle	  defect	  in	  BMP	  antagonist	  mutants	  could	  have	  been	   anticipated.	   However,	   the	   extent	   of	   the	  muscle	   defect	   in	   the	  Noggin	   null	  mice	  was	  far	  greater	  than	  reported	  for	  other	  BMP	  antagonist	  mutants	  (Matzuk	  et	  al.,	  1995).	  Reshef	  et	  al	  did	  suggest	  that	  the	  epaxial	  musculature	  in	  the	  Noggin	  null	  mice	  was	  largely	  absent	  in	  the	  posterior	  of	  the	  embryo,	  but	  next	  to	  a	  suggestion	  that	  NOGGIN	  plays	   an	   important	   role	   in	  muscle	   formation	   no	   further	   research	  was	  conducted	  on	  the	  muscles	  of	  the	  Noggin	  null	  mice	  (Reshef	  et	  al.,	  1998).	  Yet	  our	  study	  is	  the	  first	  one	  to	  investigate	  the	  muscle	  defect	  in	  Noggin	  null	  mice	  and	  our	  data	  show	  that	  the	  Noggin	  null	  mouse	  models	  the	  numerous	  in	  vitro	  data	  on	  the	   inhibitory	   effect	   of	   BMP	   signaling	   on	   fetal	   myoblast	   and	   satellite	   cell	  differentiation	  in	  an	  in	  vivo	  setting.	  	  	  
A.3.2	  The	  importance	  of	  timing	  the	  BMP	  signaling	  In	   vitro,	   BMP	   signaling	   was	   shown	   to	   balance	   the	   proliferation	   and	  differentiation	   of	   satellite	   cells.	   Upon	   differentiation,	   BMP	   signaling	   is	  downregulated	   resulting	   in	   the	   activation	   of	   the	   myogenic	   program	   and	  formation	   of	   myofibers	   (Friedrichs	   et	   al.,	   2011;	   Ono	   et	   al.,	   2011).	   In	   contrast,	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when	  BMP	  was	   applied	   ectopically	   in	   the	   chicken	  wing,	   the	   number	   of	  muscle	  fibers	  and	  PAX7	  positive	  cells	  increased	  (Amthor	  et	  al.,	  1999;	  Wang	  et	  al.,	  2010).	  However,	  when	  BMP	  was	  applied	  during	  earlier	  stages	  of	  chicken	  development,	  similar	  chondrogenesis	  and	  myogenesis	  defects	  were	  seen	  as	  in	  the	  Noggin	  null	  mice	   (Duprez	   et	   al.,	   1996a;	  Duprez	   et	   al.,	   1996b).	   Potentially	   the	   timing	   of	   the	  application	   of	   the	   ectopic	   signal	   determines	   the	   response	   and	   explains	   the	  different	  results.	  	  
A.3.3	  Intrinsic	  differences	  within	  the	  myogenic	  lineage	  It	  was	  suggested	  that	  cells	  in	  the	  same	  somitic	  environment	  could	  have	  different	  intrinsic	  properties	  as	  they	  respond	  differently	  to	  the	  same	  signals	  (Biressi	  et	  al.,	  2007).	  For	  example,	  embryonic	  myoblasts	  were	  shown	  to	  be	  insensitive	  to	  BMP	  signaling	  allowing	  them	  to	  stop	  proliferating	  and	  differentiate	   into	   the	  primary	  myofibers.	  For	  fetal	  myoblasts	  and	  satellite	  cells,	  however,	  it	  was	  shown	  that	  the	  level	   of	  BMP	   signaling	  has	   to	  be	   reduced,	   by	   either	   reducing	   the	   expression	  of	  BMP	   ligands,	   or	   antagonizing	   the	   signaling,	   in	   order	   to	   let	   differentiation	   and	  fusion	   into	   secondary	   fibers	   occur.	   This	   potentially	   explains	   our	   phenotype	   as	  the	  increased	  Bmp	  signaling	  in	  the	  Noggin-­‐/-­‐	  muscle	  would	  have	  no	  effect	  on	  the	  differentiation	  of	  the	  primary	  fibers,	  but	  inhibits	  the	  generation	  of	  the	  secondary	  fibers.	  Therefore	  the	  fetal	  myoblasts,	  which	  normally	  give	  rise	  to	  the	  secondary	  fibers	  maintain	  their	  committed	  but	  undifferentiated	  state.	  Indeed,	  we	  observed	  numerous	   mononucleated	   myoblasts	   in	   the	   Noggin	   null	   muscle,	   concomittant	  with	   a	   reduction	   of	  multinucleated	  myofibers.	   The	   limited	   number	   of	   primary	  fibers	   that	   is	   formed	  might	   therefore	   be	   unable	   to	   compensate	   for	   the	   loss	   of	  secondary	  myofibers	  resulting	  in	  a	  muscle	  that	  fails	  to	  maintain	  its	  organization.	  	  Alternatively,	  as	  in	  vitro	  evidence	  indicated	  that	  addition	  of	  BMP	  proteins	  to	  the	  medium	   of	   C2C12	   cells,	   a	   rodent	   myoblast	   cell	   lineage,	   resulted	   in	   the	  transdifferentiation	  of	  muscle	  cells	  into	  cells	  of	  the	  chondrogenic	  and	  osteogenic	  lineages	   one	   could	   hypothesize	   that	   a	   number	   of	   muscle	   progenitor	   cells	   are	  drawn	  into	  the	  chondrogenic	  lineage	  in	  the	  Noggin	  null	  limb	  (Murray	  et	  al.,	  1993;	  Katagiri	  et	  al.,	  1994).	  This	  would	  deplete	  the	  pool	  of	  muscle	  precursors	  in	  a	  way	  that	   initially	   enough	   cells	   are	   left	   to	   maintain	   the	   muscle	   organization,	   but	   at	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later	  stages,	  when	  the	  muscles	  grow	  rapidly,	  there	  are	  not	  enough	  cells	  to	  supply	  the	  muscle	  with	  cells.	  	  Taken	  together,	  the	  loss	  of	  NOGGIN	  induces	  a	  SMAD-­‐dependent	  increase	  in	  BMP	  signaling	   that	   results	   in	   an	   inhibition	   of	   fetal	   myoblast	   differentiation	   and	   a	  reduction	   in	   the	   number	   of	   satellite	   cells,	   which	   causes	   a	   severe	   late	   onset	  muscle	  defect.	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A.4	  Materials	  and	  Methods	  
	  
A.4.1	  Embryo	  processing	  Mice	  were	  sacrificed	  and	  embryos	  were	  collected	  at	  16.5,	  17.5	  and	  18	  days	  post	  coitus.	   Forelimbs	   were	   isolated	   using	   forceps	   and	   subsequently	   embedded	   in	  Tissue-­‐Tek	   (Laborimpex),	   snap	   frozen	   in	   liquid	   nitrogen	   and	   stored	   at	   -­‐80°C.	  Hindlimbs	   were	   processed	   for	   LacZ	   genotyping.	   Frozen	   sections	   (5µm)	   for	  immunological	   staining	   and	   histological	   staining	   (Haematoxylin	   and	   eosin;	  standard	  protocol)	  were	  made	  using	  a	  cryostat	  (Prosan).	  	  	  
A.4.2	  LacZ	  genotyping	  Hindlimbs	   were	   fixed	   in	   4%PFA/PBS	   for	   10	   minutes	   and	   washed	   twice	   with	  LacZ1	  solution	  (PBS,	  2mM	  MgCl2,	  5mM	  EGTA)	  for	  10	  minutes	  at	  RT,	  followed	  by	  another	  washing	  step	  with	  LacZ2	  (PBS,	  0.1M	  Na3PO4,	  2mM	  MgCl2,	  0.01%	  sodium	  deoxycholate,	   0.02%	   NP-­‐40;	   pH	   7.2-­‐7.4)	   for	   5	   minutes	   at	   RT.	   Staining	   was	  performed	   by	   applying	   staining	   solution	   (5mM	   K3Fe(CN)6,	   5mM	   K4Fe(CN)6,	  0.5mg/ml,	  X-­‐gal	  in	  LacZ2	  buffer	  for	  2-­‐3	  hours	  at	  37°C	  or	  ON	  at	  RT.	  After	  washing	  steps	  with	  PBS	  and	  clearing	  with	  2%	  KOH,	  limbs	  were	  treated	  with	  an	  increasing	  gradient	  of	  glycerol/KOH	  before	  storage.	  
	  
A.4.3	  Immunohistochemistry	  Phalloidin	  Staining	  was	  performed	  using	  manufacturers	  protocol.	  P-­‐SMAD	  Frozen	   sections	   were	   fixed	   with	   methanol	   for	   10	   minutes	   at	   -­‐20°C.	   After	  quenching	   in	   3%	   H202/MQ	   and	   washing	   in	   TBST,	   antigen	   retrieval	   was	  performed	   with	   sodium	   citrate	   buffer	   (pH6),	   followed	   by	   additional	   washing	  with	  TBST.	  Sections	  were	  blocked	  with	  Normal	  Goat	  Serum	  (Millipore)	   (1/5	   in	  TBST)	   and	   O/N	   incubated	   with	   the	   primary	   antibody	   (P-­‐SMAD	   1/5/8,	   Cell	  Signaling,	   9511S;	   1/100)	   at	   4°C.	   After	   washing,	   the	   biotinylated	   secondary	  antibody	  was	   applied	   for	   30	  minutes	   at	  RT.	   The	   signal	  was	   amplified	  with	   the	  ABC	   reagent	   (Vectastain,	   dilution	   according	   to	  manufacturers	   protocol)	   for	   30	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minutes	   at	   RT.	   After	   washing,	   the	   color	   was	   developed	   using	   DAB	   (DAKO,	  dilution	  according	  to	  manufacturers	  protocol)	  and	  sections	  were	  mounted	  using	  Pertex.	  	  Ki67	  and	  PAX7	  The	   P-­‐SMAD	   protocol	   was	   used	   with	   following	   modifications.	   Frozen	   sections	  were	   fixed	   with	   ethanol	   and	   methanol	   for	   5	   minutes	   and	   quenched	   in	   0.5%	  H202/MeOH.	  Washing	  steps	  were	  performed	  with	  PBS,	  a	  KI67	  antibody	  (DAKO	  TEC3;	   1/100)	   or	   PAX7	   antibody	   (DSHB,	   Kawakami	   Atushi,	   Yokohama,	   Japan;	  1/400)	  was	  used	  and	  blocking	  was	  done	  with	  10%NGS/PBS.	  	  Quantification	  ImageJ	   software	   was	   used	   for	   measuring	   the	   muscle	   fiber	   thickness	   and	   the	  quantification	   of	   the	   percentage	   of	   P-­‐SMAD,	   KI67	   or	   PAX7	   positive	   cells.	   The	  significance	  of	  the	  difference	  in	  expression	  was	  analyzed	  using	  the	  Student’s	  T-­‐test.	  	  
A.4.4	  qPCR	  RNA	  was	  isolated	  by	  scraping	  the	  muscles	  of	  at	  least	  10	  frozen	  sections	  16.5	  dpc	  embryonic	  limbs	  using	  the	  High	  Pure	  RNA	  Isolation	  Kit	  (Roche	  Applied	  Science).	  At	   least	   three	   RNA	   isolations	  were	   performed	   per	   condition	   and	   subsequently	  reverse	   transcribed	   using	   Primescript	   RT	   Reagent	   (Takara;	   manufacturers	  protocol).	  Real-­‐time	  PCR	  was	  performed	  in	  duplicate	  with	  gene	  specific	  primers	  (Table	  A1)	  with	  SYBR	  Premix	  Ex	  Taq	  II	  (Takara;	  manufacturers	  protocol)	  using	  Rotor-­‐gene	   6000	   detection	   system	   (Corbett	   Research,	   Westburg).	   Gene	  expression	  was	  normalized	  to	  the	  housekeeping	  gene	  Hprt1	  and	  presented	  as	  a	  ratio	   to	   control	   embryos.	   The	   significance	   of	   the	   difference	   in	   expression	  was	  analyzed	  using	  the	  Student’s	  T-­‐test.	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Gene	   Primer	  sense	  5’-­‐3’	   Primer	  antisense	  5’-­‐3’	  
Hprt1	   TGCTGACCTGCTGGATTACA	   TATGTCCCCCGTTGACTGAT	  
Id1	   GAGTCTGAAGTCGGGACCAC	   AACACATGCCGCCTCGG	  
Id2	   CCTGCATCACCAGAGACCTG	   GGGAATTCAGATGCCTGCAA	  
Id3	   TGCAGCGTGTCATAGACTACA	   TGAGCTCAGCTGTCTGGATCG	  
Msx1	   GCCAGAAGATGCTCTGGTGA	   TCAGCCGTCTGGCTGGG	  
Msx2	   GCCTCGGTCAAGTCGGAAAA	   GGCTCATATGTCTGGGCGG	  
Noggin	   GGGGCGAAGTAGCCATAAAG	   GGGGCGAAGTAGCCATAAAG	  
Table	  A1:	  Primer	  sequences	  used	  for	  qPCR	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